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ABSTRACT
Electroanalytical and Chromatographic Investigations of the 
Antineopiastic Agent Cisplatin and Related Species
Paula Shearan
The analysis of cisplatin has been investigated using 
a variety of electrochemical and chromatographic techniques.
Methods were developed for the simultaneous 
determination of cisplatin and its major hydrolysis products by 
HPLC with ultra-violet (UV) and electrochemical (EC) detection. 
The first method involved the use of reversed-phase separation 
using sulphonic acids as ion-pair reagents. Using a mercury 
based detector, limits of detection were 5 ug/ml. The second 
procedure involved the use of an alumina stationary phase.
The interaction of cisplatin with both human serum 
albumin (HSA) and the amino acid cystine was then investigated 
using adsorptive stripping voltammetry (AdSV). A mechanism was 
proposed for the electroreduction of these biologically 
important molecules. A fractional coefficient for the binding 
of cisplatin to HSA at pH 7.4 was calculated to be 0.32. The 
reactivity of hydrolysis products of cisplatin was shown to be 
greater than that of the parent drug.
Finally, a method was developed for the direct
determination of inorganic platinum in urine using differential 
pulse polarography (DPP) and AdSV, following complexation with
ethylenediammine. The method developed was compared with a
graphite furnace atomic absorption spectrometric (GFAAS)
technique.
(xi  i i )
CHAPTER ONE
CHEMICAL. PHYSICAL AND BIOLOGICAL PROPERTIES OF CISPLATIN
- 1 -
1 . 1 .  INTRODUCTION
Metal co-ordination chemistry, particularly that of 
the platinum group metals, has proved a successful area in the 
search for new anticancer drugs. Cis-dichlorodiammineplatinum 
(II), commonly known as cisplatin, is one such metal complex 
which is active as an antineoplastic agent. It is now an 
established drug; however, it was not until the early and mid 
1960's that it was recognised to have such properties, and its 
history is perhaps a prime example of serendipity in science 
and medicine.
Cisplatin was first reported in 1845 by Peyrone, and 
was originally known as Peyrone's chloride [1], Werner [2] in 
1893 first distinguished the two isomers, and assigned each 
isomer a different name, and perhaps, more importantly, 
ascribed the geometries which we are now familar with today 
(Figure 1.1.). The cis- form is the therapeutically active 
compound and will be primarily considered in this section. 
Although the compound has been known for well over a century, 
its antineoplastic properties were not realised until the 
1960's.
In 1965, Rosenberg [1] found that the application of 
an electric field to a suspension of Escherichia coli prevented 
cell division of the bacteria. His fortuitous use of platinum 
(Pt) electrodes, primarily for their inertness,led to 
interesting and unexpected results. A long and careful series 
of control experiments showed that the electric 
currents had not prevented cell division, but had caused the Pt
-2 -
electrodes to dissolve to some extent. The ammonium chloride in 
the growth medium led to the formation of (NH4 )2PtClg 
[3]. This compound was able to react photochemically to form 
any of several compounds of the general formula 
[Pt(NH3)nCl6_n ](2_n), where n = 1, 2 or 3 [3].
Rosenberg and co-workers showed that PtiNHg^Cl^, formed 
after ultraviolet (UV) light irradiation, was the active 
compound [4,5]. By testing the synthetic isomers of
Pt(NH3)2Cl4 and the related platinum(II) salt, 
P t i N H g ^ C ^ ,  it was established that only the cis- 
isomers were active [4,5].
It was reasoned that since cell division but not
growth was stopped, perhaps these compounds would prove
effective against cancerous cells, the most rapidly dividing
cells in an organism. The first results were reported in 1969
by Rosenberg et al. using cisplatin [6], where it was found 
that the dosage level that killed half a sample (LD5q) of 
Swiss white mice was determined to be 14 mg/kg. Levels below 
the LD^g were then tested for tumour growth inhibitory action 
against transplanted Sarcoma 180 (one of about 100 standard 
test tumours). Tumour growth was almost completely inhibited at 
8 mg/kg, less than the LD^g [6],
Because of the early success of this antitumour
agent, analogues of cisplatin were soon considered, and scores 
of compounds with either subsitution of chloride by other 
halides, nitrate, nitrite and other singly charged anions, or 
substitution of ammonia were investigated [7-11]. Following a
- 3 -
decade of research on analogs of his original compound, 
Rosenberg in 1979 [1] cited the following observations on the
antineoplastic activity of such platinum complexes:
(i) the complex should be electrically neutral;
(ii) not all ligands should leave or exchange;
(iii) the 2 mono- or 1 bi-dentate leaving group(s)
should be in the cis- position,-
(iv) the tightly bound ligand(s) should be a 
substitutionally inert amine,- and
(v) the leaving ability of the labile ligand(s)
should be of intermediate lability.
First clinical trials began in 1972, and success in the 
three phases of clinical evaluation (i.e. phase I,II,III) led 
to the approval of cisplatin as a human anticancer agent. 
Government approval came in the United States through the Food 
and Drug Administration (FDA) in December 1978, and in the 
United Kingdom through the Department of Health and Social 
Security in March 1979 [12]. In 1983, cisplatin became the
U.S.'s biggest selling antitumour drug [13].
- 4 -
1.2. CHEMICAL AND PHYSIOCHEMICAL PROPERTIES OF CISPLATIN
The structure of cisplatin is shown in Figure 1.1.
It is a square planar complex formed by a central atom of
platinum surrounded by chlorine atoms and ammonia groups in the 
cis- configuration. It is stable in powder form for over two 
years in a cool, dark place, and at least a year at room
temperature. The solid is only slightly soluble in water. The 
chemical properties necessary for identifying the compound are 
listed in Table 1.1.
1.2.1. Hydrolysis reactions of cisplatin
After administration of the drug, usually through 
injection or infusion in the blood stream, a variety of
chemical reactions may occur. Due to the fact that the chloride 
ion concentration in blood is rather high (103 mM), the 
cisplatin molecule retains its chloride ions and remains 
electrochemically neutral. Therefore hydrolysis reactions are 
relatively unimportant here [14]. Consequently, the high Cl~ 
concentration in blood significantly hampers the binding of
cisplatin to blood proteins. However, significant losses of
cisplatin do occur, since 50 -70% of the adminstered drug is
excreted within 24 hours [15]. The remaining cisplatin
eventually diffuses through the walls of various cells, and 
now, because of the much lower Cl- concentration inside the
- 5 -
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Figure 1.1. Structure of cisplatin
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T a b l e  1 . 1 .  P h y s i c a l  c h a r a c t e r i s t i c s  o f  c i s p l a t i n
Description orange yellow solid
Melting point 207®C
Relative molecular mass 300.1
Solubi1ity a) water: 1 mg/ml
b) dimethyl formamide (pure): 24 mg/ml
UV absorption (0.8 mg/ml, 0.1 M HC1 )
max 301.1 nm ; 
min 246 nm
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cell (4 mM), hydrolysis reactions can take place. Based on the 
work of Martin [16], it is now generally accepted that the 
hydrolysis scheme, as shown in Figure 1.2., operates inside the 
cell. The existence of these hydrolysis species of cisplatin 
has been established by chloride ion titrimetry [17,18], Of the 
hydrolysis species, cis-[Pt(NH3)2(H20)C1]+ is the 
predominant species that undergoes reactions with all kinds of 
molecules present inside the cell (DNA, RNA and proteins).
1.2.2. The chemistry of cisplatin in aqueous media - 
nucleophlic displacement of the chloride ligand
On studying the hydrolysis processes of the drug, 
addition of chloride to aqueous solutions of cisplatin would 
be expected to stabilise cisplatin by shifting the aquation 
equilibrium to the left. Since the equilibrium constant for the 
displacement of the second chloride ligand by water is small 
(K2 = 1.11 x 10-4 M) [18] compared to that for the
displacement of the first chloride ligand (K^ = 3.63 x 10 
M) [18], then evaluation of the aquation behaviour can be 
simplified by consideration of the first hydrolysis step only. 
The rate of the loss of cisplatin at any time can be given by?
—d[I ] = k±[I] - k_±[II] [Cl- ] (1.1)
dt
- 8 -
I
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Figure 1.2. Hydrolysis of cisplatin
where I = [Pt(NH3)2C 12  ^ and 
II = [Pt(nh3)2(H20)C1 ]+
At equilibrium, the rate of the forward and reverse reactions 
are equal, then -d[I]/dt = 0. The equilibrium constant for the 
first hydrolysis step may therefore be defined ass
k1 [ I I ] [ c r ]  ( 1 . 2 )
v  = ± *
From (1.2) it is clear that as [Cl- ] is increased, the ratio
of [II]/[I] must decrease (as f^) is a constant). Hence, the 
addition of chloride to such aqueous systems should force the 
equilibrium position to the left, therefore increasing the 
fraction present as intact cisplatin.
Kinetic studies on the loss of cisplatin in aqueous 
solutions were first reported by Martin and co-workers [17,18].
Greene et al. [19] were the first to study systematically the
stabilising effect of the chloride ion on the hydrolysis 
reaction, utilising UV spectroscopy and chloride ion 
titrimetry. The data presented was in good agreement with 
Martin et al. [17,18]. Hincal et al. [20] carried out a more
extensive study to determine the rate constant for the forward 
reaction involving the first hydrolysis step. Each of the 
studies [19,20] found substantial stabilisation of cisplatin in 
aqueous systems upon the addition of chloride.
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1 . 3 .  TRANSPORT
cell membrane to enter the cell, or it may require a carrier
molecule to transport it. A study was carried out by Gale et 
al. [21] to distinguish between these two cases and was based
on Michaelis-Menten kinetics for the formation of a
carrier-substrate intermediate complex, and the Lineweaver-Burk 
equation for the analysis of such rates. The results mitigate
against a carrier transport mechanism, and it is presumed at 
present that the platinum drug passively diffuses through the
plasma membrane of the cell.
1.4. MODE OF ACTION
Since the aquated forms of cisplatin have been shown 
to be very reactive, much speculation on the mode of action of 
cisplatin has centred on the aquated forms of the drug.
As outlined above once inside the cell, and
following hydrolysis, the products are capable of binding to a 
variety of molecules therein. Although the exact mechanism of 
action is still uncertain, the drug and hydrolysis products 
appear to exert their cytotoxic effects by directly binding 
with DNA. Pascoe and Roberts [22] showed that DNA is
predominantly bound with cisplatin. Their binding data is shown
in Table 1.2.
C i s p l a t i n  can e i t h e r  d i f f u s e  p a s s i v e l y  through  t h e
- 1 1 -
Table  1 . 2 .  B ind ing  d ata  f o r  c i s p l a t i n  w i th  b i o l o g i c a l  m o l e c u l e s .
Macromolecule DNA mRNA rRNA tRNA Proteins
Pt/mole 22 0.125 0.033 6.7xl0“4 6.7xl0~4
Earlier studies by Horacek and Drobnik [23] using 
spectrophotometric techniques revealed that the affinity of 
cisplatin for DNA is much lower when the chloride levels are 
increased, suggesting that it is the aquated forms that are 
responsible for activity. Also, Rosenberg [24] and Lippard 
[25,26] suggested that in the intracellular fluids where the 
chloride concentration is low, cisplatin is converted to its 
hydrolysis species, and it is these that bind with DNA to create 
antineoplastic activity.
The molecular mechanism for the cisplatin-DNA binding 
is still uncertain. It is known that cisplatin and its 
hydrolysis species do not intercalate between the base pairs of 
DNA [27,28]. There is also good reason to believe that reactions 
with the phosphate and sugar moieties of the double helix 
strands either do not occur, or, if they do to any extent, are 
not significant for the anticancer activity. Other possible 
reactions do occur, and these include intrastrand crosslinks 
[28], DNA-protein crosslinks [29], interstrand crosslinks [30], 
and finally, reactions with individual bases.
- 1 2 -
1 . 5 . METABOLISM OF THE DRUG
Hoechelle and Van Camp [31] first reported the 
biotransformation of the drug in mice (both with or without 
tumours), for both cis- and trans-dichlorodiammineplatinum(II). 
The excretion of these drugs follows a bi-phasic pattern, 
usually described by a 2-compartment model, given mathematically 
by:
rate of elimination= ke~°^ + Be-/^ (1.3)
where ^1/2 oi = and tl/2 (3 =
The initial rapid phase a  has a half-life falling in the range 
of 1/2 and 3/4 of an hour. The second much slower phase, follows 
the first, and because of much lower concentrations, data for 
the half-life is imprecise. Values of ^1/2 (3 have been 
variously reported as 37.5 hours, 5 days, 17.5 days and 44.9 
days, depending on the animal [31]. Ultimately, nearly 90% of 
cisplatin is excreted into urine (mostly during the first few 
hours to days), but detectable amounts may persist in the urine 
for weeks [32].
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1 . 6 . CLINICAL USES OF THE DRUG
Cytotoxicity of the drug depends on the extent of 
reaction with DNA, the capacity of the particular cell to excise 
damage from the template DNA, and the ability of the cell to 
synthesise DNA even after damage. Any differences are reflected 
in the sensitivity of various cell types to cisplatin. The drug, 
however, does not work equally well in all parts of the body 
[33].
The best results have been obtained with testicular 
and ovarian cancers, and indeed, the initial approval of the drug 
in 1978 was for the treatment of these two forms of cancer [34], 
Testicular cancers represent about 1% of all male malignant 
tumours. Before the availability of cisplatin, 90% of patients 
with advanced nonseminomatous testicular cancer died. However, 
with an overall response rate of 60%, cisplatin, is now 
recognised as one of the most active drugs in testicular cancers, 
and it therefore has been incorporated into combinations with 
other chemotherapeutic agents with remarkably good results. The 
basis for active testicular cancer combinations is that of the 
vinblastine and bleomycin combination reported by Samuels and 
co-workers [35,36], where response rates with vinblastin and 
bleomycin have been reported as 76%. Einhorn and Donahue [37] 
noted particularly good results when cisplatin was again used in 
combination therapy with the two drugs already mentioned: of 20 
patients treated, 15 achieved a complete remission and 5 achieved 
partial remission. Cisplatin probably found notoriety during
- 1 4 -
its use in the treatment against testicular cancer of the horse 
jockey, Bob Champion, who after remission, went on to ride the 
Grand National winner, Aldiniti.
Ovarian cancer is the most fatal gynaecological 
malignancy, and estimates are that 1 in 100 American women will 
die from it [38]. Early treatments using cisplatin showed 
significantly better results compared to previously used drugs 
[39,40]. In the years between 1975-1979, 235 women were treated 
with cisplatin, with 28% showing complete or partial remission 
[41],- and with various combination chemotherapies, all including 
cisplatin, 52% of 251 women responded to the treatment in the 
years 1977-1979. Other significant outcomes with cisplatin 
treatment have been with cervical and prostatic cancers, which 
have progressed from unresponsive to resistant [42]. In fact, the 
drug in combination therapy became headline news at the end of 
May 1989, for its reported success in the treatment of advanced 
cervical cancer. Very good results have also been obtained in the 
treatment of bladder, head and neck, lung and colon cancers [43].
1.7. TOXICITIES AND SIDE-EFFECTS
As with virtually all chemotherapeutic agents used 
against cancer, cisplatin has, by virtue of its cytotoxic nature, 
undesirable side-effects. Nausea and vomiting accompany cisplatin 
use in most patients, commencing 1 to 2 hours after dosage 
administration and lasting up to 4 to 6 hours later. This
- 1 5 -
situation is often ameliorated by slow infusion of the drug over 
a 24 hour period. These and other adverse effects are dose- 
dependent and often dose-limiting. Kidney damage was encountered 
in preliminary testing on humans, and this slowed the initial 
approval process. The kidney damage function, causing a decrease 
in the filtering capacity of the kidneys, can now be largely 
controlled via hydration of the patient by infusion of normal 
saline for several hours before drug administration, followed by 
the use of forced diuresis using mannitol. This hydration and 
diuresis before, during and after cisplatin administration has 
reduced the incidence and severity of nephrotoxicity by reducing 
the urinary platinum concentration and decreasing the renal 
residence time of the drug.
There are non-life threatening side-effects due to 
cisplatin therapy. Hearing loss, in the range of 4 - 8 kHz,
occurs in about 30% of all patients [44]. The loss is
irreversible, and can progress into the spoken range of 1 to 4 
kHz if the drug regime is not altered. Hence, careful monitoring 
of the patient for any hearing loss, and discontinuation of 
cisplatin treatment if it is found, is an effective deterent.
Hypersensitive reactions are also experienced during 
therapy, ranging from skin rash, facial flushing, wheezing 
and hypotension [32].
There is not a selective up-take of cisplatin by any 
particular tissue type, and platinum has been found almost 
everywhere in the body following administration. A typical
therapeutic dose of cisplatin gives a concentration of Pt of
- 1 6 -
about 1 ppm or 5 uM in tumour tissues.
1.8. CONCLUSIONS
A closer understanding of the interactions of 
cisplatin with biologically relevant molecules and the isolation 
of these products have been hindered by the lack of specific 
analytical methodology. Whilst studies of platinum distribution 
and clearance from various systems are many, the main problem 
with them is that they suffer from the inability to distinguish 
cisplatin and those platinum-containing compounds resulting from 
ligand substitution in cisplatin by other species. The 
introductions to Chapters 4 and 5 highlight the major analytical 
techniques commonly used for the detection of this antineoplastic 
agent and its hydrolysis products.
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2.1. ELECTROANALYTICAL TECHNIQUES
2.1.1. Fundamental concepts of electroanalytical
techniques
2.1.1.1. Modes of mass transport of electroactive species
to an electrode surface
During electrolysis, three modes of transfer are 
important [l]s
(i) migration;
(ii) convection; and
(iii) diffusion.
An excess of supporting electrolyte eliminates the migrational 
modes of transfer of the electroactive species in solution. 
Because the ions of the supporting electrolyte are in excess 
compared to the electroactive species, it is these ions that 
carry practically the total charge within the solution. 
Therefore, migration currents of the electroactive species are 
negligible. For example, the migration current, expressed in 
terms of transference number, t, of a univalent cation in the 
absence of a supporting electrolyte may be written as follows:
t =  c+ \ +/c+ \ ++ c _ X _  (2.1)
where c+ and c_ are the concentrations of the electroactive
- 2 2 -
respective ionic mobilities. If one considers a 100-fold 
addition of a univalent supporting electrolyte, the 
transference number of the electroactive cation is decreased to
c a t i o n  and an ion  r e s p e c t i v e l y ,  and \ + and are  t h e i r
c+ X++c_ X _+100c' + \  ++100c'_X_
where c ’+ and c'_ are the concentrations of the cationic 
and anionic species in the electrolyte and, \ + and X_ their 
respective ionic mobilities. Therefore, the addition of a
supporting electrolyte, whose ions can neither be oxidised of 
reduced, causes the transference number of the electroactive 
species to decrease.
Mass transfer by convection occurs under the
influence of stirring or temperature gradients in solution.
Although this mode of mass transfer of electroactive species to
the electrode surface is utilised in stripping voltammetry, it 
is not desirable in polarographic studies. Hence, the
elimination of convective mass transfer is achieved by
maintaining the solution in a quiescent state.
The diffusion mode of mass transfer is a
spontaneous process. All species (charged or uncharged) undergo 
diffusion. In polarographic studies, electroactive species may 
only be transported to the electrode surface by diffusion,
which is achieved by the elimination of migrational and 
convective modes of mass transfer.
- 2 3 -
2 . 1 . 1 . 2 . Main f e a t u r e s  o f  t h e  e l e c t r o d e  p r o c e s s
The rate of the redox reaction taking place at the 
electrode depends on the rate at which the species move from 
the bulk of the solution to the electrode (mass transfer) and 
the rate at which electrons tranfer from the electrode to 
solution species and vice-versa (charge transfer).
A simple electrochemical reaction can be depicted as
follows:
0 + n e ^ . R
where 0 and R are the oxidised and reduced forms of the 
electroactive species. Conversion of 0 to R involves the 
following steps:
(i) diffusion of 0 from the bulk solution to the
electrode surface;
(ii) transfer of electrons at the electrode surface 
to form R;and
(iii) diffusion of R from the electrode surface into 
the bulk solution.
Homogenous chemical reactions which may precede or follow the 
heterogeneous charge transfer step can also contribute to the 
overall electrode reaction.
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2 . 1 . 1 . 3 .  F a r a d a ic  and c a p a c i t a n c e  c u r r e n t s
The total current (it ) in an electrochemical
reaction arises from two main processes at the electrode
surface, namely the faradaic current (if) and the capacitance
current (ic ):
*t = *f + *c ( 2 . 2 )
The faradaic current arises from electron transfer across the 
electrode-solution interface resulting from the oxidation or 
reduction of an electroactive species. The size of this
faradaic current is dependent on mass transfer processes, and 
whether the electrolysis is restricted by diffusion, electron 
transfer, chemical kinetics or adsorption [1]. It also depends 
on the surface area of the electrode and the applied potential.
The capacitance, or charging, current results 
because of the change in structure of the electrode-solution 
interface with changing the potential on the surface area of
the electrode. At the electrode-solution interface, a
separation of charge takes place that makes the electrode
behave like a capacitor. At a given potential, a charge exists 
on the electrode and an equal and opposite charge in the 
solution. This "array" of charged species and oriented dipoles
existing at the interface is called the "electrical double 
layer". When the potential of the working electrode is changed, 
a current must flow to charge or discharge the capacitor. 
Because no
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electron transfer is involved in this process, this type of 
current is termed "non-faradaic".
For a dropping mercury electrode (DME) of area A, 
growing with time t, the charge q required to bring the double 
layer to any potential E is given by:
q = CdeA(Em-E) (2.4)
where is the capacity of the double layer per unit area
and Em is the electrocapillary maximum i.e. the potential 
where q = 0.
The potential remains virtually constant over the 
lifespan of a single mercury drop, so the capacitance current 
is virtually a function of change in the electrode area. As the 
mercury drop grows, current must flow to bring the electrical 
double layer up to the potential designated by the electrode 
potential. Hence the capacitance current can be expressed 
mathematically as follows:
ic = 0.0057Cd e (Em-E)m2/3t-1/3 (2.5)
From equation (2.5) it can be seen that when E = Em , the 
capacitance current is zero? it is negative when E is more 
positive than Em , and positive when E is more negative than 
Em . As already highlighted, a combination of if and
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1 results in the total current observed. However, in 
polarographic and voltammetric studies, only faradaic currents 
are of Interest. As will be outlined in later sections, many 
techniques are now able to discriminate against the capacitance 
current, hence improving the limits of detection of 
voltammetric methods of analysis.
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2 . 1 . 2 .  Po larography  and vo ltammetry
2.1.2.1. Introduction
The electroanaiytical techniques outlined in this 
section owe their origin to the introduction of direct current 
(DC) polarography by Jaroslav Heyrovsky in the early 1920's. 
This polarographic technique was used as the first instrumental 
method for trace metal analysis, and the subsequent award of 
the Nobel Prize in 1959 to Heyrovsky marked the importance 
attached by the scientific community to the introduction of 
this technique. For about 30 years, the technique grew in
popularity. In the late 1950's, however, there was a decline in 
its application due mainly to the growing competition from
chromatographic and spectroscopic methods. The limited 
sensitivity of DC polarography and the added difficulty
involved in the interpretation of polarographic waves also 
contributed to this decline. However, the 10 years between 1955 
and 1965 saw variations introduced in the basic polarographic 
technique. The discovery of pulse polarography by Barker in the 
early 1960's [17], which resulted in increases in sensitivity
and lower limits of detection, renewed interest in this 
electroanaiytical technique. The early 1970's heralded the use 
of voltammetry in the important area of environmental analysis, 
while the coupling of liquid chromatography with 
electrochemical (LCEC) detection offered the analyst a 
selective and sensitive tool for the determination of a wide
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variety of compounds in complex biological media (e.g. plasma, 
serum, urine, tissues).
In the following sections , the theory behind 
direct current (DC) and pulse polarography, as well as 
adsorptive stripping voltammetry (AdSV) are included.
2.1.2.2. Direct current polarography
Polarography is the voltammetric technique where 
the working electrode is a dropping mercury electrode (DME). 
The resulting current is measured as a function of the applied 
potential. The potential applied between the DME and a counter 
electrode is varied linearly with time. A plot resulting in a 
current-potential curve or "polarogram" shows the variation of 
current with the continously applied potential. A typical DC
pi
polarogram for the reduction of cadmium ion (Cd T ) is shown 
in Figure 2.1.
In region A, as the applied potential is scanned 
negatively from an initial potential of 0.0 V vs SCE, the 
current changes minimally, resulting from the sum of the 
capacitance or charging current and faradaic current, due to 
the reduction of trace impurities in solution. This current is 
known as the residual current. In region B, the reduction 
potential of the Cd2+ ions is noted as a major increase in 
current. The cadmium ions are reduced as follows:
- 2 9 -
Potentia l  (V)
Figure 2.1. Polarograms for (A) 1 M hydrochloric
acid and (B) 4 x 10"4 M Cd2+ in 1 M
hydrochloric acid. ^1/2 is the 
half-wave potential, while id 
represents the diffusion current.
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Cd2+ + 2e~^ - HcL- A Cd(Hg)
As the rate of reduction increases with increase in 
the applied potential, the current reaches a plateau or 
limiting value when the potential becomes sufficiently negative
so that the concentration of cadmium ions at the electrode
surface is effectively zero. This current is limited by the 
rate of diffusion of the species to be reduced, and as such,
the limiting current is referred to as the diffusion current 
(id ). The potential where the current is one-half of its 
limiting value is called the half-wave potential, E^/2* This
is a most important feature of the polarogram, as the Ej/2 
value is characteristic of the substance undergoing redox 
reactions, and hence may be used for qualitative 
characterisation purposes. Values of ^1/2 are almost 
independent of concentration of the electroactive species, but 
are a function of parameters such as electrolyte, pH, solvent 
system and the nature of the electroactive species [2].
The diffusion current id is directly proportional 
to the bulk concentration (C°) of the electroactive species 
from the Ilkovic equation:
id = 607nD1/2m2/3t1/6C° (2.6)
where m and t are the rate of mercury flow (mg s--'-) and drop 
time (s) respectively. To determine the diffusion current it is 
necessary to subtract the residual current from the total 
current.
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2 . 1 . 2 . 3 .  L i m i t in g  c u r r e n t s  in  po larograp hy
Most limiting currents in DC polarography are 
diffusion controlled} however, they may be controlled by 
kinetic, adsorption or catalytic processes.
2.1.2.3.1. Diffusion-controlled limiting currents
The equation that defines the diffusion current has 
been based on three laws, i.e. Faraday's law and Fick's first 
and second laws of diffusion.
Faraday's law may be expressed as follows?
i - nFdN/dt (2.7)
where i is the electrolysis current, n is the number of 
electrons transferred in the electrode process, F is the 
Faraday constant and dN/dt is the number of the moles of 
electroactive substance reaching the electrode in unit time. 
Fick's first law of diffusion may be written as:
dN/dt = DA dC°/dt (2.8)
where dN is the amount (expressed as the number of moles) of 
substance that diffuse across any plane perpendicular to, and 
at distance x from an
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electrode of surface area A, dC^/dx is the concentration
gradient and D is the diffusion coefficient. If the mass
transfer of electroactive species to the electrode is
controlled only by diffusion, then the diffusion current is
determined by the concentration gradient at the electrode
surface,- thus.*
i = nFAD(dC°)/dx)x=0 (2.9)
Ficks second law states:
dC°/dt = D(d2C°/d2x2 ) (2.10)
When equation (2.10) is substituted into equation (2.9),
assuming that the concentration of electroactive species at the 
electrode surface is zero, the equation for current flowing
towards a planar stationary electrode is given by the Cottrell 
equation:
it = nFAD1/2C° (2.11)
(TTt)1/2
where it is the current flowing at any time t. However,
corrections to the above must be made when the electrode is
considered to be a growing drop [3,4]. In this case:
i t  = 708nD1 / 2 C°m2 / 3 t 1 / 6  ( 2 . 1 2 )
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If the mean diffusion current is considered instead of the 
instantaneous current, then the numerical coefficient 708 in 
equation (2.12) is replaced by 607, giving rise to the Ilkovic 
equation [5]:
it = 607 nD1/2C°m2/3t1/6 (2.13)
Parameters such as n, D and C° are characteristic of the 
solution being studied, and if these parameters are maintained 
constant, then the diffusion current can be expressed as:
id = const. m2/3t1/|,S (2.14)
The flow rate of mercury through the capillary is 
proportional to the height (h) of the mercury column when 
corrected for back pressure hcorr:
hcorr= h “ 3.1/(mt)1/3 (2.15)
In addition, the flow rate is directly proportional to m and 
inversely proportional to t. Therefore:
id = const.hcorr2/3hcorr“1/6 = const.hcorr1/2
(2.16)
This relationship between id and hcorl*^  .is a criterion
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commonly used to verify a diffusion-controlled limiting current 
[6 ].
2.1.2.3.2. Kinetic-controlled limiting currents
The limiting currents that are controlled by the 
rate of a chemical reaction occuring immediately adjacent to 
the electrode surface are referred to as kinetic currents. 
These chemical reactions may precede, follow or run parallel to 
the main electrode process.
2.1.2.3.2.1. Preceeding chemical reactions
This reaction type may be written as follows;
0 + ne v-- ■ * R
where A is the electroinactive species, R the electrochemical 
reaction product and kf and kb are the forward and reverse 
rate constants. The equilibrium constant for the chemical 
reaction can therefore be written ass
K = kf [ 0 ] / k b [A] ( 2 . 1 7 )
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The limiting current is mostly kinetic in character [2] when 
the forward rate constant kf is small, and the equilibrium 
concentration of 0 is negligible. In this case:
Iiim = ik = 493nD1/2m2/3t2/3(kf/ kb )[A] (2.18)
However, if the equilibrium concentration of 0 is appreciable 
in the bulk solution, then the limiting current is the sum of 
the diffusion and kinetic current. Consequently:
To discover if the limiting current is kinetically controlled
1 /?
or otherwise, a plot of ilim versus hcorr ' is made. If 
the current is entirely kinetic In nature, then the limiting 
current will be independent of hcorr1//2 [6 ].
2.1.2.3.2.2. Following chemical reaction
This reaction type can be represented as
0 + ne s R
k f
R A
^b
In this situation, the limiting current is independent of the
- 3 6 -
chemical reaction, and the limiting current is purely 
diffusion-controlled.
2.1.2.3.2.3. Chemical reactions occurring parallel to the 
electrode reaction
In this reaction type, the product of an electrode 
reaction may react with other species in solution to regenerate 
the original species:
0 + ne^=^R
The above reaction is known as a catalytic process, where the 
oxidised form of the redox couple is regenerated by reaction of 
the reduced form of the species with species C, which is itself 
not reduced at the applied potential. When a negligible 
quantity of 0 is regenerated (i.e. when kf is very small), 
the current will be diffusion controlled. However, when kf 
increases, more of species 0 is produced through the catalytic 
process at the electrode than is diffusing from the bulk 
solution, and hence the catalytic current (ic ) is much 
greater than the diffusion current.
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2 . 1 . 2 . 3 . 3 .  A d s o r p t i o n - c o n t r o l l e d  l i m i t i n g  c u r r e n t
Many species dissolved in solution show a tendency 
to adsorb on the electrode surface, and this phenomenon can 
markedly affect the result of the electrochemical experiments. 
The electrode process may be represented as follows:
for reactant adsorption: Osoin?“* °ads
°ads + ne \ " * ^soln
for product adsorption s 0soln + ne Rsojn
^soln * k R ads
When the reactant species is adsorbed at the surface, then 
reduction of this species requires more energy than for the 
reduction of the solution species, due to the fact that the 
energy of adsorption must be overcome. As a result of this, at 
concentrations greater than full surface coverage, two waves 
may appear on the polarogram. The first is due to the reduction 
of the free electroactive species, whereas the second wave at 
more negative potentials is due to the reduction of the 
adsorbed species. In the case of product adsorption, however, 
less energy is required for reduction for 0sojn — «•— > RQ(js
than for 0soln  > Rsoln, so the adsorption wave occurs as
a pre-wave to the main reduction wave.
The limiting adsorption current (ia ) is given by:
- 3 8 -
i a = nFz0.85m2 / 3 t ~ 1 / 3 ( 2 . 2 0 )
where z is the maximum number of moles adsorbed per unit 
electrode surface.
2.1.2.4. Nature of the electrode process
Reversible or irreversible electrochemical 
processes are terms used to describe the nature of the electron 
transfer at the electrode surface. A reversible process, 
indicates the situation where the rate of electron transfer is 
fast enough to conform to thermodynamic predictions.
For the forward reaction, the current flowing is expressed as:
i = nFAkfC°(x=0) (2.21)
The forward and backward rate constants can be written as 
follows [7]
kf - k°exp[-cenF/RT(E-E0 )] (2.22)
kb = k°exp[ (l-Qi)/RTnF(E-E°) ] (2.23)
where k° is the heterogeneous rate constant of the electrode 
process at the standard potential (E°), and ce is the transfer 
coefficient (fraction of the applied potential influencing the
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into (2.21) is done, the following equations result:
if = nFAC°(x=0)k°exp[-o;nF/RT(E-E0 )] (2.24)
ib = nFACR (x=0)k°exp[(l-a)/RTnF(E-E°)] (2.25)
The forward current (if ) is positive and the backward current 
(i^) is negative by convention. Under equilibrium conditions, 
E = E°, and if if = i^, equations (2.24) and (2.25) can be 
combined to give the well-known form of the Nernst equation:
E = E°+(RT/nF)ln([R]/[O]x=0)) (2.26)
where R and 0 are the oxidised and reduced forms respectively. 
Therefore a reversible electrode process is defined as one in 
which the concentration of the oxidised and reduced species at
the electrode surface may be predicted by the Nernst equation.
Departures from reversible (Nernstian) behaviour are 
allowed given that the rate of the electron exchange process 
remains high, typically > 2 x 10-2 cm/sec in DC polarography.
In these cases, a small net current flow in one direction can be
maintained without large deviations from equilibrium
concentrations, so that the Nernst equation is still applicable.
Electrochemical processes, in which kinetic rather
r a t e  o f  r e d u c t i o n ) .
When s u b s t i t u t i o n  o f  e q u a t i o n  ( 2 . 2 2 )  and ( 2 . 2 3 )
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than thermodynamic laws determine the electrode surface 
concentrations of the species 0 and R, are said to be 
irreversible (non-Nernstian).
When one combines the Ilkovic and Nernst equations 
the following equation is obtained:
EDME ° E1/2+ (RT/nF)ln(i/id- i ) (2.27)
The above equation describes the shape of a polarographic wave 
for a reversible process with a diffusion-controlled limiting 
current. A plot of EDME vs l o g ^ O / i ^ i ) should be linear 
with a slope 59.1/n mV and an intercept on the axis of Ejy2 t0 
indicate the reversibility of a DC polarographic process.
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2 . 1 . 3 . C y c l i c  Voltammetrv
1938 by Matheson and Nichols [8], and since its introduction it
has become perhaps the most effective and versatile 
electroanalytical technique for the mechanistic study of redox 
systems [9-13]. Its effectiveness results from its capability 
for rapidly observing the redox behaviour of electroactive 
species over a wide potential range. Once a redox couple has 
been located, it can be characterised from the potentials of
peaks on the cyclic voltammogram and from changes caused by
variation of the scan rate.
Cyclic voltammetry (CV) consists of cycling the 
potential of a working electrode in an unstirred solution and 
measuring the resulting current. The potential of the working 
electrode is controlled versus a reference electrode such as a 
saturated calomel electrode (SCE) or a silver/silver chloride 
(Ag/AgCl) electrode.
The repetitive triangular potential excitation 
signal for CV causes the potential of the working electrode to 
sweep back and forth between two designated potentials. The 
potential excitation that is applied across the 
electrode-solution interface in order to obtain a cyclic 
voltammogram is illustrated in Figure 2.2. Single or multiple 
scans may be used. Often there is little change between the 
first and successive scans; however the changes that do result 
are important as they can reveal information about reaction
The t e c h n iq u e  o f  c y c l i c  vo ltammetry was d e v e lo p e d  in
- 4 2 -
I CYCLE 1 --------------1-------  CYCLE 2  1111
TIM E , s
Figure 2.2. Typical potential-time excitation signal 
for cyclic voltammetry.
- 4 3 -
To o b t a i n  a c y c l i c  voltammogram, t h e  c u r r e n t  a t  t h e  
w orking e l e c t r o d e  in  an u n s t i r r e d  s o l u t i o n  i s  m easured  d u r in g  
t h e  p o t e n t i a l  s c a n .  In F i g u r e  2 . 3 . ,  a t y p i c a l  c y c l i c
Oi
voltammogram f o r  Fe^T o b t a i n e d  a t  a c a r b o n  p a s t e  e l e c t r o d e
u s i n g  1 . 0  M s u l p h u r i c  a c i d  a s  t h e  s u p p o r t i n g  e l e c t r o l y t e  i s  
shown.  In  t h e  fo rw ard  s c a n ,  F e 3+ i s  e l e c t r o c h e m i c a l l y
g e n e r a t e d  a s  i n d i c a t e d  by t h e  a n o d i c  c u r r e n t .  I n  t h e  r e v e r s e
s c a n ,  t h e  F e JT i s  r e d u c e d  back  t o  Fe^T a s  i n d i c a t e d  by t h e  
c a t h o d i c  c u r r e n t .  T h e r e f o r e ,  CV i s  c a p a b l e  o f  r a p i d l y  
g e n e r a t i n g  a new s p e c i e s  d u r i n g  t h e  fo r w a rd  s c a n  and t h e n
p r o b i n g  i t s  f a t e  on t h e  r e v e r s e  s c a n .  T h i s  i s  a v e r y  im p o r t a n t
a s p e c t  o f  t h e  t e c h n i q u e .
The i m p o r t a n t  p a r a m e t e r s  o f  a c y c l i c  voltammogram
a r e  l i s t e d  be low s
( i )  the cathodic  (EpC) and anodic Peal<
p o t e n t i a l s ;  and
( i i )  t h e  c a t h o d i c  ( i p C  ^ and a n o d i c  ( ip a^  Peak
c u r r e n t s .
T he se  p a r a m e t e r s  a r e  l a b e l l e d  in  F i g u r e  2 . 3 .  One method f o r  
m e a s u r in g  ip  i n v o l v e s  e x t r a p o l a t i o n  o f  a b a s e l i n e  c u r r e n t .
The e s t a b l i s h m e n t  o f  a c o r r e c t  b a s e l i n e  i s  e s s e n t i a l  f o r  t h e  
a c c u r a t e  measurement  o f  peak c u r r e n t s .  T h i s  i s  n o t  a l w a y s  e a s y ,
p a r t i c u l a r l y  f o r  more c o m p l i c a t e d  s y s t e m s .  The s e c o n d  sweep
g e n e r a l l y  c a u s e s  t h e  main pro blem s i n c e  t h e  b a s e l i n e  i s  n o t  t h e  
same a s  t h e  r e s i d u a l  c u r r e n t  o b t a i n e d  by an i d e n t i c a l  
e x p e r i m e n t  in  s u p p o r t i n g  e l e c t r o l y t e .  D i f f i c u l t y  in  o b t a i n i n g
mechanisms [14].
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POTENTIAL . V vs $CE
F i g u r e  2 . 3 .  A t y p i c a l  c y c l i c  vol tammogram o f  
F e 2+/ F e 3+ in  1 M s u l p h u r i c  a c i d .
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a c c u r a t e  peak c u r r e n t s  h as  b e e n  s u g g e s t e d  t o  be  p e r h a p s  o n e  o f  
t h e  b i g g e s t  prob le m s  in  CV [ 1 5 ] .
Having e s t a b l i s h e d  a c o r r e c t  b a s e l i n e ,  t h e  peak  
c u r r e n t  measured d e p e n d s  on two s t e p s :
( i )  movement o f  t h e  e l e c t r o a c t i v e  m a t e r i a l  t o  t h e
working e l e c t r o d e ?  and
( i i )  t h e  r a t e  o f  t h e  e l e c t r o n  t r a n s f e r  r e a c t i o n .
The r a t e  o f  e l e c t r o n  t r a n s f e r  f o r  a r e d u c t i o n  
p r o c e s s  i s  a f u n c t i o n  o f  p o t e n t i a l  and i s  t h e o r e t i c a l l y  
d e s c r i b e d  a s :
k f  = k °  e x p  [ -  (cenF/RT) ( E - E ° ' ) ] ( 2 . 2 2 )
w her e k°  i s  t h e  s t a n d a r d  h e t e r o g e n e o u s  e l e c t r o n  t r a n s f e r  r a t e  
c o n s t a n t ,  a  i s  t h e  t r a n s f e r  c o e f f i c i e n t ,  E° i s  t h e  formal  
r e d u c t i o n  p o t e n t i a l ,  n i s  t h e  number o f  e l e c t r o n s  t r a n s f e r r e d  
i n  t h e  e l e c t r o d e  p r o c e s s ,  F i s  t h e  F arad ay  c o n s t a n t  and R i s  
t h e  u n i v e r s a l  g a s  c o n s t a n t .  The e l e c t r o n  t r a n f e r  r a t e  c o n s t a n t  
f o r  t h e  r e v e r s e  p r o c e s s ,  kb , i s  s i m i l a r l y  c o n t r o l l e d  by t h e
a p p l i e d  p o t e n t i a l  and i s  d e n o t e d  by:
kb = k°  e x p [ ( ( l -Q!)nF/RT) ( E - E ° ' ) ] ( 2 . 2 3 )
When t h e  e l e c t r o n  t r a n s f e r  p r o c e s s  i s  r e v e r s i b l e ,  t h e
d i f f e r e n c e  be tw een  a n o d i c  and c a t h o d i c  p eak  p o t e n t i a l s  i s  5 9 / n  
mV. T h i s  r e l a t i o n s h i p  may be u s e d  t o  e v a l u a t e  n .  Under
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e l e c t r o d e  s u r f a c e  i s  f a s t  en ough t o  m a i n t a i n  t h e  c o n c e n t r a t i o n s  
o f  t h e  o x i d i s e d  and r e d u c e d  forms  in  e q u i l i b r i u m  w i t h  e a c h
o t h e r .  The e q u i l i b r i u m  r a t i o  f o r  a g i v e n  p o t e n t i a l  a t  t h e
e l e c t r o d e  s u r f a c e  i s  d e t e r m i n e d  by t h e  N e r n s t  E q u a t i o n :
E = E0 ' + ( R T / n F ) l n ( [ R ] / [ 0 ] x = o ) )  ( 2 . 2 6 )
where 0 and R a r e  t h e  o x i d i s e d  and r e d u c e d  fo r m s  r e s p e c t i v e l y  
and x i s  t h e  d i s t a n c e  from t h e  e l e c t r o d e  s u r f a c e .  I t  s h o u l d  be  
n o t e d  t h a t  t h e  5 9 / n  mV s e p a r a t i o n  o f  p eak  p o t e n t i a l s  i s
i n d e p e n d e n t  o f  s c a n  r a t e  f o r  a r e v e r s i b l e  c o u p l e ,  b u t  i s  
s l i g h t l y  d e p e n d e n t  on s w i t c h i n g  p o t e n t i a l  and c y c l e  number 
[ 1 6 ] .
E l e c t r o c h e m i c a l  i r r e v e r s i b i l i t y  i s  c a u s e d  by s l o w
e l e c t r o n  e x c h a n g e  b e t w e e n  t h e  r e d o x  s p e c i e s  and t h e  working  
e l e c t r o d e .  I t  i s  c h a r a c t e r i s e d  by a s e p a r a t i o n  o f  peak
p o t e n t i a l s  t h a t  i s  g r e a t e r  t h a n  5 9 / n  mV and i s  d e p e n d e n t  on 
s c a n  r a t e .  At h i g h  s c a n  r a t e s ,  t h e  e l e c t r o n  t r a n s f e r  r e a c t i o n  
may n o t  be f a s t  enou gh  t o  m a i n t a i n  e q u i l i b r i u m  c o n d i t i o n s  a s  
t h e  p o t e n t i a l  c h a n g e s .
In  c y c l i c  v o l t a m m e t r y  t h e  p eak  c u r r e n t ,  i p ,  i s  
g i v e n  by t h e  f o l l o w i n g  e q u a t i o n  [1 4 ] ;
i = k n 3 / 2  A D1 / 2  C° v 1 / 2  ( 2 . 2 8 )
where k i s  t h e  R a n d l e s - S e v c i k  c o n s t a n t ,  A i s  t h e  a r e a  o f  t h e
reversible conditions the electron transfer reaction at the
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e l e c t r o d e ,  D i s  t h e  d i f f u s i o n  c o e f f i c i e n t ,  v i s  t h e  s c a n  r a t e  
and C° i s  t h e  c o n c e n t r a t i o n  o f  t h e  s p e c i e s  in  b u l k  s o l u t i o n .
The l i n e a r  d e p e n d e n c e  o f  i p C and i p a on v x /  ^ i s  a f u r t h e r  
c h a r a c t e r i s t i c  i d e n t i f y i n g  a r e v e r s i b l e  s y s t e m .
CV h a s  become i n c r e a s i n g l y  p o p u l a r  in  a l l  f i e l d s  o f  
c h e m i s t r y  a s  a means o f  s t u d y i n g  r e d o x  s t a t e s .  The t e c h n i q u e  
e n a b l e s  a w ide p o t e n t i a l  r a n g e  t o  be  r a p i d l y  s ca n n ed  f o r  
r e d u c i b l e  o r  o x i d i s a b l e  s p e c i e s .  T h i s  c a p a b i l i t y ,  t o g e t h e r  w i t h  
t h e  a b i l i t y  t o  u s e  a v a r i a b l e  t i m e  s c a l e ,  make t h i s  on e o f  t h e  
most  v e r s a t i l e  e l e c t r o a n a l y t i c a l  t e c h n i q u e s  a v a i l a b l e  t o d a y .  
However,  i t  must be  s a i d  t h a t  i t s  a d v a n t a g e s  l i e  m a i n l y  in  
q u a l i t a t i v e  r a t h e r  th a n  q u a n t i t a t i v e  a n a l y s i s .  Q u a n t i t a t i v e  
m easurem en ts  a r e  b e s t  o b t a i n e d  u s i n g  o t h e r  t e c h n i q u e s  e . g .  
s t e p ,  p u l s e  o r  hydr odynamic  t e c h n i q u e s .
P er ha p s  t h e  most  u s e f u l  a s p e c t  o f  CV i s  i t s  
a p p l i c a t i o n  t o  t h e  q u a l i t a t i v e  d i a g n o s i s  o f  e l e c t r o d e  r e a c t i o n s  
which  a r e  c o u p l e d  t o  homogeneous c h e m i c a l  r e a c t i o n s  [ 1 0 - 1 3 ] .
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2.1.4. PULSE POLAROGRAPHY
P u l s e  p o l a r o g r a p h y  h as  b een  d e v e l o p e d  from t h e  need  
t o  s u p p r e s s  t h e  c a p a c i t a n c e  c u r r e n t  and t h e r e f o r e  l o w e r  t h e  
d e t e c t i o n  l i m i t s  o f  v o l t a m m e t r i c  m e a s u r e m e n t s .  P u l s e  
p o l a r o g r a p h y  was f i r s t  d e v e l o p e d  by B a r k e r  [ 1 7 ] ,  a r i s i n g  from 
h i s  work on s q u a r e  wave v o l t a m m e t r y .  I n  t h i s  s e c t i o n ,  t h e  t h e o r y  
and g e n e r a l  f e a t u r e s  o f  p u l s e  p o l a r o g r a p h y  a r e  p r e s e n t e d .
2 . 1 . 4 . 1 .  G enera l  f e a t u r e s  o f  p u l s e  p o l a r o g r a p h y
There a r e  two i m p o r t a n t  s o u r c e s  o f  c u r r e n t  a r i s i n g  
from p u l s e  a p p l i c a t i o n ?
( i )  t h e  f a r a d a i c  c u r r e n t  w h ich  i s  p r o p o r t i o n a l  t o  
t h e  c o n c e n t r a t i o n  o f  t h e  r e d o x  s p e c i e s  in  
s o l u t i o n ;  and
( i i )  t h e  c a p a c i t a n c e  c u r r e n t  n e e d e d  t o  c h a r g e  t h e  
e l e c t r o d e  d o u b l e  l a y e r .
The main i d e a  b e h i n d  t h e  p u l s e  t e c h n i q u e  i s  t h a t  t h e  
c a p a c i t a n c e  c u r r e n t  w h ich  f l o w s  a t  an e l e c t r o d e  in  r e s p o n s e  t o  a 
p o t e n t i a l  p u l s e  d e c a y s  e x p o n e n t i a l l y ,  w h i l e  t h e  f a r a d a i c  c u r r e n t  
d e c a y s  a t  a much s l o w e r  r a t e .  The c u r r e n t  can  t h e n  be measured  
a t  some t i m e  a f t e r  t h e  a p p l i c a t i o n  o f  t h e  p u l s e ,  wh ich  i s  long  
en ough  s o  t h a t  t h e  c a p a c i t a t i v e  c u r r e n t  i s  n e g l i g i b l e  w h i l e  t h e  
f a r a d a i c  c u r r e n t  i s  s t i l l  a p p r e c i a b l e .  T h e r e f o r e ,  t h e  c u r r e n t  
wh ich  i s  me asur ed ,  i s  a l m o s t  a f a r a d a i c  c u r r e n t  and p r o p o r t i o n a l  
t o  t h e  c o n c e n t r a t i o n  o f  t h e  r e d o x  s p e c i e s .
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p o l a r o g r a p h y  (NPP) and d i f f e r e n t i a l  p u l s e  p o l a r o g r a p h y  (DPP).
2 . 1 . 4 . 2 .  Normal p u l s e  p o l a r o g r a p h y  (NPP)
In  NPP, t h e  e l e c t r o d e  i s  h e l d  a t  a b a s e  p o t e n t i a l ,  
Eb , a t  which n e g l i g i b l e  e l e c t r o l y s i s  o c c u r s  f o r  m os t  o f  t h e  l i f e  
o f  ea c h  mercury drop  from t h e  DME. A f t e r  a f i x e d  t i m e  (w hich  i s  
measured from t h e  b i r t h  o f  t h e  d r o p ) ,  t h e  p o t e n t i a l  i s  ch an ged  
a b r u p t l y  t o  a v a l u e  En f o r  a p e r i o d  o f  50 msec in  d u r a t i o n  
and t h e  p o t e n t i a l  p u l s e  i s  en d ed  by a r e t u r n  t o  t h e  b a s e  v a l u e  
Eb . The c u r r e n t  i s  measur ed  f o r  t h e  l a s t  1 5 - 2 0  msec o f  t h e  p u l s e  
d u r a t i o n .  The drop i s  d i s l o d g e d  j u s t  a f t e r  t h e  p u l s e  e n d s ;  t h e n
t h e  w h ole  c y c l e  i s  r e p e a t e d  w i t h  s u c c e s s i v e  d r o p s ,  e x c e p t  t h a t  t h e  
s t e p  p o t e n t i a l  i s  made a few m i l l i v o l t s  more p o s i t i v e  o r  n e g a t i v e  
w i t h  ea c h  a d d i t i o n a l  c y c l e .  The o u t p u t  i s  a p l o t  o f  sampled  
c u r r e n t  v s  s t e p  p o t e n t i a l ,  and i t  t a k e s  t h e  form shown in  F i g u r e
2 . 4 .  As a r e s u l t  o f  t h e  d e l a y  t h a t  o c c u r s  b e tw e e n  t h e  a p p l i c a t i o n  
o f  t h e  p u l s e  and t h e  s a m p l i n g  o f  t h e  c u r r e n t ,  t h e  c o n t r i b u t i o n
from t h e  c a p a c i t a n c e  c u r r e n t  i s  a t  a minimum, t h u s  s i g n i f i c a n t l y  
im p ro v in g  t h e  s i g n a l - t o - n o i s e  r a t i o .  T h i s  i s  b e c a u s e  t h e  
c a p a c i t a n c e  c u r r e n t  d e c a y s  more r a p i d l y  t h a n  t h e  f a r a d a i c  c u r r e n t .
The two main variants of pulse polarography are normal pulse
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(a)
(c)
F i g u r e  2 . 4 .  Sa m p lin g  sch em e f o r  normal p u l s e
p o l a r o g r a p h y .  ( a )  P o t e n t i a l  program, <b) 
and ( c )  C u r r e n t  and p o t e n t i a l  d u r i n g  a 
s i n g l e  d r o p ' s  l i f e t i m e .
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2.1.4.3. Differential pulse polarography (DPP)
B e t t e r  l i m i t s  o f  d e t e c t i o n  t h a n  NPP can  be o b t a i n e d  w i t h  
s m a l 1 - a m p l i t u d e  p u l s e  schemes a s  shown in  F i g u r e  2 . 5 .  The 
approach  i s  s i m i l a r  t o  NPP, b u t  s e v e r a l  major d i f f e r e n c e s  a r e  
n o t e d :
( i )  t h e  b a s e  p o t e n t i a l  a p p l i e d  d u r i n g  m os t  o f  a d r o p ' s
l i f e t i m e  i s  n o t  c o n s t a n t  from drop  t o  d ro p ,  b u t  i n s t e a d  i s  
ch an ged  s t e a d i l y  in  s m a l l  i n c r e m e n t s ,
( i i )  t h e  p u l s e  h e i g h t  i s  o n l y  1 0 - 1 0 0  mV and i s  k e p t  a t  a
c o n s t a n t  l e v e l  w i t h  r e s p e c t  t o  t h e  b a s e  p o t e n t i a l ,  and two  
c u r r e n t  m e a sur em en ts  a r e  ta k e n  d u r i n g  e a c h  d r o p ' s  l i f e t i m e .
I n  DPP, p u l s e s  o f  f i x e d  m a g n i t u d e  a r e  s u p e r i m p o s e d  on a 
l i n e a r  DC p o t e n t i a l  ramp and a p p l i e d  t o  t h e  e l e c t r o d e  a t  a t i m e
j u s t  b e f o r e  t h e  end o f  t h e  d r o p .  T h e r e f o r e ,  a t  a f i x e d  t i m e
p e r i o d  d u r i n g  t h e  grow th  o f  e a c h  drop  j u s t  b e f o r e  a p p l i c a t i o n  
o f  t h e  p u l s e ,  t h e  c u r r e n t  f l o w i n g  i d t  ^ i s  s a m p l e d .  A s m a l l  
a m p l i t u d e  p u l s e  ( E<100 mV) i s  t h e n  s u p e r i m p o s e d  on t h e  v o l t a g e  
ramp ( F i g u r e  2 . 5 . ) .  The c u r r e n t  f l o w i n g  a t  t h e  end o f  t h e  p u l s e  
i d t 2 i s  a 9 a i n  sampled  d u r i n g  a f i x e d  t i m e  p e r i o d  a f t e r  t h e  
a p p l i c a t i o n  o f  t h e  p u l s e .  The d i f f e r e n c e  b e tw e e n  t h e  two  
c u r r e n t s ,  A i , = i d t l - i d t 2 - i s  t h e  m easured  p a r a m e t e r .  To
o b t a i n  an e x p r e s s i o n  f o r  A i , t h e  f o l l o w i n g  a s s u m p t i o n s  a r e  
made:
( i )  no g row th  o f  t h e  mercury drop  o c c u r s  d u r i n g  t h e  
d i f f e r e n c e  in  s a m p l in g  p e r i o d s ;  and
( i i )  t h e  r a t i o  o f  t i m e  i n t e r v a l  b e t w e e n  p u l s e
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F i g u r e  2 . 5 .  Waveform u s e d  in d i f f e r e n t i a l  p u l s e  
p o l a r o g r a p h y .
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a p p l i c a t i o n  and c u r r e n t  me as ur em en t  t i m e  
d u r i n g  which  t h e  m ercury  drop  h a s  grown p r i o r  t o  
p u l s e  a p p l i c a t i o n ,  i s  s m a l l .
Fo r a  r e v e r s i b l e  e l e c t r o d e  p r o c e s s  t h e  d i f f e r e n t i a l  p u l s e  c u r r e n t  
i s  o b t a i n e d  from t h e  e q u a t i o n
i ( E )  = £ (  5 2 - l ) i d / (  <52+ e  ) ( l .+  e  ) ( 2 . 2 9 )
where
6 = ex p  ( -nF/RTE2 ) ( 2 . 3 0 )
and
£ =  exp  ( ( n F / R T ) ( E - E 1 / 2 ) )  ( 2 . 3 1 )
The maximum v a l u e  o f  A i ( E ) ,  where A i ( E )  = i p ,  i s  f o u n d  by
d i f f e r e n t i a t i n g  e q u a t i o n  2 . 2 9 :
i p = i d ( 5 -  l ) / (  6 + 1 )  ( 2 . 3 2 )
E q u a t i o n  ( 2 . 3 2 )  shows t h a t  ip  i s  a l i n e a r  f u n c t i o n  o f
c o n c e n t r a t i o n .  However,  c a t a l y t i c  and o t h e r  p e r t u r b a t i o n s  o f  t h e  
e l e c t r o d e  p r o c e s s ,  which  r e s u l t  in  i d v s  C p l o t s  b e i n g  c u r v e d  in  
DC p o l a r o g r a p h y ,  h a v e  an a n a l o g o u s  e f f e c t  in  b o t h  normal  and 
d i f f e r e n t i a l  p u l s e  p o l a r o g r a p h y  w i t h  r e s p e c t  t o  i Npp 
and i p  r e s p e c t i v e l y  [ 2 ] .
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measured in  t h e  d i f f e r e n t i a l  p u l s e  mode i s :
i f  = Jp u l s e  + i DC ( 2 . 3 3 )
where i p Ui s e  i s  t h e  p u l s e  c u r r e n t .  As i n d i c a t e d  in  e q u a t i o n  
( 2 . 3 3 ) ,  t h e  f a r a d a i c  c u r r e n t  measured  i s  t h e  d e s i r e d  p u l s e  c u r r e n t  
and a DC c o n t r i b u t i o n  due t o  t h e  grow th  o f  t h e  m ercury  d r o p .  T h i s  
DC f a r a d a i c  c o n t r i b u t i o n  i s  e x h i b i t e d  by a  s h i f t  i n  b a s e l i n e .  For 
r e d u c t i o n  p r o c e s s e s ,  t h e  b a s e l i n e  f o l l o w i n g  t h e  p eak  i s  s h i f t e d  
upward,  becom ing  q u i t e  p ro n o un ced  a t  s h o r t  d r o p  t i m e s  [ 1 8 ] .  For  
a n a l y t i c a l  p u r p o s e s ,  t h e  peak c u r r e n t  s h o u l d  b e  m easured  from t h e
l i n e  e x t r a p o l a t e d  from t h e  b a s e l i n e  b e f o r e  t h e  p e a k .
As t h e  c o n c e n t r a t i o n  o f  t h e  e l e c t r o a c t i v e  s p e c i e s  i s  d e c r e a s e d ,  so  
t h e  f a r a d a i c  r e s p o n s e  d e c r e a s e s  p r o p o r t i o n a l l y .  T h e r e f o r e ,  
e v e n t u a l l y  t h e  c h a r g i n g  c u r r e n t  masks t h e  f a r a d a i c  c u r r e n t .  To 
overcome t h i s  l i m i t a t i o n  a s s o c i a t e d  w i t h  t h e  c h a r g i n g  c u r r e n t ,  a 
s t a t i o n a r y  mercury drop  e l e c t r o d e  (SMDE) was i n t r o d u c e d  i n s t e a d  o f  
t h e  DME [ 1 9 ] .  With t h e  SMDE, t h e  mercury d rop  g r o w s  q u i c k l y  and 
r e m a in s  c o n s t a n t  u n t i l  t h e  drop  i s  d i s l o d g e d .  The c h a r g i n g  c u r r e n t  
in  t h i s  c a s e  i s  s i g n i f i c a n t l y  r e d u c e d  and t h e  l i m i t  o f  d e t e c t i o n  
o f  DPP i s  improved .
The p o t e n t i a l  a t  wh ich  t h e  c u r r e n t  r e a c h e s  i t ' s  maximum 
v a l u e  i s  g i v e n  by:
Ep = E1 / 2  - A E / 2  ( 2 . 3 4 )
For a reversible electrode process at a DME, the faradaic current
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The v a l u e  o f  Ep i s  s h i f t e d  in  a p o s i t i v e  d i r e c t i o n  a s  t h e  p u l s e  
a m p l i t u d e  i s  i n c r e a s e d .  F u r t h e r m o r e ,  t h e  l a r g e r  t h e  v a l u e  o f A E ,  
t h e  l a r g e r  t h e  v a l u e  o f  ( A i ) max. An i n c r e a s e s  i n A E ,  h ow ever,  
i n c r e a s e s  t h e  peak w id th ,  which  d e c r e a s e s  t h e  o v e r a l l  r e s o l u t i o n .  
In p r a c t i c e ,  v a l u e s  o f  AE b e t w e e n  10 and 100 mV a r e  u s e d .  T he se  
o f f e r  t h e  b e s t  com pr om ise  b e t w e e n  a d e q u a t e  r e s o l u t i o n  and 
s e n s i t i v i t y .
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2.1.5. Adsorptive stripping voltammetry
2 . 1 . 5 . 1 .  I n t r o d u c t i o n
In  s t r i p p i n g  a n a l y s i s ,  t h e  s u b s t a n c e  t o  be  
d e t e r m i n e d  i s  p r e c o n c e n t r a t e d  a t  t h e  w o r k in g  e l e c t r o d e  p r i o r  t o  
t h e  a c t u a l  measurement  s t e p .  Most a p p l i c a t i o n s  o f  t h i s  
t e c h n i q u e  have c e n t r e d  aro und  h e a v y  m e ta l  a n a l y s i s ,  wh ich  
e l e c t r o l y t i c a l l y  d e p o s i t  and form an amalgam w i t h  mercury .  
However,  o v e r  t h e  r e c e n t  10 y e a r s ,  t h e r e  h a s  b een  a l a r g e  
i n t e r e s t  in  t h e  u s e  o f  s t r i p p i n g  a n a l y s i s  f o r  t h e  d e t e r m i n a t i o n  
o f  b i o m a c r o m o l e c u l e s ,  d r u g s ,  o r g a n i c  and i n o r g a n i c  compounds  
t h a t  c a n n o t  be a c c u m u l a t e d  t h r o u g h  e l e c t r o l y s i s .  Hence,  an 
a d s o r p t i v e  a c c u m u l a t i o n  (an a l t e r n a t i v e  p r e c o n c e n t r a t i o n  s t e p )  
h a s  been  u s e d  f o r  t h e s e  s u b s t a n c e s .  The term " a d s o r p t i v e  
s t r i p p i n g  vo l ta m m etr y"  (AdSV) i n d i c a t e s  an e l e c t r o a n a l y t i c a l
t e c h n i q u e  where t h e  a n a l y t e  i s  p r e c o n c e n t r a t e d  i n i t i a l l y  by 
a d s o r p t i o n  a t  t h e  w o r k in g  e l e c t r o d e ,  f o l l o w e d  by v o l t a m m e t r i c  
measurement  o f  t h e  s u r f a c e  bound s p e c i e s .
The amount o f  s u b s t a n c e  a c c u m u l a t e d  a t  t h e  s u r f a c e  
o f  t h e  e l e c t r o d e  may be a f f e c t e d  by a number o f  p a r a m e t e r s  such  
a s  s o l v e n t ,  e l e c t r o d e  m a t e r i a l ,  p o t e n t i a l ,  t i m e ,  pH, i o n i c  
s t r e n g t h ,  mass t r a n s p o r t  and t e m p e r a t u r e  [ 2 0 ] .  Most a d s o r p t i v e
s t r i p p i n g  p r o c e d u r e s  u s e  t h e  h a n g i n g  mercury d ro p  e l e c t r o d e
(HMDE) f o r  m e a s u r in g  r e d u c i b l e  s p e c i e s ,  w h i l e  c a r b o n  p a s t e ,  wax 
im p r e g n a te d  g r a p h i t e  and p l a t i n u m  e l e c t r o d e s  a r e  u s e d  when
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a d v a n t a g e s  o v e r  o t h e r  w o r k in g  e l e c t r o d e s ?  i t  h a s  s e l f - c l e a n i n g  
p r o p e r t i e s ,  r e p r o d u c i b l e  s u r f a c e  a r e a  and a u t o m a t i c  c o n t r o l ,  
and a l s o  o f f e r s  l o w e r  d e t e c t i o n  l i m i t s  ( 1 0 - 1 ® -  10 - 1 1  M)
 Q  ___Q
compared t o  t h o s e  o b t a i n e d  a t  s o l i d  e l e c t r o d e s  (1 0  -  10  3
M) due t o  l o w er  b a ckground  c u r r e n t s  a t  m ercury  e l e c t r o d e s .
B a s i c a l l y ,  t h e r e  a r e  two main s t e p s  in  t h e  AdSV
t e c h n i q u e ,  which  w i l l  b e  h i g h l i g h t e d  in  t h e  f o l l o w i n g  s e c t i o n s .
2 . 1 . 5 . 2 . 1 .  A c c u m u l a t io n  s t e p
The low l i m i t s  o f  d e t e c t i o n  u s i n g  AdSV a r e
a t t r i b u t i b l e  t o  t h e  p r e c o n c e n t r a t i o n  t h a t  t a k e s  p l a c e  d u r in g  
t h e  a c c u m u l a t i o n  s t e p .  T h i s  s t e p  i s  n o r m a l l y  c a r r i e d  o u t  und er
c o n t r o l l e d  p o t e n t i a l  c o n d i t i o n s  f o r  a d e f i n i t e  t i m e  and under
r e p r o d u c i b l e  mass t r a n s p o r t  (h y d ro d y n a m ic )  c o n d i t i o n s  in  t h e  
s o l u t i o n .  The s p e c i e s  a r e  d e p o s i t e d  e i t h e r  i n  t h e  form o f :
( i )  an amalgam o r  f i l m  on t h e  s u r f a c e  o f  t h e  
me rcury  (dro p  o r  f i l m ) ; o r
( i i )  a f i l m  on a s o l i d  e l e c t r o d e .
2 . 1 . 5 . 2 . 2 .  A c c u m u l a t io n  p o t e n t i a l  and t i m e
The a c c u m u l a t i o n  p o t e n t i a l  (Ea c c ) i s  a p p l i e d  t o
t h e  working  e l e c t r o d e  t o  c a u s e  t h e  a n a l y t e  t o  d e p o s i t  o n t o  o r
oxidisable analytes are of interest. The HMDE has many
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i n t o  t h e  e l e c t r o d e  m a t e r i a l .  The a c c u m u l a t i o n  t i m e  ( t a c c )  
must  be c a r e f u l l y  c o n t r o l l e d ?  up t o  f u l l  s u r f a c e  c o v e r a g e  o f  
t h e  e l e c t r o d e ,  t h e  l o n g e r  t h e  a c c u m u l a t i o n  t i m e ,  t h e  g r e a t e r  
t h e  amount o f  a n a l y t e  a c c u m u l a t e d  a t  t h e  e l e c t r o d e  d u r in g  t h e  
s t r i p p i n g  s t a g e .
The a c c u m u l a t i o n  s t e p  in  s t r i p p i n g  a n a l y s i s  i s  
u s u a l l y  f a c i l i t a t e d  by c o n v e c t i v e  t r a n s p o r t  o f  t h e  a n a l y t e  t o  
t h e  s u r f a c e  o f  t h e  working  e l e c t r o d e .  T h i s  t r a n s p o r t  i s  
a c h i e v e d  by e l e c t r o d e  r o t a t i o n  o r  s o l u t i o n  f l o w  ( i n  mercury  
f i l m  o r  s o l i d  e l e c t r o d e s ) ,  o r  by s o l u t i o n  s t i r r i n g
( p a r t i c u l a r l y  f o r  t h e  HMDE w ork in g  e l e c t r o d e ) .  During  t h e  
a c c u m u l a t i o n  s t e p ,  o n l y  a f r a c t i o n  o f  t h e  g i v e n  s u b s t a n c e  i s  
d e p o s i t e d  on t h e  w o r k in g  e l e c t r o d e  u nd er  r e p r o d u c i b l e
c o n d i t i o n s .  I f  a c o n s t a n t  c u r r e n t  i s  m a i n t a i n e d  d u r i n g  t h e  
a c c u m u l a t i o n  s t e p ,  t h e n  t h e  c o n c e n t r a t i o n  o f  t h e  a n a l y t e  may be  
w r i t t e n  w i t h  t h e  a p p l i c a t i o n  o f  F a r a d a y ' s  law.  For t h e  HMDE, 
t h e  c o n c e n t r a t i o n  i n  t h e  d ro p ,  Cg , may be  e x p r e s s e d  by t h e  
f o l l o w i n g  e q u a t i o n  [2 1 ]:
Ca = 3 i t / 4 ' f l * r 3nF ( 2 . 3 5 )
where i i s  t h e  c a t h o d i c  o r  a n o d i c  c u r r e n t  d u r in g  t h e
a c c u m u l a t i o n  s t e p ,  and r  i s  t h e  r a d i u s  o f  t h e  mercury d ro p .  
For a mercury f i l m  e l e c t r o d e  (MFE) o f  t h i c k n e s s  L and a r e a  A, 
t h e  c o n c e n t r a t i o n  in  t h e  f i l m  i s  g i v e n  by:
Ca = i t / A L nF  ( 2 . 3 6 )
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The c u r r e n t  f l o w i n g  a t  any t i m e  i t  d u r i n g  t h e  e l e c t r o l y s i s  
s t e p  i s  g i v e n  by t h e  e q u a t i o n  [ 2 2 ]:
i t  = 0 .62nFAD2 / 3 w1 / 2 v 1 / 6 C° ( 2 . 3 7 )
wher e w i s  t h e  r a t e  o f  e l e c t r o d e  r o t a t i o n  o r  s o l u t i o n  s t i r r i n g ,  
v i s  t h e  k i n e m a t i c  v i s c o s i t y  ( d e f i n e d  a s  t h e  v i s c o s i t y  d i v i d e d  
by t h e  d e n s i t y )  [ 2 1 ] ,  and C° i s  t h e  b u l k  c o n c e n t r a t i o n  o f  
a n a l y t e  a t  t i m e  t  d u r i n g  a c c u m u l a t i o n .
2 . 1 . 5 . 2 . 3 .  The r e s t  p e r i o d
To a l l o w  f o r m a t i o n  o f  a u n i f o r m  c o n c e n t r a t i o n  o f  t h e  
a n a l y t e  in  t h e  m ercury ,  a r e s t  p e r i o d  i s  u s e d  b e tw e en  t h e  
a c c u m u l a t i o n  and s t r i p p i n g  s t e p s .  At  t h e  end o f  t h e  
a c c u m u l a t i o n ,  t h e  c u r r e n t  d r o p s  t o  a l m o s t  z e r o  and a u n i fo r m  
c o n c e n t r a t i o n  d i s t r i b u t i o n  i s  e s t a b l i s h e d  q u i c k l y .  T h i s  r e s t  
p e r i o d  a l s o  makes s u r e  t h a t  t h e  s u b s e q u e n t  s t r i p p i n g  s t e p  i s  
p er f o rm e d  i n  a q u i e s c e n t  s o l u t i o n .  A l s o ,  d u r i n g  t h e  r e s t  
p e r i o d ,  e l e c t r o d e p o s i t i o n  h e l p e d  by d i f f u s i o n  t r a n s p o r t  i s  
c o n t i n u e d .  T h i s  r e s u l t s  in  t h e  n o n - z e r o  i n t e r c e p t  in  t h e  peak  
c u r r e n t  v e r s u s  a c c u m u l a t i o n  t i m e  p l o t .
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2.1.5.3.4. The stripping step
T h i s  s t a g e  c o n s i s t s  o f  a n o d i c  o r  c a t h o d i c  s c a n s  
d e p e n d i n g  on t h e  c h a r a c t e r  o f  t h e  s t r i p p i n g  p r o c e s s .  The
r e s u l t a n t  vol tammogram r e c o r d e d  d u r i n g  t h i s  s t e p  p r o v i d e s  t h e  
a n a l y t i c a l  i n f o r m a t i o n  o f  i n t e r e s t .  The s t r i p p i n g  c u r r e n t  i s  
p r o p o r t i o n a l  t o  t h e  c o n c e n t r a t i o n  o f  t h e  a n a l y t e  on o r  in  t h e
e l e c t r o d e ,  and h e n c e  t o  i t s  c o n c e n t r a t i o n  in  t h e  sam p le
s o l u t i o n .  The peak p o t e n t i a l s  a l s o  s e r v e  t o  i d e n t i f y  t h e
s p e c i e s  o f  i n t e r e s t .
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2 . 2 . HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
2 . 2 . 1 .  I n t r o d u c t i o n
Chromatography i s  e s s e n t i a l l y  a p h y s i c a l  method o f  
s e p a r a t i o n ,  in  wh ich  t h e  co m p o n en ts  t o  be  s e p a r a t e d  a r e
d i s t r i b u t e d  b e tw e en  two p h a se s?  on e  o f  t h e s e  b e i n g  a s t a t i o n a r y  
p h a s e  and t h e  o t h e r  a m o b i l e  p h a s e  w h ich  p e r c o l a t e s  th r o u g h  o r  
o v e r  t h e  s t a t i o n a r y  p hase  [ 2 3 ] .  The c h r o m a t o g r a p h i c  p r o c e s s  
o c c u r s  a s  a r e s u l t  o f  r e p e a t e d  s o r p t i o n / d e s o r p t i o n  p r o c e s s e s  
d u r i n g  t h e  movement o f  t h e  s a m p le  c o m p o n en ts  a l o n g  t h e
s t a t i o n a r y  p h a s e ,  and t h e  s e p a r a t i o n  i s  d u e  t o  t h e  d i f f e r e n c e s
in  t h e  d i s t r i b u t i o n  c o n s t a n t s  o f  t h e  i n d i v i d u a l  c o m p o n en t s .
2 . 2 . 2 .  F e a t u r e s  o f  c h r o m a t o g r a p h i c  s e p a r a t i o n
There  a r e  two c h a r a c t e r i s t i c  f e a t u r e s  o f  
c h r o m a t o g r a p h ic  s e p a r a t i o n  [ 2 4 ] :  a )  d i f f e r e n t i a l  m i g r a t i o n  o f  
v a r i o u s  compounds ( s o l u t e s )  in  t h e  o r i g i n a l  sample? and b )  a
s p r e a d i n g  o f  t h e  m o l e c u l e s  o f  e a c h  s o l u t e  a l o n g  t h e  column
(band m i g r a t i o n ) .
2 . 2 . 2 . 1 .  D i f f e r e n t i a l  m i g r a t i o n
D i f f e r e n t i a l  m i g r a t i o n  r e f e r s  t o  v a r y i n g  r a t e s  o f  
movement o f  d i f f e r e n t  compounds t h r o u g h  t h e  column,  and i s  t h e  
b a s i s  o f  s e p a r a t i o n  in  chromatography? t h a t  i s ,  w i t h o u t  a
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d i f f e r e n c e  in  r a t e s  o f  m i g r a t i o n  f o r  two compounds,  no  
s e p a r a t i o n  would be p o s s i b l e .
D i f f e r e n t  m i g r a t i o n  r a t e s  in  l i q u i d  c h ro m a to g ra p h y  (LC)
i s  a r e s u l t  o f  e q u i l i b r i u m  d i s t r i b u t i o n  o f  d i f f e r e n t  compounds
b e tw e en  t h e  s t a t i o n a r y  p h a s e  and m o b i l e  p h a s e  and t h e r e f o r e  i s  
d e t e r m i n e d  by e x p e r i m e n t a l  v a r i a b l e s  su c h  a s :
( i )  m o b i l e  p h a s e  com ponents ;
( i i )  s t a t i o n a r y  p h a s e  com pon en ts ;
( i i i )  s e p a r a t i o n  t e m p e r a t u r e s
2 . 2 . 2 . 2 .  Band S p r e a d in g
The a v e r a g e  m i g r a t i o n  r a t e s  o f  i n d i v i d u a l  m o l e c u l e s  o f  
s o l u t e s  a r e  n o t  s i m i l a r .  The d i f f e r e n t  m i g r a t i o n  r a t e s  do n o t  
a r i s e  from t h e  d i f f e r e n c e s  in  t h e  e q u i l i b r i u m  d i s t r i b u t i o n ,  b u t  
r a t h e r  due t o  p h y s i c a l  o r  r a t e  p r o c e s s e s .  The p r o c e s s e s  l e a d i n g  
t o  m o l e c u l a r  s p r e a d i n g  a r e  d e a l t  w i t h  b e l o w .
2 . 2 . 2 . 2 . 1 .  Eddy d i f f u s i o n
T h i s  a r i s e s  from t h e  d i f f e r e n t  f l o w s t r e a m s  t h a t  t h e  
m o b i l e  p h a s e  f o l l o w s  b e tw e e n  d i f f e r e n t  p a r t i c l e s  w i t h i n  t h e  
column.  Depend ing  on t h e  f l o w s t r e a m s  s a m p le  m o l e c u l e s  f o l l o w ,  
t h e  m o l e c u l e s  may t a k e  d i f f e r e n t  p a t h s  th r o u g h  t h e  pack ed  bed  
[ 2 5 ] .
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2.2.2.2.2. Mobile phase mass transfer
T h i s  r e f e r s  t o  t h e  d i f f e r e n t  f l o w  r a t e s  f o r
d i f f e r e n t  p a r t s  o f  a s i n g l e  f l o w s t r e a m  b e t w e e n  s u r r o u n d i n g
column p a r t i c l e s .  When l i q u i d  ( m o b i l e  p h a s e )  f l o w s  c l o s e  t o  a 
p a r t i c l e  i t  moves v e r y  s l o w l y ,  w h e r e a s  m o b i l e  p h a s e  m o l e c u l e s  
in  t h e  c e n t r e  o f  t h e  f l o w s t r e a m  move f a s t e r .  T h e r e f o r e ,  sam ple  
m o l e c u l e s  n e a r  t h e  column p a r t i c l e s  move s l o w l y ,  w h i l s t  sam ple  
m o l e c u l e s  in t h e  c e n t r e  o f  t h e  f l o w s t r e a m  move f a s t e r .
2 . 2 . 2 . 2 . 3 .  S t a t i o n a r y  p h a s e  mass t r a n s f e r
I f  t h e  p a c k i n g  p a r t i c l e s  o f  a column a r e  p o r o u s ,  t h e  
m o l e c u l e s  o f  a sa m p le  d i f f u s e  i n t o  t h e  p o r e s  and h e n c e  may
p e n e t r a t e  t h e  s t a t i o n a r y  p h a s e  o r  become a t t a c h e d  in  some
f a s h i o n .  In  t h e  fo rm er  c a s e ,  t h e  m o l e c u l e s  spen d  a l o n g e r  t i m e  
in  t h e  p a c k i n g  p a r t i c l e  and t h e r e f o r e  t r a v e l  s l o w e r  down t h e  
co lumn.  Those  m o l e c u l e s  t h a t  spend  l i t t l e  t i m e  moving  i n t o  and 
o u t  o f  t h e  s t a t i o n a r y  p h a s e  move f u r t h e r  down t h e  co lum n.
2 . 2 . 2 . 2 . 4 .  L o n g i t u d i n a l  d i f f u s i o n
When t h e  m o b i l e  p h a s e  i s  moving o r  e v e n  a t  r e s t ,  
sam p le  m o l e c u l e s  t e n d  t o  d i f f u s e  ran domly  in  a l l  d i r e c t i o n s .
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T h i s  e f f e c t  i s  o n l y  s i g n i f i c a n t  a t  low f l o w  r a t e s  o f  m o b i l e  
p h a s e  f o r  s m a l l  p a r t i c l e  c o lu m n s .
2 . 2 . 3 .  R e t e n t i o n  in  l i q u i d  c h ro m a to g ra p h y
I t  i s  p o s s i b l e  t o  d e r i v e  e q u a t i o n s  f o r  t h e  
q u a n t i t a t i o n  o f  d i f f e r e n t i a l  m i g r a t i o n  and band m i g r a t i o n .
The a v e r a g e  v e l o c i t y  w i t h i n  t h e  column o f  a m o l e c u l e  o f  a 
s o l v e n t  S i s  u ( c m / s e c )  and a sa m p le  band X i s  ux< From t h e  
p r e v i o u s  s e c t i o n ,  t h e  r a t e  o f  movement o f  sa m p le  X th r o u g h  t h e  
column d ep en d s  on R ( t h e  mole  f r a c t i o n  o f  m o l e c u l e s  o f  X in  t h e  
m o b i l e  p h a s e )  and on t h e  v e l o c i t y  o f  t h e  m o b i l e  p h a s e  u th r o u g h  
t h e  e q u a t i o n :
ux = uR ( 2 . 3 8 )
When R = 0 ,  no m i g r a t i o n  o c c u r s  and ux i s  z e r o .  A l s o ,  when 
t h e  f r a c t i o n  o f  m o l e c u l e  X in  t h e  m o b i l e  p h a s e  i s  u n i t y
(R = 1 ) ,  t h e n  t h e  m o l e c u l e s  move t h r o u g h  t h e  column a t  t h e  same
r a t e  a s  m o b i l e  p h a s e  m o l e c u l e s  i . e .  ux = u.
I t  i s  p o s s i b l e  t o  e x p r e s s  R i n  a n o t h e r  f a s h i o n .  The 
c a p a c i t y  f a c t o r  k' i s  d e f i n e d  a s  t h e  r a t i o  o f  t o t a l  m o le s  o f  X 
in  t h e  s t a t i o n a r y  p h a s e  (n s ) t o  t h e  t o t a l  m o le s  o f  X in  t h e
m o b i l e  p h a s e  (nm),  and may be w r i t t e n  a s  f o l l o w s :
k' -  ns /nn (2 .39)
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As R d e s c r i b e s  t h e  mole  f r a c t i o n  o f  compound X t h a t  i s  p r e s e n t  
in  m o b i l e  p h a s e ,  t h e  f o l l o w i n g  e q u a t i o n  ca n  be d e r i v e d  from
( 2 . 3 9 ) :
( 2 . 4 0 )
Hence:
R -  1 / ( 1  + k ' ) ( 2 . 4 1 )
and
ux = u / ( l  + k ' ) ( 2 . 4 2 )
I t  i s  now p o s s i b l e  t o  r e l a t e  t h e  v e l o c i t y  o f  sa m p le  X (ux ) t o
r e t e n t i o n  t i m e  ( t r ) and co lumn l e n g t h  (L ) .  R e t e n t i o n  t i m e  i s
d e f i n e d  a s  t h e  t i m e  t h a t  e l a p s e s  from t h e  moment t h e  sa m p le  i s
i n t r o d u c e d  i n t o  t h e  c h r o m a t o g r a p h i c  s y s t e m ,  t o  t h e  p o i n t  o f
maximum c o n c e n t r a t i o n  o f  t h e  e l u t e d  p e a k .  Hence t h e  t i m e  t a k e n  
f o r  compound X t o  move t h r o u g h  a column o f  l e n g t h  L w i t h  a 
v e l o c i t y  ux i s :
The t i m e  t a k e n  f o r  an u n r e t a i n e d  compound t o  move t h r o u g h  t h e  
column i s  g i v e n  by:
t r  = L / u x ( 2 . 4 3 )
t0 = L/u (2.44)
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Combining e q u a t i o n s  ( 2 . 4 3 )  and ( 2 . 4 4 ) ,  t h e  r e t e n t i o n  t i m e  
( t r ) may be e x p r e s s e d  a s ;
t r  = u t Q/ u x ( 2 . 4 5 )
On s u b s i t u t i o n  o f  t h i s  e q u a t i o n  i n t o  e q u a t i o n ( 2 . 4 2 )  y i e l d s :
k' = ( t r  -  t 0 ) / t Q ( 2 . 4 6 )
The v a l u e  o f  k ’ r e l a t e s  where a compound e l u t e s  r e l a t i v e  t o  
u n r e t a i n e d  m o b i l e  p h a s e  m o l e c u l e s  and i s  u s e d  t o  i d e n t i f y  a 
p e a k .
B e c a u s e  t r  v a r i e s  w i t h  f l o w  r a t e ,  k' i s  s o m e t i m e s  e x p r e s s e d  
in  te r m s  o f  r e t e n t i o n  vo lum e (Vr ) .  Hence e q u a t i o n  ( 2 . 4 6 )  can  
be w r i t t e n  a s :
k' = v r  -  VQ/Vr  ( 2 . 4 7 )
where Vr = r e t e n t i o n  v o lum e,  which  i s  t h e  t o t a l  vo lume o f  
m o b i l e  p h a s e  r e q u i r e d  t o  e l u t e  t h e  c e n t r e  o f  a g i v e n  peak ,  and 
VQ i s  t h e  v o i d  volum e (w hich  i s  a me as ur e o f  t h e  i n t e r n a l  
volum e o f  a HPLC s y s t e m  from i n j e c t o r  t o  d e t e c t o r ) .
2 . 2 . 4 .  E f f i c i e n c y  o f  s e p a r a t i o n
The e f f i c i e n c y  o f  a c h r o m a t o g r a p h i c  column may be  
e x p r e s s e d  by t h e  number o f  t h e o r e t i c a l  p l a t e s ,  N, and i s  g i v e n  
by:
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N = 16(tr/w)2 (2.48)
where t r  i s  t h e  r e t e n t i o n  t i m e  o f  t h e  p eak  and w i s  t h e  b a s e  
w id th  o f  t h e  p ea k .
N i s  n e a r l y  c o n s t a n t  f o r  d i f f e r e n t  bands in  a ch rom atogram f o r  
a g i v e n  s e t  o f  o p e r a t i n g  c o n d i t i o n s .
The q u a n t i t y  N i s  a l s o  p r o p o r t i o n a l  t o  L ( t h e  column  
l e n g t h ) ,  s u ch  t h a t  an i n c r e a s e  in L r e s u l t s  in  an i n c r e a s e  in 
N, and h e n c e  b e t t e r  s e p a r a t i o n .  The p r o p o r t i o n a l i t y  o f  N and L 
can  be w r i t t e n  a s :
N = L/H ( 2 . 4 9 )
where H i s  t h e  h e i g h t  e q u i v a l e n t  o f  a t h e o r e t i c a l  p l a t e  (HETP).
2 . 2 . 5 .  R e s o l u t i o n
The aim o f  any c h r o m a t o g r a p h i c  s e p a r a t i o n  i s  
a d e q u a t e  s e p a r a t i o n  b e t w e e n  t h e  com ponents  o f  a s a m p l e  m i x t u r e .  
R e s o l u t i o n  (R) i s  a me as ur e o f  t h e  d e g r e e  o f  s e p a r a t i o n  [ 2 6 ]  
and may be d e f i n e d  a s  f o l l o w s :
R = ( t b -  t a ) / 0 . 5 ( w a + wb ) ( 2 . 5 3 )
where t Q and t b a r e  r e t e n t i o n  t i m e s  o f  compounds A and B
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I t  i s  p o s s i b l e  a l s o  t o  e q u a t e  R in  t e r m s  o f  k' and N a s  
f o l l o w s :
R = / n / 4  (o c -l/cx )  ( k 1 /  1 + k 1 ) ( 2 . 5 1 )
where a  i s  d e f i n e d  a s  t h e  s e p a r a t i o n  f a c t o r  b e tw e e n  a d j a c e n t  
p ea k s  and i s  eq u a l  t o  t h e  r a t i o  o f  t h e i r  k' v a l u e s .
a -  k ' b/ k ' g  ( 2 . 5 2 )
From e q u a t i o n  ( 2 . 5 1 ) ,  r e s o l u t i o n  can  be c o n t r o l l e d  by v a r y i n g  
a ,  N, or  k ' .
and wg and wb are their corresponding baseline peak widths.
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2.3. ELECTROCHEMICAL DETECTION IN LIQUID CHROMATOGRAPHY
2 . 3 . 1 .  I n t r o d u c t i o n
The c o u p l i n g  o f  l i q u i d  ch ro m a to g r a p h y  w i t h  
e l e c t r o c h e m i c a l  d e t e c t i o n  (LCEC) o f f e r s  a s e l e c t i v e  and 
s e n s i t i v e  t o o l  f o r  t h e  d e t e r m i n a t i o n  o f  a w i d e  v a r i e t y  o f  
compounds o f  an e a s i l y  o x i d i s a b l e  o r  r e d u c i b l e  n a t u r e .  Very low 
l i m i t s  o f  d e t e c t i o n  h a v e  b e e n  a c h i e v e d ,  in  t h e  o r d e r  o f  0 . 1  
pm ole  f o r  a number o f  o x i d i s a b l e  com pounds.  However,  due t o  
p ro b le m s  w i t h  d i s s o l v e d  o x y g e n  and e l e c t r o d e  s t a b i l i t y ,  t h e  
p r a c t i c a l  l i m i t  o f  d e t e c t i o n  f o r  e a s i l y  r e d u c i b l e  s u b s t a n c e s  i s  
a t  l e a s t  1 0 - f o l d  l e s s .
L i q u i d  ch ro m a to g r a p h y  (LC) and hydrodynam ic  
v o l ta m m e tr y  a r e  in  g e n e r a l  v e r y  c o m p a t i b l e  t e c h n i q u e s ,  and in  
c o m b i n a t i o n  y i e l d  i m p o r t a n t  a d v a n t a g e s  f o r  a number o f  t r a c e  
d e t e r m i n a t i o n s .  The t h r e e  majo r a d v a n t a g e s  a r e :
( i )  s e l e c t i v i t y ?
( i i )  low d e t e c t i o n  l i m i t s ?  and
( i i i ) low c o s t .
The u s e  o f  LC f o r  t r a c e  a n a l y s i s  r e q u i r e s  a s e l e c t i v e  d e t e c t o r  
w i t h  a r a p i d  r e s p o n s e  t i m e ,  w id e  dynam ic r a n g e  and low a c t i v e  
dead  v o lum e.
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2.3.2. Fundamental Principles of Hydrodynamic Voltammetry
Hydrodynamic v o l t a m m e t r y  i n v o l v e s  t h e  measurement  o f  
t h e  c u r r e n t  p r o d u c ed  a s  t h e  s p e c i e s  u n d e r g o e s  an o x i d a t i o n  o r  
r e d u c t i o n  p r o c e s s  a t  t h e  e l e c t r o d e  s u r f a c e .  I n  t h e  c a s e  o f  
a m p er o m etr i c  d e t e c t i o n ,  t h e  w orking e l e c t r o d e  i s  h e l d  a t  a 
f i x e d  p o t e n t i a l  a s  t h e  a n a l y t e  f l o w s  p a s t  t h e  e l e c t r o d e  
s u r f a c e .  The e l e c t r o d e  i s  o p e r a t e d  i n  t h e  l i m i t i n g  c u r r e n t  
r e g i o n  f o r  t h e  e l u t e d  compounds (e ven  th o u g h  t h e  c o n c e n t r a t i o n  
v a r i e s  a s  t h e  z o n e s  e n t e r  and l e a v e  t h e  d e t e c t o r  c o m p a r tm e n t ) .
2 . 3 . 3 .  Mass t r a n s p o r t  p r o c e s s e s  und er  h ydrodyn am ic
c o n d i t i o n s
The m ost  commonly used  t h e o r y  c o n c e r n i n g  t h e
k i n e t i c s  o f  h e t e r o g e n e o u s  c h e m i c a l  r e a c t i o n s  t a k i n g  p l a c e  in  a 
s t i r r e d  s o l u t i o n  h a s  b een  d e v e l o p e d  by N e r n s t  [ 2 7 ] .  The N e r n s t
t h e o r y  s t a t e s  t h a t  t h e r e  i s  a t h i n  l a y e r  o f  s t a t i c  l i q u i d
i m m e d i a t e l y  a d j a c e n t  t o  t h e  s u r f a c e  o f  t h e  s o l i d  b o dy .  T h i s  i s  
a l a y e r  t h r o u g h  w h ich  d i f f u s i o n  o f  t h e  r e a c t i n g  s p e c i e s  t a k e s  
p l a c e .  Beyond t h i s  l a y e r ,  c a l l e d  t h e  d i f f u s i o n  l a y e r  o f  
t h i c k n e s s  d,  t h e  s p e c i e s  i s  t r a n s p o r t e d  by c o n v e c t i o n .  I n s i d e  
t h e  d i f f u s i o n  l a y e r ,  t h e  s o l u t i o n  i s  assumed t o  be  u n s t i r r e d ,
and h e n c e ,  t h e  c o n c e n t r a t i o n  d i s t r i b u t i o n  w i t h i n  t h e  l a y e r  i s  
t h o u g h t  t o  be  l i n e a r .
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On t h e  b a s i s  o f  t h e s e  a s s u m p t i o n s ,  t h e  f l u x  o f  component  t a k i n g  
p a r t  in  t h e  h e t e r o g e n e o u s  c h e m ic a l  r e a c t i o n  c a n  be e x p r e s s e d  a s
j = D A ( ( C ° - C ) / d )  ( 2 . 5 3 )
where j i s  t h e  mass f l u x ,  D i s  t h e  d i f f u s i o n  c o e f f i c i e n t ,  C° 
i s  t h e  c o n c e n t r a t i o n  in  t h e  b u l k  s o l u t i o n ,  C i s  c o n c e n t r a t i o n  
a t  t h e  e l e c t r o d e  s u r f a c e ,  and A i s  t h e  s u r f a c e  a re a  o f  t h e  
e l e c t r o d e .
However,  e x p e r i m e n t a l  o b s e r v a t i o n s  do n o t  s u p p o r t  
N e r n s t ' s  s u p p o s i t i o n s  t h a t  t h e  l i q u i d  i s  n o t  s t a t i o n a r y  n e a r  
t h e  e l e c t r o d e  s u r f a c e  and t h e  c o n c e n t r a t i o n  g r a d i e n t  i s  n o t  
l i n e a r .  The N e r n s t  r e l a t i o n s h i p  i s  s t i l l  b e i n g  u sed  d e s p i t e  
t h e s e  l i m i t a t i o n s .  From e q u a t i o n  ( 2 . 5 3 ) ,  i t  can  be s ee n  t h a t  
e v e r y  e f f e c t  t h a t  d e c r e a s e s  d ( e . g . ,  i n c r e a s e  in  f l o w  r a t e ,  
v i s c o s i t y  d e c r e a s e , e t c .  ) i n c r e a s e s  t h e  mass f l o w .  Even th ou gh  
t h i s  d e s c r i p t i o n  i s  q u a l i t a t i v e l y  c o r r e c t ,  t h e  r e l a t i o n s h i p  i s  
n o t  s u i t a b l e  f o r  t h e  q u a n t i t a t i v e  d e s c r i p t i o n  o f  t h e  e f f e c t  o f  
t h e s e  p a r a m e t e r s .  E q u a t i o n  2 . 5 3  can  be w r i t t e n  a s ;
I  = n F A D ( ( C ° - C ) /d )  = km(C°-C)  ( 2 . 5 4 )
The mass t r a n s f e r  c o e f f i c i e n t ,  km, can  be w r i t t e n  a s  :
km = nFAD/d ( 2 . 5 5 )
and can  be c a l c u l a t e d  r i g o r o u s l y  f o r  c e r t a i n  c e l l  g e o m e t r i e s  by
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e q u a t i o n s  f o r  t y p i c a l  s y s t e m s  c a n  be e x p r e s s e d  [ 2 9 ] .
L e v i c h  g a v e  an e x a c t  t r e a t m e n t  o f  t h e  mass t r a n s p o r t  
i n v o l v i n g  c o n v e c t i o n  and d i f f u s i o n  [ 2 8 ] .  L e v i c h ' s  t h e o r y
f u n d a m e n t a l l y  s t a t e s  t h a t  " th e  t r a n s p o r t  o f  a s o l u t e  i n  a 
l i q u i d  i s  g o v e r n e d  by two q u i t e  d i f f e r e n t  m e c h a n i sm s .  F i r s t ,  
t h e r e  i s  m o l e c u l a r  d i f f u s i o n  a s  a r e s u l t  o f  c o n c e n t r a t i o n  
d i f f e r e n c e s ;  s e c o n d ,  s o l u t e  p a r t i c l e s  a r e  e n t r a i n e d  by t h e
moving l i q u i d  and a r e  t r a n s p o r t e d  w i t h  i t .  The c o m b i n a t i o n  o f  
t h e s e  two p r o c e s s e s  i s  c a l l e d  " c o n v e c t i v e  d i f f u s i o n  o f  s o l u t e  
in  a l i q u i d " .  E i t h e r  o f  t h e s e  two s t r o n g l y  d i f f e r i n g  p r o c e s s e s ,
c o n v e c t i o n  and d i f f u s i o n ,  can  b e  p r e d o m i n a n t  in  o n e  o r  a n o t h e r
p o i n t  in t h e  l i q u i d .  However,  in  t h e  v i c i n i t y  o f  t h e  s o l i d  
s u r f a c e ,  b o th  p r o c e s s e s  have s i g n i f i c a n t  r o l e s .
G e n e r a l l y ,  in  a d d i t i o n  t o  t h e  c o n v e c t i v e  d i f f u s i o n ,  
t h e  m i g r a t i o n  o f  i o n s  due  t o  t h e  e f f e c t  o f  e l e c t r i c a l  
a t t r a c t i o n  p l a y s  a r o l e  in  an e l e c t r o d e  p r o c e s s .  F u r th er m o re ,  
t h e  r a t e  o f  a homogeneous c h e m i c a l  r e a c t i o n  may dep en d upon a
h e t e r o g e n e o u s  c h e m i c a l  r e a c t i o n  in  w hich  i t  i s  i n v o l v e d .
T h e r e f o r e ,  t h e  c o n c e n t r a t i o n  d i s t r i b u t i o n  r e l a t i n g  t o  a 
h e t e r o g e n e o u s  c h e m ic a l  r e a c t i o n  can  be g i v e n  a s  f o l l o w s :
d c j / d t  =V(Dj V c i )-V V c i +Z jF V (u i c i y  ) + k ( 2 . 5 6 )
where i s  t h e  d i f f u s i o n  c o e f f i c i e n t  o f  s p e c i e s  i ,  V i s  t h e
using various hydrodynamic equations, and limiting current
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f l o w  v e l o c i t y ,  Cj i s  t h e  c o n c e n t r a t i o n  o f  s p e c i e s  i ,  z  i s  t h e  
number o f  c h a r g e s  t r a n s p o r t e d  by i ,  Uj i s  t h e  i o n i c  m o b i l i t y ,  
(j i s  t h e  s t r e n g t h  o f  t h e  e l e c t r i c  f i e l d  and kj i s  t h e  r a t e  o f  
t h e  homogeneous c h e m i c a l  r e a c t i o n .
In e q u a t i o n  ( 2 . 5 6 ) ,  t h e  f i r s t  term r e l a t e s  t o  t h e  
c o n c e n t r a t i o n  g r a d i e n t  o f  s p e c i e s  i ,  and t h e  s e c o n d  r e l a t e s  t o  
t h e  m a c r o s c o p i c  f l o w  v e l o c i t y  o f  t h e  f l u i d  and t h e  
c o n c e n t r a t i o n  o f  i .  The t h i r d  term r e l a t e s  t o  t h e  m i g r a t i o n  and 
t h e  f o u r t h  on e  i s  t h e  r a t e  o f  t h e  hom ogen eo us  c h e m i c a l  
r e a c t i o n .
-74-
2.4. GRAPHITE FURNACE ATOMIC ABSORPTION SPECTROMETRY
2 . 4 . 1 .  I n t r o d u c t i o n
Atom ic a b s o r p t i o n  s p e c t r o s c o p y  (AAS) i s  one o f  t h e  
most  common a n a l y t i c a l  methods f o r  t h e  d e t e r m i n a t i o n  o f  
e l e m e n t s .  The term "atom ic  a b s o r p t i o n "  r e f e r s  t o  t h e  a b s o r p t i o n  
o f  e n e r g y  from a l i g h t  s o u r c e ,  w i t h  a  c o n s e q u e n t  d e c r e a s e  in  
t h e  r a d i a t i o n  power t r a n s m i t t e d  t h r o u g h  t h e  f l a m e  o r  f u r n a c e .  
Measurement  o f  t h i s  a b s o r p t i o n  g i v e s  r i s e  t o  q u a n t i t a t i v e  
m ea surem en ts .  B e c a u s e  f r e e  atoms c a n n o t  u n d e r g o  r o t a t i o n a l  o r  
v i b r a t i o n a l  t r a n s i t i o n s  a s  do m o l e c u l e s  [ 3 0 ] ,  o n l y  e l e c t r o n i c  
t r a n s i t i o n s  can t a k e  p l a c e  when e n e r g y  i s  a b s o r b e d  o r  e m i t t e d .  
There a r e  a v a r i e t y  o f  ways o f  o b t a i n i n g  f r e e  atoms and 
s u b s e q u e n t  me asur em en t  o f  t h e  r a d i a t i o n  t h e y  a b s o r b  o r  e m i t .  
T hese  i n c l u d e  f l a m e  a t o m i s a t i o n  and e l e c t r o t h e r m a l  a t o m i s a t i o n .  
Combust ion f l a m e s ,  though c h e a p  t o  p r o d u c e ,  s t a b l e  in  
o p e r a t i o n ,  and d e p e n d i n g  on t h e  g a s  m i x t u r e  used  
( a i r - a c e t y l e n e ,  maximum t e m p e r a t u r e  2200°C,
n i t r o u s - o x i d e - a c e t y l e n e ,  maximum t e m p e r a t u r e  -  320 0° C) [ 3 0 ]
a b l e  t o  p ro d u c e  a  w id e  r a n g e  o f  t e m p e r a t u r e s ,  n e v e r t h e l e s s  have  
c e r t a i n  d i s a d v a n t a g e s .  The p r im a ry  o n e  i s  t h a t  t h e  a t o m i c  
va pour  c o n t a i n s  o t h e r  h i g h l y  r e a c t i v e  s p e c i e s ,  and t h e r e f o r e  i t  
i s  n o t  p o s s i b l e  t o  p r e d i c t  w i t h  c e r t a i n t y  how a g i v e n  m i x t u r e  
o f  e l e m e n t s  may r e s p o n d  in  t e r m s  o f  a b s o r p t i o n .  Many a t t e m p t s  
h ave been  made t o  p ro d uce  t h e  a t o m i c  v a p o u r  in  a c o m p l e t e l y  
n e u t r a l  o r  u n r e a c t i v e  medium, h e n c e  t h e  g r o w t h  o f  e l e c t r i c a l
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methods  t o  i n t r o d u c e  t h e  r e q u i r e d  amount  o f  h e a t  e n e r g y  i n t o  
t h e  s y s t e m .  The u s e  o f  a g r a p h i t e  f u r n a c e  f o r  g e n e r a t i n g  atom s
was f i r s t  d e s c r i b e d  by L 'v o v  [ 3 1 ] .  In  m o s t  f u r n a c e  t e c h n i q u e s ,
t h e  sam p le  i s  r a i s e d  t o  i t s  a t o m i s a t i o n  t e m p e r a t u r e  t h r o u g h  t h e
s e q u e n t i a l  s t e p s  o f  d r y i n g ,  a s h i n g ,  and a t o m i s a t i o n .  U s u a l l y  a 
f o u r t h  s t e p ,  i . e .  t u b e  c l e a n ,  i s  ad ded  in  wh ich  any s o l i d  
m a t e r i a l  r e m a i n i n g  in  t h e  t u b e  f o l l o w i n g  a t o m i s a t i o n  i s  removed  
by v o l a t i l i s a t i o n  a t  t h e  h i g h e s t  a t t a i n a b l e  t e m p e r a t u r e .  When a 
low v o l t a g e  i s  a p p l i e d  t o  t h e  en d s  o f  t h e  g r a p h i t e  t u b e ,  a 
c u r r e n t  o f  s e v e r a l  hundred am p eres  f l o w s ,  r e s u l t i n g  in  a r a p i d  
t e m p e r a t u r e  r i s e .  Hence a power s u p p l y  i s  u s e d  t o  p r o v i d e  a low 
v o l t a g e  h i g h  power waveform,  w hich  c a n  be c o n t r o l l e d  t o  g i v e  
t h e  r e q u i r e d  t e m p e r a t u r e  f o r  t h e  r e q u i r e d  t i m e  f o r  ea c h  o f  t h e
s t e p s  n o t e d  a b o v e .
2 . 4 . 2 .  A t o m i s e r  m a t e r i a l
An i d e a l  a t o m i s e r  s h o u l d  be c o n s t r u c t e d  from a 
m a t e r i a l  w h ich  i s  c h e m i c a l l y  i n e r t ,  h a s  good t h e r m a l  and 
e l e c t r i c a l  c o n d u c t i v i t y ,  and h a s  low p o r o s i t y  and h i g h  m e l t i n g  
p o i n t  [ 3 2 ] .  G r a p h i t e  a l m o s t  s a t i s f i e s  t h e s e  c o n d i t i o n s .  I t  i s  
made in  a p r o c e s s  in  wh ich  c a r b o n  i s  h e a t e d  r e s i s t i v e l y  t o  
a b o u t  3000°C and a t  normal  p r e s s u r e s  i t  s u b l i m e s  a t  a b o u t  
3500°C; s o  t h i s  s e t s  t h e  upper  l i m i t  f o r  g r a p h i t e  a t o m i s e r s .  
G r a p h i t e  i s  o x i d i s e d  a t  t e m p e r a t u r e s  much low er  th a n  t h i s  in  
c o n t a c t  w i t h  a i r ;  h e n c e ,  g r a p h i t e  a t o m i s e r s
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a r e  a l w a y s  o p e r a t e d  in  an a t m o s p h e r e  o f  n i t r o g e n  o r  a r g o n .  
However,  normal  g r a p h i t e  i s  p o r o u s  and i t s  p o r o s i t y  a p p e a r s  t o  
i n c r e a s e  a f t e r  i t  h a s  been  m a i n t a i n e d  a t  h i g h  t e m p e r a t u r e s .  
A noth er  d i s a d v a n t a g e  o f  g r a p h i t e  a s  an a t o m i s e r  m a t e r i a l  i s  
t h a t  some e l e m e n t s  r e a d i l y  form s t a b l e  c a r b i d e s  in  c o n t a c t  w i t h  
g r a p h i t e  a t  e l e v a t e d  t e m p e r a t u r e s .  P y r o l y t i c  g r a p h i t e  o v e r c o m e s  
b o th  o f  t h e s e  p r o b le m s  t o  a l a r g e  e x t e n t  [ 3 3 ] .
2 . 4 . 3 .  S e l e c t i o n  o f  o p e r a t i n g  c o n d i t i o n s
Each o f  t h e  f o u r  s t a g e s  i . e ,  d r y i n g ,  a s h i n g ,  
a t o m i s a t i o n  and t u b e  c l e a n  must  be  c a r e f u l l y  o p t i m i s e d  t o  
o b t a i n  t h e  b e s t  r e s u l t s  f o r  any p a r t i c u l a r  a n a l y s i s .
2 . 4 . 3 . 1 .  D r y in g
Du rin g t h i s  p h a s e  t h e  s o l v e n t  i s  e v a p o r a t e d  from t h e  
sample  s o l u t i o n  p r e v i o u s l y  i n j e c t e d  i n t o  t h e  g r a p h i t e  t u b e .  The 
s t e p  must be  a c c o m p l i s h e d  in  a c o n t r o l l e d  manner such  t h a t  
t h e r e  i s  a s l o w ,  e v e n  e v a p o r a t i o n  o f  t h e  s o l v e n t  from t h e  
m a t r i x ,  l e a v i n g  b e h i n d  t h e  d r i e d  s o l i d  s a m p l e .  As an e m p i r i c a l  
r u l e ,  a s e t t i n g  o f  105°C i s  h i g h  en ough f o r  a q u e o u s  s a m p l e s ,  
and t i m e  n e c e s s a r i l y  v a r i e s  a c c o r d i n g  t o  t h e  sam p le  s i z e .
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2.4.3.2. Ashing and atomisation
When t r a c e  m e t a l s  a r e  t o  be  d e t e r m i n e d  in  pure  
a q ueo us  s o l u t i o n s ,  t h i s  p h a s e  h a s  no s i g n i f i c a n c e .  However,  
when t r a c e  m e t a l s  a r e  t o  be d e t e r m i n e d  i n  v a r y i n g  amounts o f  
m a t r i x ,  t h e  a s h i n g  s t a g e  i s  p e r h a p s  t h e  m o s t  s i g n i f i c a n t  s t a g e  
in  t h e  w h o l e  f u r n a c e  programme.  The s u c c e s s  o f  t h e  a n a l y s i s  
d epends on t h e  c o r r e c t  s e l e c t i o n  o f  t h e  a s h i n g  c o n d i t i o n s .  
P ro p er  th e r m a l  d e s t r u c t i o n  o f  t h e  m a t r i x  i n  a s a m p l e  d ep en ds  on  
t h e  m a t r i x  i t s e l f .  The u s e  o f  t o o  h i g h  an a s h i n g  t e m p e r a t u r e  o r  
t i m e  r e s u l t s  in  t h e  l o s s  o f  s i g n i f i c a n t  q u a n t i t i e s  o f  t h e
a n a l y t e  b e f o r e  t h e  a t o m i s a t i o n  s t a g e .  The b e s t  method t o  
d e t e r m i n e  t h e  l i m i t s  f o r  b o t h  t h e  a s h i n g  and a t o m i s a t i o n  s t a g e s  
l i e s  in  t h e  c o n s t r u c t i o n  o f  a s h / a t o m i s e  c u r v e s  f o r  t h e  e l e m e n t s  
and m a t r i c e s  i n v o l v e d .
2 . 4 . 3 . 3 .  A s h / a t o m i s e  c u r v e s
H aving  e s t a b l i s h e d  t h e  b e s t  d r y i n g  t e m p e r a t u r e ,  t h e  
a s h i n g  s t a g e  i s  o m i t t e d ,  and an i n i t i a l  a t o m i s a t i o n  t i m e  and
low t e m p e r a t u r e  a r e  s e t .  A s u i t a b l e  vo lum e i s  i n j e c t e d  i n t o  t h e  
g r a p h i t e  t u b e  and t h e  c o m p l e t e  f u r n a c e  programme i s  c a r r i e d
o u t .  The r e s u l t i n g  peak  h e i g h t  i s  p l o t t e d  v s .  t e m p e r a t u r e ,  and
t h e  a t o m i s a t i o n  t e m p e r a t u r e  s e t t i n g  i s  i n c r e a s e d  b e f o r e  t h e  
n e x t  i n j e c t i o n .  A t y p i c a l  p l o t  i s  shown i n  F i g u r e  2 . 6 .  As t h e  
t e m p e r a t u r e  i s  i n c r e a s e d ,  s o  t h e  peak  h e i g h t  i n c r e a s e s  u n t i l  a
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F i g u r e  2 . 6 .  T y p i c a l  a s h / a t o m i s e  c u r v e
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p o i n t  i s  r e a c h e d  where t h e  pea k  h e i g h t  d o e s  n o t  i n c r e a s e .  T h i s  
p o i n t  c o r r e s p o n d s  t o  t h e  l o w e s t  t e m p e r a t u r e  f o r  c o m p l e t e  
a t o m i s a t i o n .
Having s e l e c t e d  t h e  b e s t  a t o m i s a t i o n  t e m p e r a t u r e ,  a 
s i m i l a r  p r o c e d u r e  i s  f o l l o w e d  t o  o p t i m i s e  a s h i n g  c o n d i t i o n s .  A 
p l o t  o f  peak h e i g h t  v s .  t e m p e r a t u r e  i s  a t y p i c a l  m i r r o r  image  
o f  t h e  a t o m i s a t i o n  g r a p h .  The peak h e i g h t  r e m a i n s  c o n s t a n t  
u n t i l  t h e  p o i n t  i s  r e a c h e d  where t h e  a n a l y t e  i s  l o s t  and a t  
t h i s  p o i n t  t h e  peak h e i g h t  d e c r e a s e s  r a p i d l y  w i t h  i n c r e a s i n g  
t e m p e r a t u r e .  The a s h i n g  t e m p e r a t u r e  i s  t a k e n  a s  t h e  p o i n t  
100°C c o o l e r  th a n  t h e  t u r n - o v e r  p o i n t .
2 . 4 . 3 . 4 .  Tube c l e a n
T h i s  t e m p e r a t u r e  i s  n o r m a l l y  s e t  a t  s e v e r a l  hundred  
d e g r e e s  a b o v e  t h e  a t o m i s a t i o n  t e m p e r a t u r e ,  f o r  a b o u t  5 s e c .  A 
m a t r i x ,  s u ch  a s  b l o o d  o r  serum, l e a v e s  a d e p o s i t  b e h i n d  in  t h e  
t u b e  which  may r e s i s t  rem o v a l  by any means o t h e r  t h a n  
p h y s i c a l l y  b r u s h i n g  i t  o u t .  A l s o  w i t h  some e l e m e n t s ,  c a r b i d e  o r  
n i t r i d e  f o r m a t i o n  o c c u r s  t o  g i v e  a memory e f f e c t .  T h e r f o r e  t h e  
t u b e  must be  c l e a n  f o r  a d e q u a t e  a n a l y t i c a l  r e p r o d u c i b i l i t y .
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2.4.3.5. Temperature programming
D uring  t h e  d e v e l o p m e n t  o f  t h e  f u r n a c e  t e c h n i q u e ,  i t  
became c l e a r  t h a t  some s o r t  o f  t e m p e r a t u r e  programming was 
n eed ed  i f  r e p r o d u c i b l e  r e s u l t s  were t o  be  o b t a i n e d .  A t y p i c a l  
h e a t i n g  programme i s  d e p i c t e d  in  F i g u r e  2 . 7 .  The r a t e  o f  r i s e  
o f  t h e  t u b e  t e m p e r a t u r e ,  t o g e t h e r  w i t h  r e s i d e n c e  t i m e  o f  ea c h  
t e m p e r a t u r e ,  can be s e t  and r e p r o d u c e d  by c o n t r o l s .  With t h i s  
a u t o m a t i c  f e a t u r e ,  r e p r o d u c i b i l i t y  c a n  be m a i n t a i n e d  and 
s e t t i n g s  r e p e a t e d  t o  match r e q u i r e m e n t s  o f  s a m p l e s ,  a c c o r d i n g  
t o  t h e i r  d i f f e r e n t  p h y s i c a l  and c h e m i c a l  c h a r a c t e r i s t i c s .
E l e c t r o t h e r m a l  a t o m i s a t i o n ,  a s  o u t l i n e d  h e r e ,  o f f e r s  
a d v a n t a g e s  o v e r  t h e  f l a m e  a p p r o a c h .  The f i r s t  o f  t h e s e  i s  where  
d e t e c t i o n  l i m i t s  a r e  s o u g h t  w h ich  a r e  b e lo w  t h o s e  g i v e n  u s i n g  a 
f l a m e .  As a r u l e ,  t h e  r e c i p r o c a l  s e n s i t i v i t e s  g i v e n  f o r  t h e  
m a j o r i t y  o f  e l e m e n t s  by e l e c t r o t h e r m a l  a t o m i s a t i o n  a r e  a b o u t  
1000 t i m e s  b e t t e r  t h a n  u s i n g  a f l a m e  [ 3 2 ] .  S e c o n d l y ,  
e l e c t r o t h e r m a l  methods s h o u l d  be c o n s i d e r e d  when t h e  amount o f  
sam p le  i s  l i m i t e d .  The normal  volume o f  s o l u t i o n  t a k e n  f o r  t h i s  
t e c h n i q u e  i s  < 50 u l ,  compared w i t h  0 . 5  ml n e c e s s a r y  t o  o b t a i n  
a r e a d i n g  u s i n g  a f l a m e .  T h i r d l y ,  e l e c t r o t h e r m a l  a t o m i s a t i o n  
can  o f f e r  t h e  p o s s i b i l i t y  o f  a n a l y s i n g  s o l i d  s a m p l e s  w i t h o u t  
d i s s o l u t i o n  [ 3 2 ] .  However,  t h i s  s t a t e m e n t  s h o u l d  be i n t e r p r e t e d  
w i t h  some c a u t i o n  a s  s o l i d  s a m p l in g  p r e s e n t s  a number o f  
p r o b le m s  t h a t  do n o t  o c c u r  in  s o l u t i o n  m e th o ds .
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F i g u r e  2 . 7 .  Diagram o f  t e m p e r a t u r e  o r  ramp
programming o f  t h e  f u r n a c e .  The f o u r  
s t a g e s  o f  h e a t i n g  a r e  shown a s  s t e p s .
82-
2.5. REFERENCES
1 .  Moloy J . T . ,  J .  Chem. E d u c . . 1 9 8 3 . 6 0 . 2 8 5 .
2 .  Bond A.M., Modern P o l a r o g r a p h i e  Methods in  A n a l y t i c a l  
C h e m i s t r y . . (Marcel Dekker Inc?  New York,  1 9 8 0 ) .
3 .  I l k o v i c  D . ,  J .  Chim. P h y s . , 1 9 3 8 , 3 5 , 1 2 9 .
4 .  I l k o v i c  D . ,  C o l l e c t .  Chem. Commun., 1 9 3 4 , 6 , 4 9 8 .
5 .  Heyrovs ky J . ,  and Kuta J . ,  P r i n c i p l e s  o f  P o l a r o g r a p h y . .  
Academic P r e s s ,  New York,  1 9 6 0 ) .
6 . Zuman P . ,  and H eyrovsky  J . ,  P r a c t i c a  1 Po 1a r o g r a p h y . .  
(Academic P r e s s ,  New York,  1 9 6 9 )  pp 1 9 - 4 0 .
7 .  Crow D . R . ,  P o l a r o g r a p h y  o f  Metal  C o m p l e x e s . .
(Academic P r e s s ,  New York,  1 9 6 9 ) .
8 . Matheson L . A . ,  and N i c h o l s  N . ,  T r a n s .  E l e c t r o c h e m .  S o c . ,  
1 9 3 8 , 7 3 , 1 9 3 .
9 .  N i c h o l s o n  R . S . ,  and S h a i n  I . ,  A n a l .  Chem., 1 9 6 4 . 3 6 . 7 0 6 .
1 0 .  Evans D .H . ,  Acc.  Chem. R e s s . ,  1 9 7 7 . 1 0 . 3 1 3 1 .
1 1 .  Heineman W.R., and K i s s i n g e r  P . T . ,  Am. L a b . ,  1 9 8 2 . 1 4 . 2 9 .
1 2 .  Evans D .H . ,  O ' C o n n e l l  K.M.,  P e t e r s o n  R . A . ,  and K e l l y  M . J . ,  
J .  Chem. E du c . ,  1 9 8 3 . 6 0 . 2 9 0 .
1 3 .  K i s s i n g e r  P . T . ,  and Heineman W.R.,  J .  Chem. E d u c . ,  
1 9 8 3 , 6 0 , 7 0 2 .
1 4 .  Cauquis  G. ,  and P a r k e r  V . D . ,  O r g a n ic  E l e c t r o c h e m i s t r v . .  
(Marcel  Dekker I n c .  New York,  1 9 7 3 ) .
1 5 .  Adams R . N . ,  E l e c t r o c h e m i s t r y  a t  S o l i d  E l e c t r o d e s . .  (Marcel  
Dekker Inc? New York,  1 9 6 9 ) .
1 6 .  Bard A . J . ,  and F a u l k n e r  L . R . ,  E1e c t r o c h e m i ca  1 M e t h o d s . .
-83-
1 7 .  B ark er  G .C . ,  Z. A n a l .  Chem.,  1 9 6 0 . 1 7 3 . 7 9 .
1 8 .  Bond A.M.,  and Grabark B . S . ,  A n a l .  Chim. A c t a . , 1 9 7 7 ,  
8 8 , 2 2 7 .
1 9 .  P e t e r s o n  W.M., A m er .L a b . ,  1 9 7 9 ,  1 1 , 6 9 .
2 0 .  W a n g J . ,  A m er .Lab . ,  p 4 1 , ( 1 9 8 5 ) .
2 1 .  Wang J . ,  S t r i p p i n g  A n a l y s i s :  P r i n c i p l e s .  I n s t r u m e n t a t i o n
and A p p l i c a t i o n . . (VCH P u b l i s h e r s  I n c .
D e e r f i e l d  Beach ,  F l o r i d a ,  1 9 8 5 ) .
2 2 .  Copela nd  T . R . ,  and S k o g e r b o r  R . K . ,  A n a l .  Chem., 1 9 7 4 ,
4 6 . 1 2 5 7 A .
2 3 .  P o o l e  C.M.,  and S c h u e t t e  S . A . ,  C on tem porary  P r a c t i c e  o f  
Chro matogra phy . . ( E l s e v i e r ,  1 9 8 4 ) .
2 4 .  Snyder L.R; and K i r k l a n d  J . J . ,  I n t r o d u c t i o n  t o  Modern 
L i g u i d  C h rom atograp hy . . ( J . W i l e y  and S o n s ,  C h i c h e s t e r ,  
1 9 7 9 ) .
2 5 .  H am i l to n  R . J . ,  and S e w e l l  P . A . ,  I n t r o d u c t i o n  t o  High 
P er fo rm a nc e  L i g u i d  C h ro m a t o g ra p hy . .  (Chapman and H a l l ,  
London,  1 9 7 7 ) ,  pp.  1 2 - 3 6 .
2 6 .  Knox J . H . , ( e d i t o r ); High P er fo rm a n c e  L i g u i d  
Chrom atogra phy . . (E d in burgh  U n i v e r s i t y  P r e s s ,  Edinbur gh  
1 9 7 8 ) ,  pp.  5 - 1 9 .
2 7 .  N e r s t  W., Z. P h y s .  Chem., ( L e i p z i g ) ,  1 9 0 4 . 4 7 . 5 2 .
2 8 .  L e v i c h  V .G . ,  P h y s i o c h e m i c a l  H y d r o d y n a m ic s . .  ( P r e n t i c e  
H a l l ,  Englewood C l i f f s , N . J ;  1 962 .
2 9 .  S t u l i k  K. ,  and Pacakova  V . ,  E l e c t r o a n a l v t i c a l  me asurements
in  f l o w i n g  1 i g u i d s . .  ( E l l i s  Horwood P u b l .  C h i c h e s t e r . )
Fundamentals and Applications.. (Wiley, New York,1980)
84-
3 0 .  Bauer H.H; C h r i s t i a n  G.D; and O ' R e i l l y  I . E ; I n s t r u m e n t a l  
A n a l y s i s ;  ( A l l y n  and Bacon I n c . )
3 1 .  L 'v o v  B.V; S p e c t r o c h i m .  A c ta ;  1 9 6 1 . 1 7 . 7 6 1 .
3 2 .  P r i c e  W.J; S p e c t r o c h e m i c a l  A n a l y s i s  by Atom ic A b s o r p t i o n : 
(P u b l .  H ey d en . )
3 3 .  L 'v o v  B.V; S p e c t r o c h i m .  A c ta ;  1 9 7 0 . 2 4 B . 5 3 .
-85-
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY 
OF CISPLATIN AND ITS HYDROLYSIS PRODUCTS
CHAPTER THREE
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3.1. INTRODUCTION
c i s - d i c h l o r o d i a m m i n e p l a t i n u m ( I I )  ( c i s p l a t i n )  h a s  a l r e a d y  been  
o u t l i n e d  i n  C h a p ter  1 .  The p a r t i c u l a r  s t r u c t u r e  and  
p h y s i o c h e m i c a l  p r o p e r t i e s  o f  c i s p l a t i n  h a v e  p r e s e n t e d
p a r t i c u l a r  p r o b le m s  in  t h e  d e v e l o p m e n t  o f  a n a l y t i c a l  p r o c e d u r e s  
wh ich  p r o v i d e  t h e  n e c e s s a r y  s e l e c t i v i t y  and s e n s i t i v i t y  f o r  t h e  
d e t e r m i n a t i o n  o f  t h e  i n t a c t  drug  in  b i o l o g i c a l  f l u i d s .  The 
a n a l y t i c a l  methods  may be c o n v e n i e n t l y  d i v i d e d  i n t o
n o n - s e l e c t i v e  m e th o ds ,  which  d e t e c t  o n l y  t h e  p la t i n u m  m e t a l ,  
and s e l e c t i v e  m eth ods ,  which  a r e  c a p a b l e  o f  d e t e c t i n g  t h e  
i n t a c t  compound.  The methods which  r e l y  on t h e  n o n - s e l e c t i v e  
d e t e r m i n a t i o n  o f  p la t i n u m  i n c l u d e  X - r a y  f l u o r e s c e n c e  (XRF),  
p r o t o n  i n d u c ed  X - r a y  e m i s s i o n  (PIXE),  i n d u c t i v e l y  c o u p l e d  
p la sm a  (I C P ) ,  f l a m e l e s s  a t o m i c  a b s o r p t i o n  s p e c t r o m e t r y  (FAAS) 
and h i g h  p e r f o r m a n c e  l i q u i d  c h r o m a to g r a p h y  (HPLC) w i t h  
p r e - c o l u m n  d e r i v a t i s a t i o n .  T h i s  c h a p t e r  w i l l  d e a l  w i t h  HPLC 
t e c h n i q u e s  in  b o t h  n o n - s e l e c t i v e  and s e l e c t i v e  modes f o r  t h e  
d e t e r m i n a t i o n  o f  c i s p l a t i n ,  and a l s o  l o o k  a t  t h e  u s e  o f  a lum ina  
a s  a s t a t i o n a r y  p h a s e  f o r  t h e  s e p a r a t i o n  o f  c i s p l a t i n  and i t s  
h y d r o l y s i s  p r o d u c t s .
3 . 1 . 1 .  N o n - s e l e c t i v e  methods
One o f  t h e  most  u s e f u l  methods  f o r  t h e  d e t e r m i n a t i o n  
o f  p l a t i n u m  in  b i o l o g i c a l  s a m p le s  i n v o l v e s  d e r i v a t i s a t i o n  w i t h
The history and clinical background of
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d i e t h y l d i t h i o c a r b a m a t e  (DDTC), t o  y i e l d  a c o m p lex  w i t h  a s i n g l e  
chromophore in  t h e  UV r e g i o n  o f  t h e  s p e c t r u m .  The co m p lex  can  
b e e x t r a c t e d  i n t o  c h l o r o f o r m  and s e p a r a t e d  by normal  p h a s e  [ 1 ] 
o r  r e v e r s e d - p h a s e  [ 2 ]  modes o f  HPLC. T h i s  r e a c t i o n  was  
o r i g i n a l l y  a d a p t e d  s i m u l t a n e o u s l y  by B a n n i s t e r  e t  a l .  [ 1 ]  and  
Borch e t  a l .  [ 2 ]  f o r  t h e  d e t e r m i n a t i o n  o f  p l a t i n u m  e x c r e t e d  
i n t o  u r i n e .  T h i s  method,  w h ich  h as  a d e t e c t i o n  l i m i t  o f  3
n g / m l ,  was a d a p t e d  s u b s e q u e n t l y  f o r  t h e  a n a l y s i s  o f  p la sm a
u l t r a f i l t r a t e  [ 3 ] .  Andrews e t  a l .  [ 3 ]  were t h e n  a b l e  t o  
d e t e r m i n e  c i s p l a t i n  in p la sm a u l t r a f i l t r a t e  f o l l o w i n g  
d e r i v a t i s a t i o n  w i t h  DDTC, w i t h  q u a n t i t a t i o n  c a r r i e d  o u t  u s i n g  a 
n i c k e l  c h l o r i d e  i n t e r n a l  s t a n d a r d .  The c h r o m a t o g r a p h i c  
s e p a r a t i o n  was a c h i e v e d  u s i n g  r e v e r s e d - p h a s e  HPLC on a C18  
r a d i a l  c o m p r e s s i o n  co lu m n.  The c o m p le x  e l u t e d  w i t h  
m e t h a n o l / w a t e r  ( 4 / 1 )  a t  a f l o w  r a t e  o f  1 . 5  m l / m i n ,  and was
d e t e c t e d  a t  254 nm. The l i m i t  o f  d e t e c t i o n  was 0 . 1  ug /ml
c i s p l a t i n  in  t h e  u l t r a f i l t r a t e .  T h i s  a p p r o a c h  f o r  t h e
d e t e r m i n a t i o n  o f  c i s p l a t i n  was v a l i d a t e d  by c o m p a r i s o n  w i t h  
g r a p h i t e  f u r n a c e  a t o m i c  a b s o r p t i o n  s p e c t r o m e t r i c  (GFAAS) 
d e t e r m i n a t i o n s  in  d u p l i c a t e  s a m p l e s .
3 . 1 . 2 .  S e l e c t i v e  methods
A g r e a t  d e a l  o f  e f f o r t  has  b e e n  d i r e c t e d  t o w a r d s  t h e  
d e v e l o p m e n t  o f  s e l e c t i v e  methods f o r  t h e  d e t e r m i n a t i o n  o f  
c i s p l a t i n  and i t s  a n a l o g u e s  in  b i o l o g i c a l  f l u i d s .  Most o f  t h e  
l i t e r a t u r e  has  d e a l t  w i t h  t h e  a n a l y s i s  o f  c i s p l a t i n ,  and t h e
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methods o f  c h o i c e  h a v e  been  l a r g e l y  b a s e d  on HPLC. However,  
HPLC o f  c i s p l a t i n  i s  n o t  p a r t i c u l a r l y  s t r a i g h t f o r w a r d ,  due t o  
d i f f i c u l t y  in  d e t e c t i o n  and poor c h r o m a t o g r a p h i c  p r o p e r t i e s .
A l th o u g h  c i s p l a t i n  i s  a n e u t r a l  m o l e c u l e ,  i t  may be
r e t a i n e d  on c a t i o n i c  s t a t i o n a r y  p h a s e s  s u c h  a s  P a r t i s i l  10 SAX 
[ 4 , 5 ] .  An a l t e r n a t i v e  t o  u s i n g  c h e m i c a l l y  bonded s t a t i o n a r y  
p h a s e s  [ 4 , 5 ]  i s  t o  u s e  s o l v e n t  g e n e r a t e d  p h a s e s  [ 6 - 9 ] ,  in  which  
t h e  c a t i o n i c  s u r f a c t a n t  h e x a d e c y l t r i m e t h y l a m m o n i u m  bromide  
(HTAB), i s  p h y s i c a l l y  a d s o r b e d  o n t o  t h e  s u r f a c e  o f  s i l i c a  g e l
o r  a l k y l s i l y l s i 1 i c a s .  The a d v a n t a g e  o f  t h e s e  t y p e s  o f
s t a t i o n a r y  p h a s e  i s  t h a t  t h e y  ca n  be o p e r a t e d  w i t h  p u r e l y
aq ue o us  m o b i l e  p h a s e s  wh ich  a r e  c o m p a t i b l e  w i t h  t h e
e l e c t r o c h e m i c a l  d e t e c t o r s  a s  d e s c r i b e d  by B a n n i s t e r  e t  a l .
[ 1 0 ] ,  and t h e  p o s t - c o l u m n  r e a c t i o n  d e t e c t o r s  a s  d e s c r i b e d  by 
Marsh e t  a l .  [ 9 ] ,  T hese  s o l v e n t  g e n e r a t e d  s y s t e m s  have a l s o  
b een  use d  f o r  t h e  ch ro m a to g ra p h y  o f  o t h e r  p l a t i n u m ( I I )  and 
p l a t i n u m ( I V )  c o m p l e x e s  in  a d d i t i o n  t o  c i s p l a t i n  [ 6 - 9 ] .
R i l e y  e t  a l .  [ 6 ] t r i e d  t o  i d e n t i f y  t h e  s i t e s  o f
i n t e r a c t i o n  on a c a t i o n i c  s t a t i o n a r y  p h a s e  ( P a r t i s i l  10 SAX),  
a s  t h e r e  a p p e a r s  t o  be  t h r e e  p o t e n t i a l  s i t e s  on t h i s  p h a s e  f o r  
i n t e r a c t i o n  o f  c i s p l a t i n ;  namely
( 1 ) q u a t e r n a r y  ammonium g ro u p s ?
( i i )  s i l a n o l  m o i e t i e s ;  and
( i i i )  h y d r o ca rb o n  g r o u p s .
They lo o k e d  a t  t h e  e f f e c t  o f  m eth ano l  on t h e  r e t e n t i o n  o f  
c i s p l a t i n  on t h i s  column and compared i t  t o  a h y d r o p h o b ic  
s t a t i o n a r y  p h a s e  (pi Bondapak C-^g) and s i l i c a  g e l  ( P a r t i s i l
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5 ) .  The r e t e n t i o n  o f  c i s p l a t i n  on a bonded a n i o n - e x c h a n g e  
column i n c r e a s e d  w i t h  i n c r e a s i n g  m e th a n o l  c o n c e n t r a t i o n ,  w h i l s t  
c i s p l a t i n  was p o o r l y  r e t a i n e d  and i t s  r e t e n t i o n  d e c r e a s e d  
s l i g h t l y  w i t h  i n c r e a s i n g  m eth ano l  c o n c e n t r a t i o n  in  t h e  o t h e r
two c o lu m n s .  T h e s e  r e s u l t s  s u g g e s t  t h a t  t h e  drug  i s  r e t a i n e d  on 
P a r t i s i l  10 SAX p r i m a r i l y  a s  a r e s u l t  o f  i n t e r a c t i o n s  w i t h  t h e  
bonded q u a t e r n a r y  ammonium g r o u p s  and t h a t  t h e s e  i n t e r a c t i o n s  
a r e  s t r e n g t h e n e d  by t h e  p r e s e n c e  o f  m e th a no l  i n  t h e  m o b i l e
p h a s e .  T h e s e  i n t e r a c t i o n s  a r e  b e l i e v e d  t o  o c c u r  v i a  i o n - d i p o l e  
i n t e r a c t i o n s  o f  t h e  n e u t r a l  dru g  and c a t i o n i c  g r o u p s  on t h e
s t a t i o n a r y  p h a s e .  The poor r e t e n t i o n  o f  c i s p l a t i n  on s i l i c a  
i n d i c a t e  t h a t  d i s p e r s i o n  f o r c e s  a r i s i n g  from d i p o l e  
i n t e r a c t i o n s  p l a y  a minor r o l e  i n  t h e  r e t e n t i o n  o f  c i s p l a t i n  on 
P a r t i s i l  10 SAX and s i m i l a r l y ,  t h e  r e s u l t s  o b t a i n e d  on t h e  
h y d r o p h o b i c  s t a t i o n a r y  p h a s e  i n d i c a t e s  t h a t  s o l v o p h o b i c  
i n t e r a c t i o n s  o f  c i s p l a t i n  w i t h  t h e  h y d r o c a r b o n  m o i e t i e s  o f  
P a r t i s i l  10 SAX a r e  r e l a t i v e l y  u n i m p o r t a n t .  H i n c a l  e t  a l .  [ 5 ]  
c o u p l e d  s t r o n g  a n i o n -  and s t r o n g  c a t i o n - e x c h a n g e  co lumns  t o
p e r m i t  r e t e n t i o n  o f  b o th  c i s p l a t i n  and t h e  p o s i t i v e l y  c h a r g e d
h y d r o l y s i s  p r o d u c t s .  However,  t h i s  method was u sed  a s  a 
s t a b i l i t y  i n d i c a t i n g  a s s a y  f o r  c i s p l a t i n  in  f o r m u l a t i o n s  and  
n o t  a s  a b i o a s s a y .  R i l e y  e t  a l .  [8 ] a p p l i e d  t h e  s e p a r a t i o n  o f  
p l a t i n u m  c o m p l e x e s  on s o l v e n t  g e n e r a t e d  a n i o n - e x c h a n g e r s  t o  t h e  
a n a l y s i s  o f  c i s p l a t i n  in  u r i n e  u s i n g  a u to m a te d  column  
s w i t c h i n g ,  w h er e a s  K i t z  e t  a l .  [ 1 1 ] u t i l i s e d  t h e  r e t e n t i o n  o f  
c i s p l a t i n  on i o n - e x c h a n g e r s ,  by c o u p l i n g  a s t r o n g
c a t i o n - e x c h a n g e r  ( p r e - c o l u m n )  and a s t r o n g  a n i o n - e x c h a n g e r
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plasm a and u r i n e  w i t h  UV d e t e c t i o n  and co lumn s w i t c h i n g .
I t  s h o u l d  a l s o  be  n o t e d  t h a t  P a r s o n s  e t  a l .  [ 1 2 ] ,  u s e d  a 
r e v e r s e d - p h a s e  column m o d i f i e d  by a l k y l s u l p h o n i c  a c i d s  f o r  t h e  
ch ro m ato gra phy  o f  h y d r o l y s i s  p r o d u c t s  from c i s p l a t i n  in  f r e s h  
and aged s o l u t i o n s .  T h i s  c h a p t e r  a l s o  p r e s e n t s  r e s u l t s  u s i n g  
i o n - p a i r  ch ro m a to g ra p h y  w i t h  e l e c t r o c h e m i c a l  d e t e c t i o n  f o r  t h e  
d e t e r m i n a t i o n  o f  c i s p l a t i n  and h y d r o l y s i s  p r o d u c t s  [ 1 3 ] .  
D a l e y - Y a t e s  and Mc B r i e n  u s e d  sod ium d o d e c y l s u l p h a t e  a s  an
i o n - p a i r  r e a g e n t  f o r  t h e  s e p a r a t i o n  o f  p l a t i n u m  s p e c i e s  [ 1 4 ] .
C i s p l a t i n  h as  a low s o l u b i l i t y  in  o r g a n i c  s o l v e n t s
and i s  n o t  r e a d i l y  e x t r a c t e d  from b i o l o g i c a l  f l u i d s .  T h e r e f o r e ,  
b i o a n a l y s i s  o f  i n t a c t  c i s p l a t i n  o r  i t s  a n a l o g s  n e a r l y  i n v o l v e s  
d i r e c t  i n j e c t i o n  o f  t h e  b i o l o g i c a l  f l u i d  (p lasm a o r  u r i n e ) .  
However,  t h i s  d o e s  p l a c e  a l a r g e  s t r a i n  on t h e  a b i l i t y  o f  t h e  
d e t e c t i o n  s y s t e m  t o  d i f f e r e n t i a t e  b e t w e e n  a n a l y t e  and t h e  
p o t e n t i a l l y  i n t e r f e r i n g  e n d o g e n o u s  compounds.  S e v e r a l  d e t e c t i o n  
s y s t e m s  have b een  u s e d  f o r  t h e  o n - l i n e  d e t e c t i o n  o f  
p l a t i n u m - c o n t a i n i n g  d r u g s  and i n c l u d e  UV a b s o r p t i o n  [ 1 , 8 ,  
1 1 , 1 5 ] ,  UV a b s o r p t i o n  f o l l o w i n g  p o s t - c o l u m n  d e r i v a t i s a t i o n  [ 9 ] ,  
and r e d u c t i v e  e l e c t r o c h e m i s t r y  [ 1 2 , 1 6 - 1 8 ] .  In  a d d i t i o n  t o  
o n - l i n e  t e c h n i q u e s ,  f r a c t i o n  c o l l e c t i o n  and d e t e r m i n a t i o n  o f  
t h e  f r a c t i o n s  by GFAAS h a s  a l s o  been  u s e d  in  c o m b i n a t i o n  w i t h  
HPLC f o r  t h e  d e t e r m i n a t i o n  o f  c i s p l a t i n  in  plasma u l t r a f i l t r a t e  
[ 1 5 ]  and u r i n e  [8 ].
D i r e c t  UV d e t e c t i o n  [ 7 , 1 1 ]  p r o v i d e s  l i m i t s  o f  
d e t e c t i o n  o f  a b o u t  1 jug/ml a t  280 nm and a b o u t  20  n g /m l  a t  210
(analytical column) for the determination of cisplatin in
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nm. U n t r e a t e d  u r i n e  c a n n o t  be  i n j e c t e d  i n t o  a m o b i l e  p h a s e  o f  
g r e a t e r  t h a n  60% a q u e o u s  m e t h a n o l ,  due t o  t h e  p r e c i p i t a t i o n  o f  
i n o r g a n i c  s a l t s .  C i s p l a t i n  can  be a n a l y s e d  in  u r i n e  w i t h  d i r e c t  
UV d e t e c t i o n  a t  280 nm u s i n g  a s o l v e n t  g e n e r a t e d  a n i o n  ex c h a n g e  
s y s t e m .  But ,  in  t h i s  c a s e ,  a u to m a te d  column s w i t c h i n g  i s  
r e q u i r e d  t o  s e p a r a t e  t h e  dru g from e n d o g e n o u s  s u b s t a n c e s  [ 8 ] .  
K i t z  e t  a l .  [ 1 1 ]  h a v e  d e s c r i b e d  a s e n s i t i v e  HPLC method w i t h  
d i r e c t  UV d e t e c t i o n  a t  210 nm f o r  t h e  a n a l y s i s  o f  i n t a c t  
c i s p l a t i n  i n  u r i n e  and p lasm a f o l l w i n g  co lumn s w i t c h i n g .
On r e v i e w i n g  t h e  l i t e r a t u r e ,  t h e  method o f  c h o i c e  
f o r  t h e  d e t e r m i n a t i o n  o f  i n t a c t  c i s p l a t i n  a p p e a r s  t o  be HPLC
w i t h  e i t h e r  e l e c t r o c h e m i c a l  d e t e c t i o n  [ 1 0 , 1 2 , 1 6 - 1 8 ]  or  UV 
d e t e c t i o n  f o l l o w i n g  p o s t - c o l u m n  d e r i v a t i s a t i o n  [ 9 ] .  Both  
methods r e q u i r e  min imal  p r e - t r e a t m e n t  o f  u r i n e  o r  plasma  
u l t r a f i l t r a t e  and r e s u l t  in  d e t e c t i o n  l i m i t s  o f  2 5 - 5 0  n g / m l .  
The u s e  o f  e l e c t r o c h e m i c a l  d e t e c t i o n  o f  c i s p l a t i n  in  t h e  
r e d u c t i v e  mode was d e s c r i b e d  i n i t i a l l y  by B a n n i s t e r  [ 1 0 ] ,  who 
a p p l i e d  p o l a r o g r a p h i c  d e t e c t i o n  f o l l o w i n g  HPLC s e p a r a t i o n  o f
c i s p l a t i n .  The column e l u e n t  was p a s s e d  i n t o  an e l e c t r o c h e m i c a l
d e t e c t o r  c o n s i s t i n g  o f  a d r o p p i n g  me rcury  e l e c t r o d e  (DME) 
o p e r a t e d  a t  0 . 0 0  V ( v s  A g / A g C l ) .  The u s e  o f  a v e r y  low 
o p e r a t i n g  p o t e n t i a l  a l l o w s  t h e  s e l e c t i v e  d e t e c t i o n  o f  
c i s p l a t i n ,  e l i m i n a t i n g  t h o s e  c o m p o n en ts  o f  u r i n e  which  
i n t e r f e r e  when UV d e t e c t i o n  i s  u s e d .  The d i s a d v a n t a g e s  o f  t h i s  
s y s t e m  a r e :
( i )  o x y g e n  must be  e l i m i n a t e d  from t h e  s y s t e m  by
r i g o r o u s  p u r g i n g  w i t h  n i t r o g e n ,
-92-
( H i ) t h e  d ep en d e n c y  o f  r e l a t i v e  r e s p o n s e  on t h e  
n a t u r e  o f  t h e  l i g a n d s  c o - o r d i n a t e d  w i t h  P t .
P o l a r o g r a p h i c  d e t e c t i o n  o f  c i s p l a t i n  a c h i e v e d  l i m i t s  o f  
d e t e c t i o n  o f  70 ng/ml  in  u r i n e  and p la s m a .  T h i s  was improved
l a t e r  by o t h e r s  [ 1 7 , 1 8 ]  who u s e d  t h e  more c o n v e n i e n t  g l a s s y  
c a r b o n  e l e c t r o d e  d e t e c t o r .
The p o s t - c o l u m n  r e a c t i o n  d e t e c t i o n  s y s t e m  d e s c r i b e d  
by Marsh e t  a l .  [9 ]  i s  p e r h a p s  an a l t e r n a t i v e  t o  
e l e c t r o c h e m i c a l  d e t e c t i o n .  I n  t h i s  s y s t e m ,  s e p a r a t i o n  was  
a c h i e v e d  on a s o l v e n t  g e n e r a t e d  a n i o n - e x c h a n g e r  and t h e  
p l a t i n u m - c o n t a i n i n g  s p e c i e s  a r e  s e l e c t i v e l y  d e r i v a t i s e d  t o  g i v e  
h i g h l y  U V - a b s o r b in g  s p e c i e s  b e f o r e  t h e y  e n t e r  t h e  s p e c t r o m e t e r .  
The d e t e c t i o n  s y s t e m  i s  b a s e d  on t h e  p r i o r  o b s e r v a t i o n s  o f  
H u s s a i n  e t  a l .  [ 1 9 ] ,  t h a t  a s t r o n g l y  UV a b s o r b i n g  s p e c i e s  i s  
p ro d u c e d  when c i s p l a t i n  i s  r e a c t e d  w i t h  b i s u l p h i t e  i o n s .  In  
o r d e r  f o r  t h i s  r e a c t i o n  t o  be  r e p r o d u c i b l e ,  t h e  p l a t i n u m  
c o m p l e x e s  must  f i r s t  be  r e a c t e d  w i t h  p o t a s s i u m  d i c h r o m a t e  
b e f o r e  d e r i v a t i s a t i o n  w i t h  b i s u l p h i t e .  The n a t u r e  o f  t h e  
co m p lex  o r  c o m p l e x e s  formed i n  t h e  r e a c t o r ,  and t h e  p r e c i s e  
r o l e  p l a y e d  by t h e  d i c h r o m a t e  i o n s  a r e  unknown. N e v e r t h e l e s s ,  
t h e  r e a c t i o n  d e t e c t o r  has  an e x c e l l e n t  l i n e a r ,  dynam ic r a n g e ,
r e s u l t i n g  in  d e t e c t i o n  l i m i t s  o f  40 ng /m l  in  b i o l o g i c a l  f l u i d s
( c o m p a r i b l e  t o  t h o s e  l i m i t s  o b t a i n e d  by HPLC w i t h
e l e c t r o c h e m i c a l  d e t e c t i o n ) .
(ii) the temperamental nature of the system,
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3.2. THE USE OF AN ALUMINA STATIONARY PHASE IN HPLC
The u s e  o f  a l u m i n a  a s  a s t a t i o n a r y  p h a s e  m a t e r i a l  in  
modern l i q u i d  ch ro m a to g ra p h y  h a s  n o t  b e e n  w i d e l y  r e p o r t e d  o v e r  
t h e  p a s t  t e n  y e a r s .  In  c l a s s i c a l  a d s o r p t i o n  ch ro m a t o g r a p h y  i t  
must  co m pete  w i t h  s i l i c a ,  and b o t h  m a t e r i a l s  h a v e  b e e n  l a r g e l y  
s u p e r c e d e d  by c h e m i c a l l y  m o d i f i e d  s i l i c a s .
L i k e  s i l i c a ,  a l u m i n a  can  be c o n s i d e r e d  a s  a t y p i c a l
p o l a r  a d s o r b e n t ,  and most  s e p a r a t i o n s  p r o c e e d  i n  t h e  same way
on t h e  two o x i d e s .  However,  wher e s i l i c a  i s  o n l y  a c t i v e  th r o u g h  
i t s  s u r f a c e  h y d r o x y l  g r o u p s ,  a l u m i n a  p o s s e s s e s  tw o  a l t e r n a t i v e  
p o s s i b i l i t i e s  f o r  i n t e r a c t i o n  w i t h  s o l u t e s .  The a c i d i c  s i t e s  o f  
a l u m i n a  a d s o r b  b a s i c  s o l u t e s  t h r o u g h  n u c l e o p h i l i c  i n t e r a c t i o n s ,  
and t h e  same s i t e s  may a l s o  form c h a r g e  t r a n s f e r  c o m p l e x e s  w i t h  
t y p i c a l  e l e c t r o n  d o n o r s  su c h  a s  a r o m a t i c  s o l u t e s  [ 2 0 ] .  On t h e
o t h e r  hand,  a c i d i c  s o l u t e s  may i n t e r a c t  w i t h  b a s i c  s i t e s  on t h e
a l u m i n a  s u r f a c e  t h r o u g h  t h e  t r a n s f e r  o f  a p r o t o n  l e a d i n g  t o  
c h e m i s o r p t i o n .  In g e n e r a l ,  a l u m i n a  i n t e r a c t s  s t r o n g l y  w i t h  
p o l a r i s e d  m o l e c u l e s .
3 . 2 . 1 .  I o n - e x c h a n a e  p r o p e r t i e s  o f  a lu m in a
Alumina a c t s  a s  a t y p i c a l  i o n - e x c h a n g e r ,  b u t  i s  a l s o  
a m p h o t e r i c  in  n a t u r e ,  s o  t h a t  i t s  i o n - e x c h a n g e  p r o p e r t i e s  a r e  
s t r o n g l y  p H - d e p e n d e n t .  T h i s  a m p h o t e r i c  c h a r a c t e r  can  be
e x p l a i n e d  by t h e  p r e s e n c e  o f  two d i s t i n c t  t y p e s  o f  h y d r o x y l
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g r o u p s  on t h e  a lu m i n a  s u r f a c e  ( F i g u r e  3 . 1 . ) .  From t h i s  i t  can  
be s e e n  t h a t  t h e r e  a r e  h y d r o x y l  g r o u p s  c h e m i s o r b e d  o n t o  a c i d i c  
s i t e s  (Al a t o m s ) ,  w h i l s t  t h e r e  a r e  p r o t o n s  c h e m i s o r b e d  o n t o  
o x y g e n  a t o m s .  T h e r e f o r e ,  when n e u t r a l  a l u m i n a  i s  washed w i t h  
NaOH, t h e  c h e m i s o r b e d  p r o t o n s  w i l l  be n e u t r a l i s e d  and r e p l a c e d
by sodium i o n s .  T h e s e  Na+ i o n s  c a n  e x c h a n g e  w i t h  o t h e r
c a t i o n s  and a r e  r e s p o n s i b l e  f o r  t h e  c a t i o n - e x c h a n g e  p r o p e r t i e s  
o f  a l k a l i n e  a lu m in a  a t  h i g h e r  p H ' s .  However,  when t h e  a l k a l i n e  
a lum ina  i s  washed w i t h  HC1, t h e  p r o t o n s  o f  t h e  a c i d  g i v e  r i s e  
t o  two e f f e c t s :
( i )  t h e y  d e s o r b  t h e  h y d r o x y l  g r o u p s ,  w h ich  a r e
t h e n  r e p l a c e d  by Cl" i o n s  t o  g i v e  r i s e  t o
t h e  a n i o n - e x c h a n g e  p r o p e r t i e s  o f  a c i d i c
a lu m i n a ;  and
( i i )  t h e  p r o t o n s  a l s o  r e p l a c e  t h e  Na+ i o n s
a t t a c h e d  t o  t h e  o x y g en  a t o m s .
So,  a s  a r e s u l t  o f  t h e s e  w a s h i n g s ,  a lu m i n a  e x h i b i t s  c a t i o n  and  
a n i o n - e x c h a n g e  p r o p e r t i e s  o v e r  f a i r l y  bro ad  pH r a n g e s .
However,  i t  i s  p o s s i b l e  t o  d e f i n e  a pH wher e t h e  n e t  
c h a r g e  on t h e  s u r f a c e  i s  z e r o  i . e .  t h e  z e r o  p o i n t  c h a r g e  (ZPC).  
G e n e r a l l y ,  a t  pH v a l u e s  b e l o w  t h e  ZPC, a l u m i n a  c a n  be u s e d  a s
an a n i o n - e x c h a n g e r  wher e t h e  n e t  c h a r g e  on t h e  column i s
p o s i t i v e ,  and a t  pH v a l u e s  h i g h e r  t h a n  ZPC, a l u m i n a  e x h i b i t s  
c a t i o n - e x c h a n g e  p r o p e r t i e s  where t h e  n e t  c h a r g e  i s  n e g a t i v e .  
The ZPC o f  a lu m in a  d e p e n d s  on t h e  n a t u r e  o f  t h e  b u f f e r  i o n s  
u s e d ;  f o r  ex a m p le ,  i n  t h e  p r e s e n c e  o f  a c e t a t e  i o n s  t h e  ZPC =
6 . 5 ,  f o r  c i t r a t e  i o n s  i t  i s  3 . 5 ,  f o r  b o r a t e  i o n s  i t  i s  8 . 3 ,  f o r
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carbonate ions i t  i s  9 .2  and for  phosphate ions i t  i s  6 .5  [21] .  
So, s e l e c t i v i t y  using the alumina column can be manipulated by 
ju d ic ious  choice of  the pH o f  the  mobile phase.
3 . 2 . 2 .  Applications o f  alumina s tat ionary  phase
Most of  the l i t e r a tu r e  on alumina has concentrated on the  
separation of  basic  compounds. For instance,  Lingeman e t  a l .  
[21] invest igated  both alumina and s i l i c a  for the separat ion of  
some basic  so lu te s ,  e s p e c i a l l y  quaternary ammonium compounds. 
This study a lso  involved the  in v e s t ig a t io n  o f  the re ten t ion  
behaviour o f  amines and quaternary ammonium ions as a function  
o f  the type and concentrat ion o f  organic modifier,  pH and type  
and concentration o f  the competing ion and buffer components in 
the mobile phase.
The separation o f  prote ins  i s  one o f  the most 
challenging areas in l iqu id  chromatography and has received a 
l o t  o f  a t ten t ion  in the l i t e r a t u r e  over recent  years .  Various 
new materials  have been developed over the decade, mostly 
directed  towards ion-exchange and s i z e  exclus ion  
chromatography. However, in t h i s  context,  alumina presents  an 
a t t r a c t i v e  a l tern a t iv e ,  as both mechanisms can be combined. In 
the separation of prote ins ,  the concept o f  ZPC has a c lo se  
p a r a l l e l  in the d e f i n i t i o n  o f  the i s o e l e c t r i c  poin t  (p i)  o f  a 
prote in ,  where the net charge o f  the prote in  i s  zero.  So for  pH 
> p i ,  the  net charge o f  the prote in  i s  negative,and for pH <
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pi ,  the charge on the prote in  i s  p o s i t i v e .  Therefore the  
r e l a t i v e  values o f  the ZPC o f  alumina and the pi o f  the protein  
are important for ion-exchange separation using the alumina 
column. Laurent e t  a l .  [22] used t h i s  s ta t ion ary  phase for the  
separation o f  some standard prote ins ,  such as bovine serum 
albumin, ovalbumin, myoglobin, trypsinogen, lysozyme and
chymotrypsinogen a t  pH 9 (phosphate bu ffer ) .
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3.3. EXPERIMENTAL
3 .3 .1 .  Materials
C isp la t in  was obtained from Sigma; samples of  the  
formulated drug Neoplatin (containing s a l i n e ,  mannitol and 
c i s p l a t i n )  were obtained as a g i f t  from University  College  
Dublin (Pharmacology Department), having previously  been 
donated by the B ris to l  Myers Company. All so lu t io n s  were 
prepared in water obtained by passing d i s t i l l e d  water through a 
Mill i-Q water p u r i f i c a t io n  system. So lut ions  prepared in sa l in e  
were prepared in 0.15 M NaCl.
The mobile phase composition used throughout the
study involving the C^g column was 10 mM sodium acetate ,  pH
4 .6 ,  which was 5 mM in octanesulphonic  a c id .  The mobile phase 
was f i r s t  degassed using an u l t ra so n ic  bath and f i n a l l y  
deoxygenated with helium for 20 min.
The mobile phase composition used for  separation
involving alumina was in the main 0 .05  M phosphate buffer,  
prepared using disodium hydrogen phosphate and dihydrogen 
sodium phosphate, and adjust ing  the pH accordingly .  Methanol, 
a c e t o n i t r i l e  and te tra e th y l  ammonium bromide (TEABr) were a l l  o f  
a n a ly t ica l  grade. All mobile phases were f i l t e r e d  i n i t i a l l y  and 
degassed for 20 min.
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3.3.2. Apparatus
The s y s t e m  u s e d  f o r  t h e  d e t e c t i o n  o f  t h e  c i s p l a t i n  
s p e c i e s  a t  t h e  mercury (Hg) e l e c t r o d e  was a P r i n c e t o n  A p p l i e d  
R e s e a r c h  C o r p o r a t i o n  (PARC) Model 174A p o l a r o g r a p h i c  a n a l y s e r ,  
i n t e r f a c e d  w i t h  a PARC model 303A s t a t i c  mercury  drop  e l e c t r o d e  
(SMDE). A l a r g e  drop  was u s e d  r o u t i n e l y  t h r o u g h o u t  t h i s  
i n v e s t i g a t i o n .  The c e l l  was m o d i f i e d  w i t h  a PARC Model 310 f l o w  
a d a p t e r  f o r  l i q u i d  c h r o m a t o g r a p h i c  d e t e c t i o n .  The 
c h r o m a t o g r a p h i c  s y s t e m  c o n s i s t e d  o f  a W ate rs  RR/066 s o l v e n t
d e l i v e r y  s y s t e m  w i t h  a Waters U6 K i n j e c t i o n  p o r t  in  c o n j u n c t i o n
w i t h  a guard  column c o n t a i n i n g  W aters  C18  C o r a s i l  ( 3 7 . 5 0  um) 
m a t e r i a l  and a Waters  a n a l y t i c a l  column (15 cm x 3 . 9  cm) packed  
w i t h  a N u c l e o s i l  10  C^g s t a t i o n a r y  p h a s e .  Chromatograms w ere  
r e c o r d e d  on a P h i l i p s  PM 8251A c h a r t  r e c o r d e r  u s i n g  a c h a r t  
s p e e d  o f  300 mm/hr. The m o b i l e  p h a s e  was c o n t i n u o u s l y  pur ged  
w i t h  h e l i u m  t o  m i n i m i s e  t h e  i n t e r f e r e n c e  due t o  d i s s o l v e d  
o x y g e n .
For s e p a r a t i o n s  on t h e  a l u m i n a  column,  t h e  
c h r o m a t o g r a p h i c  s y s t e m  c o n s i s t e d  o f  an ACS Model 353 t e r n a r y
s o l v e n t  s y s t e m  w i t h  a Rheodyne 71 25  i n j e c t o r  (20 f i l  i n j e c t i o n
l o o p )  in  c o n j u n c t i o n  w i th  a guard  co lumn c o n t a i n i n g  a lu m in a  
p a c k i n g  m a t e r i a l  o b t a i n e d  from W aters  and a T e c h s p h e r e  5 
a l u m i n a  (15 cm x 4 . 6  mm) a n a l y t i c a l  co lu m n .  The UV d e t e c t o r  was 
a Shimadzu SPD - 6 A UV s p e c t r o p h o t o m e t r i c  d e t e c t o r  c o n n e c t e d  t o
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a P h i l p s  PM 8252 d u a l  pen r e c o r d e r .  Chromatograms w ere  r e c o r d e d  
u s i n g  a c h a r t  s p e e d  o f  300 mm/hr. The w a v e l e n g t h s  u s e d  t o  
d e t e c t  c i s p l a t i n  were 205 o r  220 nm d e p e n d i n g  on t h e
t r a n s p a r e n c y  o f  t h e  b u f f e r .
3 . 3 . 3 .  Methods
For t h e  HPLC i n v e s t i g a t i o n s  u s i n g  t h e  Hg d e t e c t o r ,  1 
mg/ml s t o c k  s o l u t i o n s  o f  b o t h  f o r m u l a t e d  and n o n - f o r m u l a t e d  
c i s p l a t i n  were p r e p a r e d  by d i s s o l v i n g  an a p p r o p r i a t e  amount  o f  
e a c h  drug in  e i t h e r  0 . 1 5  M NaCl o r  d e i o n i s e d  w a t e r .  In  t h e  
a l u m i n a  s t u d y ,  1 mM s t o c k  s o l u t i o n s  o f  c i s p l a t i n  w ere  p r e p a r e d  
in  b o t h  0 . 1 5  M and d e i o n i s e d  w a t e r .  B lank  s o l u t i o n s  o f  b o t h  
w a t e r  and NaCl w ere  i n j e c t e d  d u r i n g  b o th  s t u d i e s .  In  t h e  
s t a b i l i t y  s t u d y  o f  c i s p l a t i n  u s i n g  t h e  a lu m in a  co lu m n,  s a m p l e s  
o f  c i s p l a t i n  in  b o t h  NaCl and w a t e r  were i n j e c t e d  e v e r y  hour  
o v e r  a p e r i o d  o f  t i m e .
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3 . 4 . HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH
ELECTROCHEMICAL DETECTION FOR THE DETERMINATION OF
CISPLATIN AND ITS HYDROLYSIS PRODUCTS
3 . 4 . 1 .  O p t i m i s a t i o n  o f  m o b i l e  p h a s e  c o n d i t i o n s
A l a r g e  p a r t  o f  t h i s  s t u d y  i n v o l v e d  t h e  o p t i m i s a t i o n  
o f  c h r o m a t o g r a p h ic  c o n d i t i o n s  f o r  t h e  s e p a r a t i o n  o f  c i s p l a t i n  
and p o s s i b l e  p r o d u c t s .  Based on t h e  work o f  P a r s o n s  and Leroy
[ 1 2 ] ,  t h e  u s e  o f  10 mM sodium a c e t a t e ,  pH 4 . 6 ,  c o n t a i n i n g  
h e p t a n e s u l p h o n i c  a c i d  a s  a m o d i f i e r ,  had b e e n  s u g g e s t e d  a s  t h e
optimum m o b i l e  p h a s e  f o r  t h e  s e p a r a t i o n  o f  c i s p l a t i n  and i t s
h y d r o l y s i s  p r o d u c t s .  During  t h e  e a r l y  s t u d i e s ,  t h e  u s e  o f  
s i m i l a r  m o b i l e  p h a s e s  c o n t a i n i n g  b o t h  p e n t a n e s u l p h o n i c  a c i d  and  
o c t a n e s u l p h o n i c  a c i d  a s  m o d i f i e r s  were i n v e s t i g a t e d .  The u s e  o f  
t h e  l a t t e r  g a v e  s l i g h t  improvement  w i t h  r e s p e c t  t o  r e s o l u t i o n  
and s e n s i t i v i t y  o f  t h e  ch romatograms  f o r  c h l o r i d e ,  c i s p l a t i n  
and p o s s i b l e  h y d r o l y s i s  p r o d u c t s .  I f  no m o d i f i e r s  w ere  u sed  in  
t h e  m o b i l e  p h a s e ,  chrom atog rams showed a s i n g l e  b ro a d  peak  w i t h  
a s h o u l d e r .  R e t e n t i o n  t i m e s  were n o t  a f f e c t e d  by i n c r e a s i n g  t h e  
c o n c e n t r a t i o n  o f  t h e  i o n - p a i r  r e a g e n t s  i n v e s t i g a t e d .  I t  was
fo u n d ,  how eve r ,  t h a t  t h e  c o n c e n t r a t i o n  o f  o c t a n e s u l p h o n i c  a c i d  
in  t h e  m o b i l e  p h a s e  had t o  be  g r e a t e r  t h a n  4 mM b e f o r e
c i s p l a t i n  was r e s o l v e d  from any o t h e r  s p e c i e s .  I n c r e a s i n g  t h e  
c o n c e n t r a t i o n  o f  o c t a n e s u l p h o n i c  a c i d  in  t h e  m o b i l e  p h a s e  a b o v e  
t h i s  l e v e l  had no e f f e c t  upon t h e  r e t e n t i o n  t i m e  o f  c i s p l a t i n .  
For a l l  s u b s e q u e n t  i n v e s t i g a t i o n s ,  t h e  m o b i l e  p h a s e  was made 5
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mM in octanesuphonic ac id .  The optimum flow ra te  was found to  
be 1 .0  ml/min. A typ ica l  chromatogram using the condit ions  
out lined previously  Is shown in Figure 3 .2 .  At lower flow 
ra tes ,  the r eso lu t io n  was decreased from th a t  shown in Figure
3.2 ,  whereas at  higher flow r a te s ,  the peaks e luted  c lo se  to  
the so lvent  front .
3 . 4 . 2 .  Optimisation of  parameters a f f e c t i n g  e lectrochemical
de tec t ion  a t  a mercury e lec tro d e
This part o f  the study involved in v e s t ig a t io n  of  the  
use of  three d i f f e r e n t  current sampling schemes, i . e .  sampled 
DC, normal pulse  and d i f f e r e n t i a l  pu lse  modes which were 
applied from a constant potent ia l  appl ied  t o  the HMDE. Sampled 
DC detect ion  involves  considerat ion o f  the  appl ied potent ia l  
only.  On s e t t i n g  the i n i t i a l  p o t e n t ia l ,  the current i s  measured 
(sampled) for  a short period of  t ime a t  the end of  the drop
time s e t  on the instrument. However, in normal pulse and
d i f f e r e n t i a l  pu lse  modes, two p o t e n t ia l s  are considered; that  
i s ,  the i n i t i a l  applied potent ia l  and the p o ten t ia l  reached on 
appl icat ion  o f  the pulse .  With carefu l  s e l e c t i o n  of these  
values ,  the half-wave p o t e n t ia l s  o f  the  reac t ion  of  in t er e s t  
can be pos i t ioned between the two p o ten t ia l  s e t t i n g s .  In the  
normal pulse mode, the current i s  measured a t  the end of  the
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p u l s e ,  w h i l s t  in  t h e  d i f f e r e n t i a l  p u l s e  mode, t h e  c u r r e n t  i s  
measured b e f o r e  and a t  t h e  end o f  t h e  a p p l i e d  p u l s e ,  and i t  i s  
t h e  d i f f e r e n c e  in  t h e  c u r r e n t  t h a t  i s  r e c o r d e d .  Compared t o  
sampled  DC and normal  p u l s e ,  t h e  d i f f e r e n t i a l  p u l s e  mode o f f e r s  
an improvement  in  s e l e c t i v i t y  and l o w e r  l i m i t s  o f  d e t e c t i o n ,  
and was t h u s  used  t h r o u g h o u t  t h e s e  s t u d i e s .
As can be s e e n  from F i g u r e  3 . 2 . ,  d e p e n d i n g  on t h e  
c o n c e n t r a t i o n  o f  c i s p l a t i n  s o l u t i o n  i n j e c t e d ,  a maximum o f  
t h r e e  p ea k s  (w i t h  a s h o u l d e r  on t h e  t h i r d )  were d e t e c t e d .  In  
o r d e r  t o  i d e n t i f y  t h e s e  p e a k s ,  t h e  f o l l o w i n g  ap pro a ch  was
t a k e n .  When c h l o r i d e  i o n s  were i n j e c t e d  s o l e l y  o n t o  t h e  co lu m n,  
t h e  f i r s t  peak  a t  t p =  3 . 0  min was t h e  o n l y  one d e t e c t e d  (peak  
1 ) .  When a s o l u t i o n  o f  c i s p l a t i n  in  w a t e r  was p r e p a r e d  and  
i m m e d i a t e l y  i n j e c t e d  o n t o  t h e  co lum n,  o n l y  peak 3 ( i . e  a t  tjj= 
4 . 0  min)  was d e t e c t e d .  The s e c o n d  pea k  a t  t^ =  3 . 6  min and t h e  
s h o u l d e r  on t h e  t h i r d  peak  a p p e a r e d  a t  h i g h  c o n c e n t r a t i o n s  o f  
c i s p l a t i n  ( >100  /¿g/ml ) , a n d  a l s o  in  s o l u t i o n s  t h a t  had b een
l e f t  t o  s t a n d  f o r  a few d a y s .  Hence ,  i t  would ap p e a r  t h a t  t h e s e  
a r e  b o t h  due t o  t h e  f o r m a t i o n  o f  h y d r o l y s i s  p r o d u c t s ,  in
a c c o r d a n c e  w i t h  t h e  f i n d i n g s  o f  P a r s o n s  and Leroy  [ 1 2 ] .
I t  was o b s e r v e d  t h a t  a t  c o n c e n t r a t i o n s  < 100 / i g / m l ,  
t h e  chromatogram showed o n l y  two w e l l  d e f i n e d  p e a k s  w i t h  
r e t e n t i o n  t i m e s  o f  3 . 0  and 4 . 0  min,  wh ich  have a l r e a d y  b een
shown t o  be  c h l o r i d e  and c i s p l a t i n  r e s p e c t i v e l y .
C h r o m a t o v o l ta m m e tr i c  c u r v e s  were t h e n  c o n s t r u c t e d  in  
o r d e r  t o  d e t e r m i n e  t h e  optimum a p p l i e d  p o t e n t i a l  t h a t  would
g i v e  t h e  h i g h e s t  s e n s i t i v i t y  f o r  t h e  d e t e r m i n a t i o n  o f
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3Time min
F i g u r e  3 . 2 .  HPLC t r a c e  o f  an a g e d  s o l u t i o n  o f  1 
mg/ml o f  c i s p l a t i n ,  u s i n g  an HMDE a s  
d e t e c t o r ?a p p 1 i e d  p o t e n t i a l ,  + 0 . 0 5  V v s  
A g / A g C l . ( l )  sod ium c h l o r i d e ?  ( 2 )  
h y d r o l y s i s  p r o d u c t  o f  c i s p l a t i n ?  ( 3 )  
c i s p l a t i n ?  and ( 4 )  h y d r o l y s i s  p r o d u c t  
o f  c i s p l a t i n .
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cisplatin, in addition to chloride and hydrolysis products. 
These curves were constructed by plotting the current for each 
peak as a function of the initial applied potential in the 
range 0.00 V to + 0.20 V (versus Ag/AgCl). These applied
potentials were increased in a step-wise manner (20 mV) over a 
series of injections. The resulting chromatovoltammetric curves 
are shown in Figure 3.3., from which the optimum potential for 
detection of the platinum species at the mercury electrode can 
be seen to be + 0.05 V (versus Ag/AgCl).
Using an applied potential of + 0.05 V, linear
calibration graphs were obtained for the three peaks. Linear 
regression analysis of the data obtained for the the cisplatin 
peak shows that the current was related to the concentration by 
the equation: I = 0.470C + 0.084 (r = 0.99). The limit of
detection of cisplatin at the Hg working electrode, based on a 
signal to nose ratio of 3:1, was found to be approximately 5 
fig/m 1.
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Electrode potential V  vs. Ag - AgCI
Figure 3.3. Chromatovoltammetric curve obtained for 
an aged solution of 1 mg/ml of cisplatin 
at an HMDE; potential range, 0.00 to 
+0.16 V vs Ag/AgCl. (A) cisplatin? (B) 
sodium chloride? and (C) hydrolysis
product of cisplatin.
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3.5. THE APPLICATION OF A NON-MODIFIED POLAR STATIONARY
PHASE (ALUMINA) IN COMBINATION WITH AQUEOUS SOLVENT
MIXTURES FOR THE SEPARATION OF CISPLATIN AND ITS
HYDROLYSIS PRODUCTS
In this investigation, the retention behaviour of 
cisplatin and its hydrolysis products (Chapter One, Figure 1.2) 
were studied as a function of pH and concentration of buffer 
components in mobile phase, type and concentration of organic 
modifier and also concentration of competing -ion, 
tetraethyammoniura bromide (TEABr). On optimisation of 
chromatographic conditions, the alumina stationary phase was 
applied to monitor the stability of cisplatin prepared both in 
water and saline.
3.5.1. Effect of concentration of buffer in mobile phase
Aluminium oxide shows anion-exchange properties at 
pH values below the zero point charge (ZPC) and cation-exchange 
behaviour above this pH value. Hence for the analysis of 
positively charged compounds, the pH of the mobile phase should 
be higher than the ZPC. A phosphate buffer was chosen in this 
study to allow investigations over a wide pH range. The ZPC of 
alumina using phosphate is 6.5 [21].
The ion-exchange capacity of alumina in respect of 
cisplatin and its hydrolysis products was initially monitored 
using a series of eluents of different concentrations of
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sodium dihydrogen phosphate in the range 0.01 - 0.1 M. During 
the separation of cisplatin using the alumina column, four 
major peaks were observed as shown in Figure 3.5. The effect of 
varying the concentration of the buffer on these 4 peaks is 
shown in Figure 3.6. These peaks have been identified as 1) 
Cl- , 2) cisplatin and the hydrolysis products A and B. Over 
the concentration range studied, there was little change in the 
retention of the parent drug, whilst there is a small decrease 
in the retention of Cl-. A decrease in the concentration of 
buffer gave rise to a large increase in retention times for 
both hydrolysis products. However, using a buffer concentration 
of 0.1 M did not resolve peaks A and B successfully, and a 
mobile phase of 0.01 M phosphate buffer revealed tailing of
peak B. It was decided to use a concentration of 0.05 M
phosphate buffer for the separation of cisplatin and its
hydrolysis products in subsequent studies.
3.5.2. Effect of pH
In aqueous solutions, cisplatin undergoes slow 
hydrolysis. Chloride is removed from the coordination sphere of 
the Pt(II) ion and replaced by a water or hydroxide ion. So, at 
neutral pH's, several hydrolysis products may be present in 
solution (Figure 1.2.). A study of the retention behaviour of
cisplatin and its hydrolysis products over a pH range between
4.5 and 11.0 was carried out, using a mobile phase of 0.05 M
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0 . 6 4  AUFS
Time (min)
Figure 3.5. Typical chromatograms of (a) 0.15 M NaCl 
(b) 1 mM cisplatin in water. Stationary
phase, alumina column. Mobile phase, 
phosphate buffer, 0.05 M, pH 5.5.
Flow rate 1 ml/m in.
UV detection using 205 nm.
(1) Cl", (2) cisplatin, and hydrolysis 
products A and B of cisplatin.
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Figure 3.6. Effect of buffer concentration on the 
retention of cisplatin, hydrolysis 
products and Cl- ions. Mobile phase, 
sodium dihydrogen phosphate at various 
concentrations. Flow rate 1 ml/min.
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phosphate buffer. The behaviour of the four species over this 
pH range is shown in Figure 3.7.
The retention behaviour of peaks 1 and 2, i.e. 
chloride and cisplatin, are virtually unaffected by the change 
in pH. The fact that the neutral molecule and anions are hardly 
retained, is in agreement with the assumption that the most 
important interactions on the aluminium oxide surface are 
electrostatic in nature [21]. This observation also indicates 
that the interaction between the active sites on the alumina 
surface and the neutral cisplatin molecule are minimal compared 
to the interactions previously reported on strong 
anion/cation-exchangers that have chemically bonded [4,5] or 
have solvent generated ion exchange properties [6-9]. The 
neutral drug in fact elutes close to the solvent front (Figure
3.5.) with a retention time of 2.4 min. Therefore, the 
non-modified alumina stationary phase in conjunction with 
aqueous mobile phases, does not lend itself as a successful 
model for the separation of cisplatin, especially in biological 
matrices, as most of the endogenous (and therefore potentially 
interfering) components of such matrices, also tend to elute 
with similar retention times to that of the neutral drug.
On the other hand, Figure 3.7. does indicate that 
the retention of the possible hydrolysis products i.e peaks A 
and B, are affected by changes in pH. Peak B was always the 
predominant species of the two over the pH range studied. 
Figure 3.7. shows an increase in retention of peak B on 
increasing the pH from 4.5 to 6.5. Above this pH, however, a
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Figure 3.7. Effect of pH on the retention of
cispiatin, hydrolysis products A and B 
and Cl- ions. Mobile phase, 0.05 M 
phosphate buffer; Flow rate 1 ml/min.
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decrease in retention of this species on the alumina was found. 
Similar behaviour in retention was also observed for peak A, 
although the decrease in retention was not as dramatic as that 
noted for peak B. This decrease in retention at high pH's for 
both hydrolyis products, can perhaps be attributed to the 
reduced degree of protonation of these species at high pH 
values.
At pH's lower than the ZPC, i.e 6.5, there was a 
decrease in retention time for the hydrolysis products. This 
behaviour is perhaps to be expected since the column is 
positively charged at pH values below the ZPC. Hence, due to 
electrostatic repulsion, these cationic species would be
expected to elute quickly.
At pH values between 5 and 6.5, a maximum retention 
of the two positively charged species was observed. This 
behaviour would tend to suggest that the distinct regions of 
anionic-and cationic-exchange behaviour of the alumina column 
as reported in the literature, may not be as clear-cut as 
previously thought. These results would suggest that there is 
an overlap of these areas of ionic character. Using a mobile 
phase of pH values between 5 and 6.5 seems to give rise to a 
column whose ionic behaviour is neither strongly anionic or 
completely neutral in character, compared to the nature of the 
column using mobile phases of low pH. Therefore, based on this 
supposition, one can perhaps tentatively try to identify the 
hydrolysis species. The species that has the shorter retention 
time, i.e peak A, may perhaps be the doubly positively charged
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species, eluting earlier than the singly charged species (peak 
B), due to electrostatic repulsion between the doubly charged 
species and the moderately positively charged column at pH 
values between pH values of 5 and 6.5. Also peak B is always 
larger in magnitude than peak A, which also suggests that peak 
B is indeed the positively charged mono-aquo hydrolysis 
product, and this behaviour is in agreement with the literature 
that has shown that the mono-aquo species is the predominant 
hydrolysis product of cisplatin (Chapter One, Section 1.2.1.). 
Due to the high quality of chromatographic separation and 
resolution of the hydrolysis species, a mobile phase of 0.05 M 
phosphate buffer, pH 5.5, was chosen to separate cisplatin and 
its hydrolysis products.
3.5.3. EFFECT OF ORGANIC MODIFIER
The effect of organic modifiers such as methanol and 
acetonitrile on the retention and selectivity of the separation 
of cisplatin and its hydrolysis products is shown in Figures 
3.8. a and b. As already noted in section 3.5.2. in the absence 
of any organic modifier, the system had adequate selectivity to 
permit the separation of the hydrolysis products; however, it 
did not successfully permit the separation of the neutral drug. 
Clearly, the addition of either methanol or acetonitrile does 
not affect the poor retention characteristics of cisplatin and 
the Cl- ions. [At this stage of the experimental procedure,
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aged solutions of cisplatin were being used, and this accounts 
for the third hydrolysis product noted in the chromatographic 
separation (peak C) and subsequently monitored throughout the 
following procedures]. Increases in methanol concentrations led 
to a slow increase in retention for peak B and sharper increase 
in retention for peaks A and C. The use of acetonitrile
revealed slower increases in retention for peaks A and C, 
whilst there was again longer elution of peak A with increasing 
acetonitrile concentrations. However, methanol concentrations 
of >40% resulted in poor resolution of peaks A and C, and with 
the use of acetonitrile, inadequate base-line resolution of all 
three degradation products resulted.
Clearly, in the alumina system, the addition of
organic modifiers such as methanol and acetonitrile does not
improve resolution of the different hydrolysis products; and in 
fact, it results in poorer chromatography compared to the 
separation and resolution that can be achieved with water-rich 
eluents. In general, the shape and base-line resolution of the 
chromatographic peaks was not better when organic/aqueous 
solvent mixtures were used as eluents, and analysis time was 
also dramatically increased.
3.5.4. Effect of competing-ion
The influence of different concentrations of the 
competing ion, tetraethylammonium bromide (TEABr), was then
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Figure 3.8a. Effect of methanol on addition to 
aqueous mobile phase on retention 
behaviour of cisplatin, hydrolysis 
products, and Cl“ ions. Mobile phase, 
phosphate buffer, 0.05 M, pH 5.5;
Flow rate 1 ml/min.
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studied, in order to see if this would affect (primarily) the 
retention of the neutral drug.
However, increasing the concentration of TEABr had 
no influence on the retardation of either Cl- or the neutral 
compound (Figure 3.9.). On the other hand, the increased 
concentration of this long chained competing-ion did influence 
the retention behaviour of the three hydrolysis products. The 
solute cations compete with TEA+ ions in the eluent for the 
active sites on the alumina surface. It would appear that the 
smaller solute ions are displaced by the larger TEA+ ions, 
resulting in a slight decrease in retention times for the three 
hydrolysis products. The use of TEABr required a change of 
wavelength from 205 nm to 220 nm to monitor the products (due 
to decreased transparency of the mobile phase on the addition 
of TEABr). The overall chromatographic shape of these species, 
in particular peak C, was poorer compared to the chromatography 
obtained using a purely aqueous mobile phase.
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3.5.5. CONCLUSION
The following points may be drawn from the 
chromatographic separation of cisplatin and its degradation 
products, using the non-modified alumina column as the 
stationary phase.
(i) Alumina is an amphoteric ion-exchanger which acts as a 
cation-exchanger in basic eluents and as a 
anionic-exchanger in acidic pH.
(ii) However, the transition from one mechanism to the other 
seems to be gradual, and not as clear-cut as perhaps 
suggested in the literature.
(iii) The pH of the eluent should be chosen in such a way that 
the solute ions are fully protonated, and so that the 
alumina surface possesses ion-exchange capacity.
(iv) At neutral pH's and below, cisplatin becomes hydrolysed 
to form positively charged degradation products.
(v) Neutral molecules and anions are hardly retained on this 
system hence, cisplatin (neutral) and Cl- ions (from 
hydrolysis and NaCl) were not retained. This behaviour
is in agreement with the assumption that the principal 
interactions on the alumina surface are electrostatic in 
nature [22].
(vi) The above observation also indicates that the 
interactions between the active sites on the alumina 
surface and neutral cisplatin are ineffective, compared 
to the
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interactions reported using strong cation/anion exchange 
columns that are chemically bonded or solvent generated 
ion-exchange columns, where the drug is retained via 
ion-dipole interactions of the drug and surface 
quaternary ammonium groups [4-9].
(vii) At pH's > 7 (where the column behaves as a cationic
exchanger), the hydrolysis products are not fully 
protonated, and this may explain the decreases in 
retention of the products at high pH's.
(viii At pH's < 5, a decrease in retention of the products was 
observed, due to the electrostatic repulsion between 
these positively charged species and the positively 
charged sites on the column,
(ix) In addition to pH, the concentration of a hydrophobic 
long chained competing-ion (TEABr) and the influence of 
the addition of organic modifiers (methanol and
acetonitrile) were examined. The competing-ion and the
organic modifiers did influence the retention behavior 
of the cationic products on this system, but had little 
or no influence on the resolution of these species. In 
general, the chromatography was not enhanced on the 
addition of any of the above components.
(x) An aqueous eluent of phosphate buffer 0.05 M, pH 5.5, 
successfully and selectively separated the major 
hydrolysis products of the antineoplastic agent 
cisplatin. The separation being superior to that 
reported by Hincal et al. [5].
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The above system was then applied to monitor the stability of 
the drug in both aqueous and saline solutions.
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3.5.6. The application of a non-modified stationary phase 
with aqueous mobile phases to monitor the 
degradation of cisplatin to cationic species in
both aqueous and saline solutions.
The alumina stationary phase, using an aqueous 
mobile phase, proved to be a useful method in monitoring the 
disappearance of cisplatin from aqueous solutions. In this
system, the chromatography is unambigious and one can isolate
Cl- ions and cisplatin (neutral), if not quite from the
solvent front, from the decomposition products. Typical 
chromatograms are shown in Figures 3.10. a and b, and 3.11.a 
and b, for 1 mM solutions of cisplatin dissolved in both water 
and saline. Peaks 1 and 2 are the Cl- ion and the neutral 
drug respectively, whilst peaks A and B are the major 
hydrolysis products, and peak C an unidentified hydrolysis 
product.
The fate of the drug in both solutions can be seen 
graphically in Figures 3.12. and 3.13., where the decrease of 
the drug and increase of the hydrolysis products and Cl- ion
in terms of peak height is shown over a period of time. The
larger increase in Cl- noted in saline conditions is due to 
the initial large concentration of Cl~. Initially, it can be 
seen that there is a larger degree of hydrolysis of cisplatin 
in water compared to the drug dissolved in saline; whilst
hydrolysis products A and B increase in size under aqueous
conditions compared to saline conditions. The peak height of 
peak C does not change over the experimental time scale.
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Figure 3.10. Typical chromatograms of 1 mM solution 
of cisplatin dissolved in water.
(a) cisplatin at time = 0
(b) cisplatin at time = 8 hours.
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eFigure 3.11. Typical chromatograms of 1 mM solution 
of cisplatin dissolved in saline (0.15 
M NaCl).
(a) cisplatin at time = 0
(b) cisplatin at time = 8 hours.
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Figure 3.12. Fate of cisplatin, hydrolysis products, 
and Cl" ions over a period of time 
when the drug was dissolved in water.
Pe
ak
 
h
ei
g
h
t 
(c
m
)
T i m e  ( H o u r s )
1 )  p e a k  1 ( C 3 ~ ) ,  2 )  p e a k  2 ( c i s p l a t i n )  3 )  h y d r o l y s i s  p r o d u c t  B ,
4 )  h y d r o ] y s i s  p r o d u c t  C
Figure 3.13. Fate of cisplatin, hydrolysis products,
and, Cl- ions over a period of time,
when the drug was dissolved in saline.
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observed that there was an initial rapid loss of the drug, and
after 40 hours the system appeared to reach equilibrium, with a 
significant fraction of the drug still remaining intact. Figure 
3.14, shows plots of percentage cisplatin remaining vs. time, 
for solutions of cisplatin prepared both in water and saline. 
For the hydrolysis of cisplatin in water it was observed that 
there is an initial rapid loss of the drug, i.e. 10% in a 1/2
hour and over 55% loss after 8 hours. Accompanying this
disappearance of cisplatin was an increase in the height of 
peak B. This peak appeared on immediate injection of the drug, 
and increased linearly in height up to 2 hours after
preparation. A second major peak (peak A) was noted 1 hour
after preparation, and had previouly been identified as another 
hydrolysis product. A complete identification of these peaks 
results was made from comparison of the spectra of peak 2 
(cisplatin) and peaks 3 and 4. The spectra of all 3 three peaks 
were almost similar,except that there is a shift in maximum 
absorption at 220 nm (cisplatin) to lower wavelengths for peaks 
A and B. The shift may be due to protonation of the cisplatin 
molecule; so these spectral patterns would suggest that peaks A 
and B are the protonated species of the parent molecule. These
results, along with the interpretation of retention behaviour
of these peaks (Section 3.5.2.) reinforces the identification 
that peak A is due to the doubly charged di-aquo species (III) 
and B is due to the singly charged mono-aquo species (II).
When the data in Figure 3.14. was plotted as the In of
When the loss of cisplatin in water was monitored, it was
-129-
c
is
p
la
ti
n
 
re
m
a
in
in
g
 
in
 
s
o
lu
ti
o
n
t i m e  ( h o u r s )
Figure 3.14. Plot of % cisplatin remaining in both 
aqueous (A) and saline (B) solutions as 
function of time, for an initial 
concentration of 1 mti cisplatin.
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cisplatin remaining vs time, linearity was observed up to about 
8 hours (Figure 3.15.), suggesting that the reaction was first 
order.
Most of the literature (Chapter One, Section 1.2.2 
) reports that the rate of loss of cisplatin follows the 
stepwise replacement of chloride, as shown below;
NH. c i\  /  v
Pi >  n o  —
/  \
NH. Cl
c i i  p l m n  ( I )
NH\  / C1 
P i 
/  \
NH, OH,
II
+ Cl
f  N H .  a  
\ /
Pt
NH, \ h ,
♦
+  H , 0  ~
*  - 4
' n h , n  o h , '
P t
/  \
N H ,  O H ,
*  I
+  a
From the above equations, the addition of chloride to aqueous
solutions of cisplatin would be expected to stabilise cisplatin
by shifting the aquation equilibrium to the left. The 
experimental data is in agreement with this (see Figures 3.12 
and 3.13.). There was a 10% loss of the drug after 8 hours in 
saline compared to the 10% loss after 1/2 hour when the drug 
was dissolved in water. The hydrolysis species do not increase 
to any significant extent in saline, and the peak at 4.8 min
(peak A) is not observed at all over the experimental time
scale.
However, the first aquation reaction suggests that 
the reaction
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should not obey simple first order kinetics since the reverse 
reaction is a second order process. These processes are in
agreement with the experimental data, as the rate of
disappearance of (I) does not equal the rate of appearance of
(II). From consideration of the second aquation reaction one 
showed that the disappearance of (II) leads to the appearance 
of (III), the di-aquo species (peak A) which is observed in the 
chromatograms. In this case, when cisplatin was dissolved in 
water, the reaction kinetics in first reaction are pushed to 
the right.
However, the equilibrium constant for the 
displacement of the second chloride ligand is small (^ 2 =
1.1 x 10-4 M) relative to that for the displacement of the
first chloride ligand (K-^  = 3.63 x 10~3 M) [23]. Therefore 
it has been assumed only the first aquation reaction as being 
significant in determining the rate loss of cisplatin. 
Therefore, the rate of loss of cisplatin at any time can be 
expressed as:
-d[I]/dt = k± [I] - k ^ t l l H c r ]
Assuming k_^ is negligible (as there are Cl- ions present)
Figure 3.15 gives a rate constant of 2.13 x 10 s . This
experimental result is a little lower than the values of Martin
et al [24] of 2.5 x 10“5 s_1 , and 2.47 x 10“5 s“1
obtained by Hincal et al. [5]. The fact that this experiment
was not carefully controlled with respect to temperature (i.e.
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the HPLC system and solutions were not thermostated to 25°C 
as in [5]), and also there was a certain ambiguity in the 
location of t=0 (as at least 30 min were required to dissolve 
the drug completely), may account for the deviation from 
published results.
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Figure 3.15. Ln plot for loss of cisplatin in water 
from the data presented in Figure 3.14.
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CHAPTER FOUR
ELECTROANALYTICAL STUDIES OF BIOLOGICALLY IMPORTANT 
DISULPHIDE-CONTAINING MOLECULES. AND THEIR INTERACTIONS
WITH C IS P L A T IN
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4.1. INTRODUCTION
Despite the widespread clinical application of 
cisplatin, its behaviour in biological systems is not fully 
understood. As already outlined in Chapter One, the 
concentration of the intact drug appears to fall rapidly 
following intravenous infusion of the drug. This slow 
elimination has been attributed to redistribution and extensive 
protein binding. These biotransformation products have not been 
successfully isolated. However, there are some indications that 
reactions with divalent sulphur-containing species such as 
cystine, methionine, peptides and proteins containing these 
amino acid are taking place [1,2].
In aqueous media, the two labile Cl“ groups of 
cisplatin can dissociate and hydrolysis products can be formed 
(see Chapter One, Figure 1.2.). It is these species that are 
believed to be the reactive forms of cisplatin that produce 
covalent attachments to DNA (the target within the cell). Also, 
it is the hydrolysed forms of cisplatin that can react with the 
species outlined above. The protein-bound cisplatin appears to 
have little activity [3], whilst it has also been indicated 
that direct reaction of cisplatin with sulphur-containing 
components within the cell also results in non-cytotoxic 
products.
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In order to more fully understand the nature of protein-drug 
binding, the use of AdSV has been investigated to study the 
interactions of cisplatin with human serum albumin (HSA) and 
with one of its constituent "building blocks", the amino acid 
cystine. Cystine (Figure 4.1.) plays an important role in the 
structure of some proteins (Figure 4.2.), and it also contains 
disulphide groups, which have been implicated in cisplatin 
binding [1,2]. As the electrochemical reduction of proteins has 
been attributed to a large extent to the reduction of 
disulphide groups, the significance of the AdSV behaviour 
becomes important in trying to establish both the 
electrochemical behaviour of proteins and amino acids, and 
drug- protein/amino acid binding, by the comparison of 
voltammograms from both types of disulphide-containing 
molecules.
The following sections take a look at some of the 
elctroanalytical techniques which have used to determine some 
proteins and amino acids containing disulphide links.
4.1.1. Electrochemical behaviour of proteins containing
disulphide/thiol groups
In principle, simple disulphides give rise to 
cathodic waves at the dropping mercury electrode (DME), which 
are due to their reduction to the corresponding thiol:
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IIch 2  -  s -  s -  ch 2
Figure 4.1. Structure of the amino acid, cystine, 
shown here in its zwitterionic form.
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Figure 4.2. Conformation and binding sites of 
albumin.
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However, it has been noted that polarisation time and the type 
of electrode used may be responsible for the number of 
reducible disulphide groups in proteins. For example, when 
using the DME, it has been found that only 2 disulphide bridges 
of insulin are reduced at -0.60 V vs SCE [5], whereas in the 
investigation of albumin [4] only 4 out of the 17 bridges were 
found to be reduced. However, when the hanging mercury drop 
electrode (HMDE) was used, 3 disulphide bridges in insulin and 
9 in albumin were reduced. A study which investigated the use 
of 8 M urea to denature albumin showed similar results [4], 
perhaps indicating that slow surface denaturation possibly 
occurs to some extent at the HMDE, whilst this doesn't appear 
to happen at the DME.
Bovine serum albumin (BSA) and human serum albumin 
(HSA) are proteins in the form of a single polypeptide chain of 
molecular mass 69,000. BSA is crosslinked by 17 disulphide
bonds [4]. The molecule also contains one free sulfhydryl 
group.
The reduction of the disulphide links in HSA by ¡3 
mercaptoethylamine hydrochloride was examined by Markus and 
Kharush [6], This study looked at the reduction in the 
presence and absence of sodium dodecyl sulphate (SDS), which 
acts as a denaturing agent. SDS causes the unfolding of the 
protein molecule, so that all the disulphide bonds become 
accessible to reduction, whereas only one bond was reduced when
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the experiment was carried out in the absence of SDS. Kolthoff 
and co-workers [7] used a rotating mercury pool electrode to 
carry out amperometic titrations of the -S-S- groups of both 
native and BSA denatured with silver nitrate in the presence of 
sulphite. Leach et a 1.[8 ] noted that BSA was not 
electrochemically reducible directly at a mercury pool in the 
pH range 2.9 - 9.0 at potentials of between -1.2 and -2.0 V vs 
SCE; but when ^-mercaptoethanol was used, 15 -S-S- bonds were 
reduced when the potential was held at -1.2 V vs SCE. Behr et
al. [9] found that the adsorption of BSA onto the HMDE blocked
the reduction of cadmium ions at low pH's but not at pH 7.0, 
which they ascribed to a change in the charge of BSA with 
increased pH.
Polarographic studies were carried out looking at 
the reduction of the disulphide bonds of insulin, ribonuclease 
chymotrypsin, trypsin, haemoglobin and BSA, by Weitzman and 
Cecil [10] using the DME. These disulphide containing proteins 
all gave rise to a single cathodic wave at pH 1.0 which was 
shown to involve the reduction of some of the groups, whilst at 
pH 7.1 and 9.2, a second cathodic wave was observed for some of 
the proteins. This second wave appeared after the first wave 
had reached its limiting value, and was also shown to involve
the reducton of -S-S- groups. AC polarography has been used to
study the reduction processes of disulphide bonds and free 
Zn(II) in several types of insulin preparations [11].
Stankovich and Bard [4] examined the 
electroreduction of bovine serum albumin (BSA) in solutions of
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potential step chronocoulometry as well as by cyclic voltametry 
at a mercury pool electrode by controlled potential
coulometry. They proposed a mechanism involving the reduction 
of an adsorbed monolayer of BSA in which at short time periods, 
3 or 4 disulphide bonds were reduced. When the product remains 
adsorbed for large time periods, all the disulphide bonds (17) 
are reduced resulting in an insoluble product which cannot be 
re-oxidised.
4.1.2. Electroanalysis of proteins containing disulphide/
thiol groups
The early 1980's saw an increase in the use of 
electroanalytical techniques to determine trace levels of serum 
proteins and albumin. For instance, Hertl developed a 
differential pulse polarographic assay for serum protein [12]. 
He found that both human serum and HSA showed a differential 
pulse polarographic wave at -0.60 V. When solutions were
sufficiently dilute, i.e. < 7.0 jug/ml at neutral pH's, the
polarographic response was linearly related to solution 
concentrations, whereas at high pH values, (pH 12.6) a 
near-linear response to 70 /¿g/ml was obtained (at the expense 
of slow sample equilibration time). Forsman [13] has 
investigated the use of stripping voltammetry for the 
determination of some well known disulphide-containing proteins 
and peptides such as
pH 7.4 at the hanging mercury drop electrode by double
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insulin, ribonuclease, oxytocin etc. His study showed that for 
most of the proteins (except insulin), stripping voltammetry in 
the presence of excess copper(II) resulted in detection limits 
of 2xl0-9 M.
More recently, Smyth and co-workers [14,15] were 
able to utilise adsorptive stripping voltammetry to study the 
behaviour of HSA and BSA. The adsorptive stripping voltammetric 
behaviour of both proteins were optimised with respect to 
accumulation potential, accumulation time and scan rate, giving 
limits of detection of 2.9xl0-8 M (HSA) and 2xl0-9 to
_ o
1.5x10 ° M (BSA). Trace measurements of trypsin and
chymotrypsin using the same techniques were carried out by Wang 
and co-workers [16]. The adsorbed proteins yielded well
defined waves at -0.30 V vs Ag/AgCl giving rise to limits of
n
detection of 3x10 ' M.
A new analytical method, based on the adsorptive
preconcentration of biomacromolecules on an electrode, the 
transfer of the adsorbed layer into a new medium (containing 
background electrolyte), and subsequent voltammmetric analysis 
has recently been proposed by Palecek and Postbieglova [17]
for the analysis of some proteins, lipids and polysaccharides. 
This technique made it possible to carry out the voltammetric 
analysis of large biomolecules adsorbed from media not suitable 
for conventional voltammetric analysis.
Since it has been widely assumed that the
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electrochemical behaviour of these proteins is due to the 
presence of disulphide/thiol moieties, many workers have 
studied the amino acids cystine and cysteine (both containing 
sulphur groups).
Stankovich and Bard [18] studied the 
electroreduction of cystine and the oxidation of cysteine with 
respect to pH at the HMDE by cyclic voltammetry and at a 
mercury pool using coulometry. The mechanism proposed for the 
reduction of cystine involved the reduction of an adsorbed 
monolayer of cystine to form solution phase cysteine. Mercury 
electrodes have been used by Bond et al. [19] to compare the 
behaviour of homocysteine (a product of methionine metabolism 
not normally detectable in human tissue fluids), cysteine, and 
the disulphides cystine and homocystine. The former two
molecules are closely related in structure, and the resulting 
polarograms indicated that they have similar limiting currents 
per unit concentration and shape, as well as similar E - ^  
values of -0.125 V. Differential pulse polarography of
homocysteine showed limits of detection of approximately 10“  ^
M, whilst differential pulse cathodic stripping voltammetry
_Q
yielded detection limits of 10 M. Unlike the thiols, there 
was a difference noted in the electrochemical reduction of the 
disulphides ( E c y s t i n e  - 0.455 V, homocystine - 0.650 V).
Work has recently been published describing a method for the
determination of cystine and cysteine in sea water and fresh 
water again using CSV. In the presence of added copper (II)
ions, a limit of detection of 0.1 nM was obtained [20], Kuzel
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[21] in 1973 was able to use polarographic techniques to 
quantitatively determine cystine excreted in the urine as a 
result of cystinuria, using a sulphite-nickel electrolyte 
solution
Other electrode types have been sucessfully used in 
the determination of sulphydryl compound. Hitchman and Nyasulu
[22] used copper electrodes (which were cathodically treated
before analysis) for the direct potentiometric determination of 
a number of proteins, L-cysteine and L-histidine, whilst the 
use of chemically modified electrodes, made by incorporating 
cobalt phthalocyanine (CoPC) into conventional carbon paste 
electrodes, were shown to catalyse the electrooxidation of
cysteine, homocysteine, and N-acetylcysteine. When used as the 
working electrode in amperometric detection following HPLC, 
limits of detection for the above were of the order of 2.7
pmole.
4.1.3. Electroanalytica1 studies of antiaen-antibody
interactions
It was as far back as the early 1950’s when
polarographic techniques were investigated to see if they could 
be used to monitor immunological reactions. Breyer and 
Radcliff [23], using an azoprotein as the antigen, carried out 
experiments that showed on the addition of specific and 
non-specific sera, the polarographic wave of the azoprotein
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varied, i.e. on addition of the specific antiserum to the 
azoprotein, a sharp decrease in the wave was observed, whereas 
when non-specific serum was added, only a decrease due to the 
diluent effect was seen. Kano and co-workers [24] then studied 
the Brdicka currents of human immunoglobin G (IgG) and sheep 
anti-human IgG. These currents (polarographic catalytic 
hydrogen evolution currents produced by proteins in the 
presence of a cobalt salt) were studied by direct current and 
differential pulse polarographic methods. For a mixture of IgG 
and anti-IgG, the currents were smaller than the sum of 
currents due to IgG and anti-IgG in separate solutions; the 
difference being attributed to complex formation between IgG 
and anti-Ig G. Using differential pulse polarography, limits 
of detection of 10~11^ M of antigen (or antibody) were 
obtained.
Adsorptive stripping voltammetry has also proved 
successful in monitoring immunological reactions. Smyth and 
co-workers [14,25] have used this technique to follow the 
voltammetric behaviour HSA and anti-HSA as well as IgG and 
anti-IgG, and monitored the interaction of these molecules. 
Limits of detection for HSA were 2.9 x 10-8 M, whilst linear 
calilration curves were obtained for both IgG and anti-IgG in 
the range lxlO-9 - lxlO-^ M and lxlO-9 - lxlO-8 M 
respectively.
Chemically modified electrodes have also been 
investigated to monitor antigen-antibody reactions. Yamamoto 
et al. [26] investigated the immunological reaction of human 
chorionicgonadatropin (hCG) in a potentiometric
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investigation using a cyanogen bromide-treated electrode coated 
with the corresponding anti-serum. It was found that the 
potential of the modified electrode shifted in the positive 
direction upon contact with a solution of hCG, and the rate of 
the reaction at the interface between electrode and solution 
was the order of 104 mol“1 s in diethyl barbiturate 
buffer.
-149-
4.2. EXPERIMENTAL
4.2.1. Materials
All materials used were of analytical grade and 
solutions were prepared in water obtained by passing distilled 
water through a Milli-Q water purification system. Throughout 
the electrochemical studies, a 0.1 M phosphate buffer (pH 7.4) 
was prepared using disodium hydrogen phosphate and sodium 
dihydrogen phosphate. Cystine was obtained from BDH Chemical 
Ltd and cisplatin was obtained from Sigma. Stock solutions of 
both cystine and cisplatin were prepared in water.
4.2.2. Apparatus
All voltammograms were obtained using a Princeton 
Applied Corporation (PARC) Model 264A Polarographic Analyser 
combined with a PARC Model 303 magnetic stirrer and an
Omnigraphic Model 2000 x-y recorder.
4.2.3. Procedures
Before each investigation, the electrolyte was
purged with nitrogen for 8 min. Following the addition of 
analyte to the cell, the electrolyte was further purged for 2
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accumulation potential (Eacc^ was aPPiied to the cell for the 
required accumulation time (tacc), with continous stirring.
The solution was then maintained at rest during the
equilibration period of 30 s. A differential pulse scan was 
then initiated using an initial potential (Eacc) and scanning 
to -1.00 V. During most of the studies, a scan rate of 10 mV/s, 
pulse amplitude of 50 mV and a large drop was used. The
adsorptive stripping cycle was repeated using a new drop.
min. After this step, the potential relating to the
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4.3. ELECTROANALYTICAL STUDIES OF THE DISULPHIDE-
CONTAINING AMINO ACID. CYSTINE
4.3.1. Cyclic voltammetry of cystine
A typical cyclic voltammogram for a 4.0 x 10~^ M 
solution of cystine in phosphate buffer, pH 7.4, using an 
initial potential of +0.20 V (without accumulation), is shown 
in Figure 4.3. Cystine gives rise to two reduction peaks at 
-0.15 V (peak A) and -0.49 V (peak B), and an anodic peak in 
the reverse scan at -0.45 V. The main cathodic peak at -0.49 V
peak B, shows a linear dependence on scan rate, v, for v =
50-500 mV/s (Figure 4.4.) and together with its 
morphology,seems to indicate an adsorption-controlled process. 
According to Stankovich and Bard [18] and Kolthoff and Barnum
[37], and together with this experimental evidence, the process 
corresponds to the reduction of cystine to cysteine, according 
to the following mechanism:
RSSR + 2H+ + 2e~ *2RSH
The oxidation wave that appears on the reverse scan is not
directly related with cystine itself. It has a shape
corresponding to that of a diffusion process and the peak
current i_ a 1/9 r
P' is linear with v ' . Kolthoff and Barnum [37]
did not find an anodic polarographic process with cystine.
However they did find such an anodic process for cysteine. By
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Bcystine in phosphate buffer, pH 7.4, in 
an unstirred solution. Scan rate 500 
mV/s -
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30 100 200 300 400 500
s c a n  r a t e  ( v )  m V / s
Figure 4.4. Dependence of cathodic peak current 
(in „) on scan rate (v), for a 
4 x 10“  ^M cystine solution in 
phosphate buffer, pH 7.4.
600
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comparison with their experimental findings, the anodic process 
here can be ascribed to the oxidation of cysteine, arising from 
the reduction of cystine. Peak A at Ep = -0.15 V, also has a 
shape corresponding to a diffusion-controlled process. This 
peak can be attributed to the reduction of R-S-Hg-S-R species, 
the mechanism of which is outlined in detail later.
Subsequent repetitive scans yielded lower peak currents for all 
three processes compared to those of the first trace. This 
change in repetitive cycling would appear, to indicate that both 
the reduced and oxidised forms of this amino acid are not very 
strongly adsorbed, as other molecules containing -S-S- links 
are [13]. It does however show similar adsorption behaviour to 
BSA [12] on repetitive CV scans. This decrease in current is 
more than likely due to the depletion of the layer of species 
adjacent to the electrode surface.
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cystine
The AdSV behaviour of cystine was examined, paying 
particular attention to the effect of accumulation potential 
(Eacc )- accumulation time (tacc), drop size, scan rate and 
pulse amplitude, plus the effect of concentration of the amino 
acid.
The effect of accumulation time on the AdSV
_ 7
behaviour of a 10 M solution of cystine is shown in Figure
4.5. Two peaks were noted at -0.35 V (peak A) and -0.55 V (peak 
B). The peak currents for peak A were larger than for peak B
(Figure 4.5.), when there was no (or only a very small)
accumulation time used. This dependence of current on tacc 
for both peaks is represented graphically in Figure 4.6. Peak A 
shows a linear increase up to 50 s; however, above this time, a 
plateau region was observed in the plot. A well defined linear 
increase in current with increasing tacc was observed for 
peak B. However, at times > 500 s, linearity was not adhered 
to. This behaviour may be attributed to:
(i) saturation of Hg electrode with cystine; and/or
(ii) adsorption equilibrium being obtained.
The effect of stirring (i.e. mass transport) during 
the preconcentration period was also examined. For example, 
with solution stirring, both stripping peaks were between 85 
-88-fold larger than the corresponding peaks in a quiescent 
solution (Figure 4.7.)
4.3.2. Adsorptive stripping voltammetric behaviour of
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E ( V )
Figure 4.5. AdSV behaviour of 1.0 x 10-7 M
cystine at various tacc between 0 - 
180 s, using an Eacc of + 0.10 mV/s, 
pulse amplitude 50 mV and large drop. 
tacc: (1) 000 s, (2) 20 s, (3) 60 s,
(4) 100 s, (5) 140 s, (6) 180 s.
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Figure 4.6. Dependence of peak currents for peaks
A and B with tacc (concentration of 
cystine, 10-7 M).
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BFigure 4.7a. AdSV behaviour of 4 x 10 7 M cystine
in a quiescent solution.
(1) tacc 0 s, (2) tacc 200 s.
Eacc +0.20 V, scan rate 10 mV/s,
pulse amplitude 50 mV.
Figure 4.7b. AdSV behaviour of 4 x 10-7 M cystine
in a stirred solution.
) tacc 0 s, (2) tacc 200 s.
Conditions as in Figure 4.7a.
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The two peaks noted for the adsorption and subsequent reduction 
of cystine showed varying behaviour with respect to 
accumulation potential. The dependence of the peak currents
for both peaks A and B, over the potential range +0.3 ---0.20
V, is shown in Figure 4.8. Both peaks exhibited a similar 
behaviour over the potential range +0.30 V to +0.10 V, where a
maximum current was obtained for both peaks for an Eacc of
+0.20 V. This was subsequently chosen as the optimum potential 
to monitor the behaviour of the amino acid. However, at 
potentials more negative than +0.10 V, peak A was not clearly 
observed, whilst peak B showed a decrease in current at 
potentials more negative than +0.10 V.
This variation in current of cystine with variation 
of Eacc, together with the information gathered from the CV 
experiments allows the nature of these two peaks to be 
ascribed. Peak B appears to have all the characteristics of an 
adsorbed species. Its CV behaviour and peak potential is 
similar to that published by Stankovich and Bard [18], and its 
AdSV behaviour is rather similar to those waves found at
similar potentials for cystine [37] and for the 
disulphide-containing proteins HSA [14], BSA [15] and IgG [25]. 
The peak at -0.56 V as already outlined can therefore be
ascribed to the reduction of cystine to cysteine according to 
the reaction:
RSSR + 2H+ + 2e ■>2RSHads
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Figure 4.8. Dependence of peak currents for peaks A 
and 8 of cystine with Eacc-
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The nature of peak A is more complex. Peak A was found only 
when accumulation was carried out at positive potentials. 
During this accumulation, there appears to be an equilibrium 
between the bulk solution concentration of cystine and that of 
the adsorbed species at the electrode surface. The mechanism 
ascribed for peak A (in agreement with work published for the 
reduction of thiuram disulphides and diphenyl disulphides
[38]), suggests the addition of mercury across the disulphide 
1inkage:
and the subsequent reduction of this mercury salt to cysteine*.
From the experimental evidence, the equilibrium process may be 
expressed as follows:
The formation of this mercurous cysteinate seems to be
concentration dependent of the bulk cystine solution, and this 
equilibrium appears to be reached very quickly (see plateau
region for peak A in Figure 4.6.). The higher the bulk solution
concentration of cystine, the higher the mercury salt
formation, hence the greater the magnitude of response (compare
R-S-S-R — Hq >R-S-Hg-S-R
R-S-Hg-S-R + 2e- + 2H+ > 2RSH + Hg
RSHgSRads
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Figures 4.5. and 4.7a and b. The formation of this mercurous 
cysteinate only occurs in the presence of Hg(II) ions, as noted 
from the fact that peak A is seen only during accumulation at
positive potentials. The wave noted during CV experiments -at
0.15 V, which showed linearity with v1^ ,  corresponds more 
than likely to peak A using AdSV. Hence peak A is diffusion
controlled, whilst peak B suggests an adsorption controlled 
behaviour.
The AdSV behaviour of peak B of cystine was then 
evaluated with respect to drop size, scan rate and pulse 
amplitude. These results are collated in Table 4.1., and from 
this it should be noted that the optimum conditions for the
determination of cystine ares Eacc +0.20 V, pulse amplitude 
50 mV, scan rate 10 mV/s and "large " drop size. Under these 
conditions, a calibration curve was obtained for the 
determination of cystine, using an accumulation time of 200 s.
_o n
The plot was linear over the range 5 x 10 ° M - 8 x 10 ' M.
These results compare favorably with those obtained by van den
Berg et al [20], who used cathodic stripping voltammetry to
determine cystine and cysteine in sea-water, in the presence of
Cu(II). Using an accumulation period of 4 min, limits of
0
detection were of the order 1 x 10 M. The technique 
reported here has improved on the sensitivity for cystine
determination compared to that reported by Kutzel [21], who
applied a polarographic method using a sulphite-nickel 
electrolyte, to determine cystine in urine. The reproducibility 
of this technique held for cystine concentrations between 1 - 6  
mM.
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tac<
20
40
60
80
100
200
300
400
500
600
700
80
200
200
200
200
200
200
200
200
200
200
200
200
200
200
Eacc drop size scan rate -E (A)' Ip (A)/ ,-Ep(B) V B)
(mV/s) - *'(V) (nA) (V) (nA)
+ 0.10 1 10 -0.35 7.8 -0.54 5.9
+ 0.10 1 10 -0.35 21.5 -0.54 13.7
+0.10 1 10 -0.35 35.3 -0.54 33.5
+0.10 1 10 -0.35 39.2 -0.54 45.3
+ 0.10 1 10 -0.35 41.2 -0.54 84.6
+ 0.10 1 10 -0.35 43.1 -0.54 131.8
+ 0.10 1 10 -0.35 43.1 -0.54 220.4
+ 0.10 1 10 -0.35 45 -0.54 261.5
+ 0.10 1 10 -0.35 45 -0.54 295.3
+ 0.10 1 10 -0.35 45 -0.54 322.8
+ 0.10 1 10 -0.35 47 -0.54 301.1
+ 0.10 1 10 -0.35 47 -0.54 301.1
+ 0.05 1 10 -0.35 — -0.54 91.8
+ 0.10 1 10 -0.35 62 -0.54 179.60
+ 0.20 1 10 -0.35 141 -0.54 371
+ 0.30 1 10 -0.35 32.6 -0.54 24.5
+ 0.00 1 10 -0.35 — -0.54 97.95
-0.10 1 10 -0.35 — -0.54 48.97
-0.20 1 10 -0.35 — -0.54 38.7
+ 0.20 1 10 -0.35 242 .8 -0.54 316
+ 0 .20 m 10 -0.35 148.9 -0.54 191.8
+ 0.20 s 10 -0.35 124 -0.54 144.8
+ 0.20 1 2 -0.35 132.6 -0.54 126.8
+ 0.20 1 5 -0.35 242 .8 -0.54 330.6
+ 0.20 1 10 -0.35 295.9 -0.54 459
+ 0.20 1 20 -0.35 269 -0.54 451
Table 4.1. Influence of accumulation time ^acc^'
accumulation potential (Eacc^ droP
size and scan rate on peak current of 
peak A (ip (A)) and peak B (ip (B))-
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4.4. INTERACTIONS OF CISPLATIN WITH BIOLOGICALLY
SIGNIFICANT DISULPHIDE-CONTAINING MOLECULES
4.4.1. AdSV behaviour of HSA in the presence of cisplatin
The typical voltammetric behaviour of HSA (2.5 x 
10-7 M), in 0.1 M phosphate buffer, pH 7.4, using an
accumulation time of 300 s is shown in Figure 4.9. The 
voltammograms were recorded using a negative going scan. Two 
peaks were noted; peak A ! at -0.44 V and peak B' at -0.56 V. 
The behaviour observed is in accordance with that reported by 
Rodriquez et al. [14]. However, on the addition of the 
antineoplastic agent, cisplatin, the currents for both these 
peaks decreased (Figure 4.10.). The decrease in peak B' was
_ Q
linear with respect to cisplatin concentrations < 1 x 10 ° M, 
whilst peak A' decreased in a non-linear manner. A slight 
increase in current was also noted at about -0.68 V, when
_ o
cisplatin concentrations > than 1 x 10 ° M cisplatin were 
added to HSA. This wave was not observed when HSA was present 
only in the cell. The substantial decrease of stripping 
current for peak B' may be attributed to the inaccessabi1ity of 
the disulphide linkages of the protein for reduction at the 
electrode surface, due to cisplatin binding.
Following these experimental observations, it was 
decided to investigate the use of AdSV to monitor the 
interaction of HSA with cisplatin, using the observed decrease 
in current for HSA (by monitoring peak B') upon the addition of
-165-
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Figure 4.9. Typical AdSV behaviour of 2.5 x 10-7 M 
human serum albumin (HSA), in phosphate 
buffer, pH 7.4, using tacc 300 s,
Eacc +0.20 V, scan rate 10 mV/s, pulse 
amplitude 50 mV.
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Figure 4.10. AdSV behaviour of HSA in the presence
of cisplatin.
(1) HSA 2.5 x 10-7 M, (2) (1) + 0.5 x 
10-8 M cisplatin (3) (1) + 1 x
10-8 M cisplatin, (4) (1) + 1.5 x
10-8 M cisplatin, (5)
(1) + 2 x 10-8 M cisplatin, (6) (1) +
2.5 x 10-8 M cisplatin, (7) (1) + 3 x
10~8 M cisplatin, (8) (1) + 3.5 x
10~8 M cisplatin.
Eacc +0-10 v ? fcacc 300 Sf scan rate
10 mV/s, pulse amplitude 50 mV.
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The use of electrochemical techniques to study 
drug-albumin interactions are not new. Squella et al. [27] 
monitored the binding of HSA with chlordiazepoxide using 
alternating current (AC) polarography, whilst Livertoux and 
Bessiere [28] monitored the interactions of fiurazepam and 
diazepam with HSA using both DPP and AC polarography. The 
binding characteristics of albumin with cadmium [29], azo dyes 
[30-33], vanadium [34] and molybdate ions [35] have also been 
evaluated using polarographic techniques. However, the use of 
AdSV is perhaps a new approach to monitor the interactions of 
proteins and drugs. Rodriquez et al [36] have used this 
technique to monitor the interaction of IgG with diazepam and 
fiurazepam. The mathematical approach taken by Squella et al. 
[27] has been adapted to evaluate our experimental results, 
where the binding studies were investigated by increasing the 
cisplatin concentration at a fixed HSA concentration, as shown 
in Figure 4.10.
The currents for albumin in the presence and absence 
of cisplatin may be denoted as Ip and Ip Q , respectively, 
and c, cb and Cf, are the concentration of the total, bound 
and free albumin, where:
the drug.
C = C r + Cv. (4.1)
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Then:
Ip/Ip( 0  « [cf + kcb ]/c (4.2)
where k is the fractional coefficient, and is the value of 
1 ,^ /1 ^ n when a sufficient excess of cisplatin has beenr  r  /
added to interact with all the HSA and cisplatin. Graphically, 
the value may be obtained by extrapolation:
lira Ip/Ip i 0  = k (4.3)
c f — > 0
The addition of gradually increasing amounts of cisplatin 
results in the reduction of the peak B'of HSA until it attains 
a constant value. The effect of increasing cisplatin 
concentration on this peak current ratio is shown in Figure
4.11. From this graph one can obtain a fractional coefficent 
for the HSA-cisplatin system, at pH 7.4, of k = 0.32. The 
fractional coefficients reported for the chlordiazepoxide-HSA 
system [27] are similar to that reported here. This would 
suggest that there is strong interaction of cisplatin with HSA.
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Figure 4.11.  Dependence of  I p/ I p 0 on c i s p l a t i n
concentration at a fixed HSA
—7concentration of 2 x 10 M, in 
phosphate buffer, pH 7.4.
c i s p l a t i n  ( x 10 8 M)
The behaviour of HSA in the presence of cisplatin, monitored by 
the decrease in the current for peak B', shows similarities to 
those studies previously devised to determine the interaction 
of HSA with benzodiazepine drugs [28,36] (these drugs have 
shown to exhibit high binding affinities for albumin). Riley et 
al.[2 ] were able to assess cisplatin reactivity with peptides 
and proteins using HPLC. On incubation of HSA with cisplatin 
they found that this protein had at least one or more reactive 
sites that are readily accessible to cisplatin. Therefore by 
comparison, the experimental results presented here suggest 
that cisplatin also has a high affinity for HSA, similar to 
that reported for the benzodiazepine drugs [36].
A means of expressing this binding affinity between 
HSA and drug is by an expression of binding constants and 
binding sites. One of the most common methods to determine 
these parameters from experimental data, is the use of the 
Scatchard plot [27,28,36,39]. However, this method was not 
applicable to the HSA-cisplatin system reported here, as this 
plot requires the measurement of the concentration of ligand 
bound to protein, at a series of values of concentration of 
free ligand in solution, containing a fixed total protein 
concentration. In order to obtain more reliable data it will be 
necessary in the future to utilise another technique such as 
HPLC, to separate free and bound cisplatin. One way of doing 
this might involve the use of an alumina column (see Chapter 
Three).
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4.4.2. AdSV behaviour of cystine in the presence of
cisplatin
The experimental evidence reported in Section 4.4.1. 
is rather ambiguous when it comes to trying to interpret the 
interaction between the protein and the drug. It was decided 
therefore to take the study a step further and investigate the
affinity of the drug for cystine, the amino acid containing
disulphide bonds in its structure, and which plays an important 
role in maintaining the tertiary structure of HSA.
The AdSV behaviour of cystine has already been
outlined in Section 4.3., and using those conditions already 
optimised, 2 peaks were noted at -0.37 V (peak A) and at -0.52
_C
V (peak B) for a 2 x 10 ° M cystine solution. Gradual
increments of a 1 0  M solution of cisplatin were then added 
to the cell already containing cystine, and Figure 4.12. shows 
the resultant voltammetric peaks for cystine upon the addition 
of cisplatin. The current response observed for both peaks is 
similar to that noted for the addition of cisplatin to HSA, 
although the observed current decrease with increasing drug
concentrations for both peaks appears linear compared to the
behaviour noted for peak A' and B'in HSA. The mechanism 
proposed for the AdSV behaviour of cystine, suggests that peak 
B is due to the reduction of cystine to give cysteine. Thus it
would appear that the interaction of cisplatin with cystine
occurs at these disulphide groups. It is these bonds that are
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Figure 4.12. AdSV of 2.0 x 10-  ^ M of cystine
in the presence (1 ) cystine 2 x 
10~ 6 M, (2) (1) + 1 x 1 0 " 8  M
cisplatin, (3) (1) + 2 x 10“8M
cisplatin, (4) (1) + 3 x 10- 8  M
cisplatin, (5) (1) + 4 x 10- 8  M
cisplatin, (6 ) (1) + 5 x 10- 8
cisplatin, (7) (1) + 6 x 10- 8  M
cisplatin, (8 ) (1) + 7 x 10- 8  M
cisplatin.
Eacc  = V ' t a c c  1 0 0 s < scan
rate 10 mV/s pulse amplitude 50
mV.
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responsible for the electrochemical activity of the amino acid, 
and hence binding of drug to these bonds results in the
decrease in currents for the original cystine waves.
The degree of interaction of drug to the amino acid 
was influenced by concentration of the added drug, where at
_7
concentrations > 10 M cisplatin, the cystine peaks are
virtually eliminated. Studies were also undertaken to look at 
the effect of incubation times on the interactions of cisplatin 
and cystine, and also the degree of interaction of a freshly 
prepared sample of cisplatin compared to that of an aged 
sample. The experimental results suggest that the degree of 
interaction in the cystine/cisplatin system was greatly
influenced by the incubation time allowed. The cell was 
thermostatted at 37°C and the cystine-cisplatin mixture 
allowed to react over a 1 hour period. Under these conditions, 
there was an 80% decrease in the original peak current for peak 
B of cystine. It was then decided to monitor what happened
within the system over certain time intervals. There are a few 
points to note from the voltammograms shown in Figure 4.13. The 
accumulation potential was held at 0.00 V, hence the 
non-appearance of peak A (see Section 4.3.2.). On running the 
voltammograms every 10 min, during incubation at 37°C, there 
was a shift to slightly more positive potentials for peak B
from -0.53 V to -0.45 V after a 70 min incubation period. There 
is also the appearance of a new wave at -0.61 V, which becomes 
more defined with longer incubation times. From
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Figure 4.13 Effect of incubation at 37°C of
cystine-cisplatin system, over a 
period of time (80 min).
(1) cystine 2 x 10“ 5  M,
(2 ) addition of 1  x 1 0 - 8  M cisplatin
(3) - (10), scans of the
cystine-cisplatin system taken every 
1 0  min.
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interactions between cystine and cisplatin are concentration 
dependent and are influenced by the temperature and length of 
incubation time at this temperature. Physiological conditions, 
such as those used here i.e., 37°C and pH 7.4, reveal perhaps 
stable and favourable interaction conditions for interaction 
between the drug and amino acid, as noted in the shift to 
positive potentials and the new wave.
The affinity for cisplatin to cystine was also
followed with respect to the age of the interacting drug where
the degree of interaction of fresh and aged samples of 
cisplatin with cystine were compared. The results revealed that 
freshly prepared samples of cisplatin gave rise to smaller 
decreases in peak current of the original cystine peak, whilst 
interactions of an aged solution of the drug with the amino 
acid resulted in a larger decrease in the peak currents of peak 
B (Figure 4.14.). This behaviour may perhaps be attributed to 
the presence of the positively charged hydrolysis products of 
cisplatin, i.e, the mono-aquo and di-aquo species, which result 
from the degradation of the drug due to ageing, and have been 
suggested in the literature to bind particularly well across 
molecules containing disulphide groups [1 ,2 ].
the overall experimental results it would appear that
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Figure 4.14. Effect of ageing of cisplatin on the 
current of peak B of cystine.
(A) Fresh solution
(B) Aged solution (4 days old)
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CHAPTER FIVE
VOLTAMMETRIC AND GRAPHITE FURNACE ATOMIC 
ABSORPTION SPECTROPHOTOMETRIC METHODS 
FOR THE DIRECT DETERMINATION OF 
INORGANIC PLATINUM IN URINE
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5.1. INTRODUCTION
The determination of platinum (Pt) in plasma and 
urine of patients treated with the antineoplastic agent 
cisplatin requires a sensitive assay technique, and has proven 
an interesting challenge to the analytical chemist. The most 
widely used technique for the determination of platinum in body 
fluids following cisplatin therapy is graphite furnace atomic 
absorption spectrometry (GFAAS). Early pharmacokinetic 
experiments were undertaken to determine the total platinum 
levels in plasma or urine using this technique [1-4]. As 
already outlined in Chapter One, acute nephrotoxicity is the 
limiting factor in dosage escalation of cisplatin. The 
introduction of prehydration and a mannitol-induced diuresis 
substantially decreased the incidence of renal toxicity. Kelsen 
et a 1. [5] used GFAAS to perform a cisplatin nephrotoxicity 
study, to correlate acute nephrotoxicity with plasma platinum 
concentrations.
The advantage of this technique is that relatively 
little sample pretreatment is required, and urine, plasma and 
plasma ultrafiltrate can be introduced directly into the 
graphite furnace. However, in order to improve detection 
limits, many tissue samples are subjected to time-consuming and 
potentially hazardous, wet- or dry-ashing procedures prior to 
platinum analysis [6-9]. Typical wet ashing methods include the 
use of acids such as nitric or perchloric acids, and limits of 
detection using these methods are in the region of 0 . 1  ug/g of
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wet tissue [7]. As these ashing techniques are potentially 
hazardous, Siddik et al. [9] reported on the application of
tissue solubilisation in hyamine hydroxide
(methylbenzenethonium hydroxide) in the GFAAS determination of 
total tissue platinum. Limits of detection were comparable
between the hyamine hydroxide (0.25 ¿ig/g) and nitric acid (0.15 
ug/g procedures. However, the solubilisation of tissues offers 
several advantages over conventional digestion procedures. 
Larger numbers of samples can be processed with relatively 
greater safety using hyamine hydroxide, and solubilisation also 
eliminates the need for sample observation, which is necessary 
with the HNO3 digests, to prevent charring.
Matrix removal may also be influenced by the 
temperature programmes used throughout sample analysis.
Platinum is relatively non-volatile, and temperatures of 
between 2300°C [8,10,11] and 2700°C [7,9] are required for
atomisation. However, when the samples are complex like plasma 
and tissue samples, the most important stage in the entire 
furnace programme is the ashing stage. The ultimate aim is to 
remove the matrix completely, leaving behind the analyte in a 
form which results in maximum atomisation. Therefore this step 
is very much matrix dependent, with plasma and urine requiring 
temperatures of 700 - 1200°C [8,11,12], whilst tissue samples
require higher temperatures for complete matrix removal [7,9].
Graphite furnace atomic absorption spectroscopy does 
provide the necessary sensitivity for monitoring Pt levels in
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clinical samples. Due to the high temperarures required for 
atomisation, however, rapid decomposition of the pyrolytic 
graphite surface occurs leading to analytical inaccuracy. Also, 
this technique responds only to total levels of Pt and cannot 
differentiate between Pt complexes and their respective 
degradation and biotransformation products. Bannister et al. 
[8 ] developed a method of analysis for free circulating Pt 
species in blood plasma. The separation of protein bound and 
free Pt species was effected by centrafugal ultrafiltration, 
followed by the conversion of Pt in the ultrafiltrate to a 
cationic complex by reaction with ethylenediammine. This 
product was then collected on paper impregnated with a 
cation-exchange resin and Pt was eluted from the disk with 5 mM 
HC1. The limit of detection using GFAAS was 35 ¿ig/1 of plasma.
Platinum speciation, however, can be achieved by 
interfacing (either on-line or off-line) a separation/ 
chromatographic step with the GFAAS detection method. 
Fractionation of the HPLC eluent and subsequent determination 
by GFAAS is time consuming, but has been used by Riley et al. 
[13], who combined the separation of Pt in urine using column 
switching on solvent generated anion-exchangers, giving limits 
of detection of 2  ptg/ml urine.
Platinum compounds can be determined based on 
electrochemical reduction or oxidation processes. Although the 
polarographic reduction of platinum (II) complexes has been the 
subject of investigations for years, its electrode reaction 
mechanism is still not completely understood [14]. The
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complications associated with the reduction of these complexes 
has been reviewed by Harrison et al. [15]. Laitinen and Onstott 
[16] reported the appearance of unusual reduction waves (with 
maxima and minima) for the tetrachlorplatinate (II) ion at the 
DME. The catalytic currents observed at strongly negative 
potentials [17-20] have also been a subject of interest. The 
analytical utility of the catalytic current has been recognised 
previously; for instance Pt was determined in hydrochloric acid 
solutions [17] and after derivatisation with EDTA [18] or 
ethylenediammine [12,19,21-24]. In the latter case, a DPP assay 
for cisplatin was performed after acid oxidative hydrolysis of 
biological samples and reaction with ethylenediammine, giving 
limits of detection of 0.5 ng/ml platinum.
The interfacial behaviour of Pt complexes has also 
been utilised to reduce limits of detection. Wang et al.[25] 
exploited the interfacial accumulation of cisplatin at mercury 
electrodes as an effective preconcentration process prior to 
the voltammetric measurement. The voltammetric response was 
evaluated with respect to preconcentration time and potential, 
concentration dependence, nature of electrolyte, the presence 
of surfactants and other variables. Using a preconcentration 
potential of -0.20 V, a linear calibration plot was obtained up 
to 2.4 x 10" 6 M, and the adsorptive stripping voltammetric 
technique was adapted for the indirect assay of cisplatin in 
untreated urine samples.
Previous stripping voltammetric methods for 
determining Pt include the masking of the sulphide or thiourea
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peak by Pt, and the deposition of Pt on a graphite or glassy 
carbon electrode from solutions containing PtCl^j and 
PtClg2- ions following by anodic stripping voltammetry 
[26,27]. The sensitivity of these methods, however, is not high 
and only levels above 1 0 ~ 8  M platinum can be determined, 
compared to measurement of catalytic hydrogen waves produced by 
Pt complexed with ethylenediammine [19] or formazone [24], 
which give limits of detection of 10~^ M. Van den Berg et 
al. [28] improved the existing limits of detection (0.04 pM) by 
measurement of the catalytic hydrogen wave at a mercury 
electrode, following complexation of Pt with formazone (complex 
is adsorbed for 1-20 min at -0.925 V). This adsorptive cathodic 
stripping voltammetric method was used to determine Pt levels 
in sea water. However, the technique did suffer from the 
formazone peak that interferes with the measurement of the Pt 
peak, as the latter appears on a shoulder on the former.
The following section illustrates the usefulness of 
differential pulse polarography and adsorptive stripping 
voltammetry when applied to the determination of Pt after 
complexation with ethylenediammine. The technique was applied 
to the direct determination of Pt in urine samples, and the DPP 
technique was compared to a GFAAS method.
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5.2. EXPERIMENTAL
5.2.1. Materials
All chemicals were of analytical reagent grade. The 
platinum atomic adsorption standard (P-6401) containing 1 mg/ml 
of platinum (Pt) in dilute HC1 was obtained from Sigma Ltd. All 
solutions were prepared in water which had been obtained by 
passing distilled water through a Milli-Q water purification 
system. A buffer solution was prepared that was 0.5 M in boric 
acid and 0.59 M in ethylenediammine. This buffer was used in 
most of the voltammetric investigations. Human urine samples 
were donated by healthy volunteers.
5.2.2. Apparatus
Voltammetric investigations were carried out using a 
Princeton Applied Research (PAR) Model 264 polarographic 
analyser in conjunction with a PAR Model 303 SMDE electrode 
assembly and a Houston Omnigraphic Model 2000 x-y recorder.
An Instrumentation Laboratory (IL) Model 357 atomic 
absorption spectrometer was operated in conjunction with an IL 
Model 655 graphite furnace atomiser and pyrolytic graphite 
furnace cells for the GFAAS measurements.
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5.2.3. Methods
For voltammetric investigations, a 10 mg/1 stock 
solution of Pt was prepared by taking 0.1 ml of the atomic 
absorption standard solution and diluting to 10.0 ml with 0.15 M 
NaCl solution. From this solution, standards in the range 0.2 -
1 . 0  mg/ 1  were prepared bt the appropriate dilution with boric
acid-ethylenediammine solution. Prior to voltammetric 
investigations, the solutions to be analysed were placed in a 
boiling water bath for 2 0  min and allowed to cool to room 
temperature. The solutions were then de-gassed with oxygen-free 
nitrogen for 8  min prior to recording the appropriate
voltammograms.
For graphite furnace atomic absorption spectrometric 
(GFAAS) investigations, a 10 mg/1 stock solution was prepared by 
taking 0 . 1  ml of the atomic absorption standard solution and
diluting to 10.0 ml with dilute HN03 (1+499).
For polarographic determinations of Pt in urine 
samples, 1 . 0  ml samples were diluted to 6 . 0  ml boric acid/ 
ethylenediammine buffer and placed on a boiling water bath for
20 min. After cooling to room temperature, the pH of the
solutions were adjusted to 10.0 with 0.1 M NaOH, and the
solutions were made up to 1 0  ml with water prior to voltammetric 
investigations. For GFAAS determinations, 1.0 ml urine samples 
were diluted to 6.0 ml with the dilute HNO3 solution prior to 
direct injection of the sample solution into the furnace cell 
and running of the temperature programme.
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The test solutions were always deoxygenated by purging with 
nitrogen for 8  min.
In the GFAAS investigations, the following 
instrumental parameters were used in the determination of Pt in 
both aqueous and urine samplest
light source 
lamp current 
wavelength 
bandpass 
integration time
purge gas 
flow rate
sample size
hollow cathode lamp 
10 mA 
265.9 nm 
0.5 nm
8  s (Pt in aqueous samples) 
12 s (Pt in urine samples) 
argon
30/5 standard cubic 
feet/hour air 
25 /Al
Deuterium background correction was used throughout. 
The temperature programme employed with the furnace involved the 
following steps: drying for 5 s at 70°C, then for 45 s at 
110°C; ashing for 20 s at 750°C then for 20 s at 1000°C! 
atomisation for 10 s at 2500°C.
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5.3. Differential Pulse Polaroaraphy (DPP) of Pt(II)
5.3.1. Basis of Method
Differential pulse polarography using the catalytic 
wave of [Pt(en)2 ]2+ was proposed by Alexander et al. [19] 
for the assay of traces of platinum in metal ore samples. The 
catalytic process is believed to follow the mechanism shown 
belows
[Pt(en)2 ]2+ads + 2e~---- » [Pt(en) 2 ]ads
[Pt(en)2 ]ads + 2H+ ------> [Pt(en ) 2 ]2+ads + H2
9-1-The mechanism indicates that the complex [Pt(en ) 2 ] ads 
(which acts as the catalyst) is reduced to a lower oxidation 
state, which is highly reactive and reduces protons to hydrogen.
5.3.1.1. Effect of pH
In optimising the conditions for the DPP 
determination of Pt(II), based on the catalytic wave generated 
by Pt(II) complexed with ethylenediammine, the complexation 
reaction was investigated at pH values between 7.0 and 11.0. At
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pH 7.0, the DPP peak for the [Pt(en)2 ]2+ complex was 
relatively broad, and the peak current was lower than that 
observed at higher pH's. At pH 11.0, the DPP peak was masked to 
a large extent by the electrolyte decay. Between pH values of
8.0 and 10.0, the DPP waves were well defined, but a pH of 10.0 
gave rise to the largest peak current and the best resolution 
from the electrolyte decay (Figure 5.1.).
5.3.1.2. Effect of the presence of chloride ions
In the initial studies, when the Pt(II) standards 
were prepared in the boric acid/ethylenediammine buffer (i.e. in 
a solution not containing chloride ions), the resulting DPP 
peaks gave rise to irreproducible responses, due to the 
instability of the Pt(II) in this buffer. In order to improve 
this situation, and to better mimic the matrix of urine, the 
Pt(II) standards were made up in 0.15 M NaCl prior to carrying 
out the complexation reaction. This resulted in better 
reproducibility of response and improved somewhat the shape of 
the DPP peak of the [Pt(en)2 ]2+ complex. The presence of 
chloride ions also resulted in a slight shift in the peak 
potential to more positive values, -0.50 V for [Pt(en)2 ] 
complex when Pt standard was made up in 0.15M NaCl compared to a 
value of -0.57 V in distilled water (Figure 5.2.).
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Figure 5.1. Effect of pH on DPP behaviour of 
[PtCem^]2"1" complex
a) pH 8.0
b) pH 10.0
(concentration of Pt 1.0 /xg/ml)
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- E  V
Figure 5.2. Differential Pulse polarographic
behaviour of the [ Pt(en} 2 12+ complex
(1 . 0  f iq /m l in boric acid-ethy lene 
diammine buffer, pH 10.0
a) when Pt standard was made up in 
distilled water; and
b) when Pt standard was made up in 0.15 
H NaCl.
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5.3.1.3. Effect of temperature on formation of the
Oi
Pt(en> 2 complex
Previous work [23] has shown that formation of the 
[Pt(en)2 ]2+ complex reaches a maximum between 15 and 2 0  min. 
A reaction time of 20 min was therefore employed for all
investigations.
The temperature of the water bath where the
complexation occurred was also carefully monitored throughout 
the initial studies. It was found that a temperature of at least 
95^C was needed for sucessful complexation of Pt(II) and
ethylenediammine. Hence for all subsequent studies, a reaction 
temperature of 100°C was used.
5.3.1.4. Calibrat ion
Using the experimental conditions outlined above,a
linear calibration curve was obtained for current (I) versus 
concentration (C) of Pt(II) (in aqueous solutions) between 0.2
and 1.0 jug/ml. Linear regression analysis of the data yielded a 
straight line plot which followed the equation I = 2.29 C -8.51 
x 10- 3  (correlation coefficient 0.99) (Figure 5.3a.). The
standard solutions were re-analysed 24 hours later, resulting in
increased current signals for the various Pt concentrations.
Leaching of Pt or other metallic species from the glassware may 
provide interferents to the accurate analysis of Pt, hence it is
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Pt.ng ml
Figure 5.3. Calibration graphs obtained for a) DPP 
and b) GFAAS methods in aqueous solution 
and in urine.
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necessary that the Pt standards be prepared freshly everyday.
5.3.1.5. Direct determination of Pt(II) In urine
Having established the optimum conditions for the 
polarographic determination of Pt(II) following complexation
with ethylenediammine (in aqueous samples), it was decided to 
look at the possibility of using the complexation reaction to 
determine Pt(II) in urine samples. The procedure for the 
preparation and subsequent analysis of the urine samples has
already been outlined in Section 5.2.3. On increasing Pt(II) 
concentration, an increase in current was seen at -1.66 V
(Figure 5.4.). A calibration curve indicated that linearity was 
obtained over Pt(II) ranges of 0.2 - 1.0 /ig/ml, with linear
regression analysis of the data yielding a plot following the 
equation I = 0.727 C - 0.019 (correlation coefficient 0.996)
(Figure 5.3.a). The negative intercept and decrease in slope in 
comparison to the data obtained for the calibration plots of 
Pt(II) satandards in aqueous solutions, indicates that there is 
interference in the urine matrix that masks or binds to the
platinum, hence reducing the levels that can accurately be 
determined. Limits of detection for the direct determination of 
inorganic Pt(II) in urine following complexation with 
ethlyenediammine is 0.4 /ig/ml with a 31% recovery of the Pt 
complex.
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eFigure 5.4. DPP of Pt standards in urine
a) black urine b) 0 . 2 /¿g/ml Pt
c) 0.4 jug/ml Pt d) 0 . 6 f iq /m l Pt
e) 0.8 /¿g/ml Pt f) 1 . 0 /ig/ml Pt
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5.3.2. Graphite furnace atomic absorption spectroscopy
(GFAAS)
5.3.2.1. Optimisation of operational parameters
In GFAAS, care must be taken to select the proper 
conditions for the drying, ashing and atomisation stages. When 
dealing with trace metals in purely aqueous solutions, the 
ashing phase has no real significance. However, as in this case, 
when trace metals are to be determined in varying amounts of 
complex matrices (plasma, urine ,tissues, etc,), the ashing 
stage is perhaps the most important phase in the entire furnace 
programme. Thermal destruction of the matrix of a sample is very 
much sample dependent, but the ultimate aim is to remove the 
matrix completely, leaving behind the analyte in a form which 
results in maximum atomisation efficiency. However, it should 
also be noted, that the use of too high an ashing temperature or 
time can result in the loss of significant quantities of the 
analyte before the atomisation stage is reached.
A programme of sequential operations was optimised 
bearing the above points in mind. The programme outlined in 
Section 3.2.3. is similar to that reported by Pera and Harder
[7 ], but the ashing temperature in this programme was maintained 
at 1000°C, instead of 1500°C, in order to guard against loss 
of platinum before atomisation. 10 ul aliquots of Pt(II) 
standards prepared in diluent (see Section 5.2.3.) were analysed 
for Pt concentrations over the range 0.2 - 1.0 /ig/ml. Linear
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regression analysis of the data yielded a straight line 
plot which followed the equation A = 0.144C + 5.66 x 1CT3
(correlation coefficient 0.990) (Figure 5.3.b). Having found 
that this programme was successful in the analysis of Pt in 
aqueous solutions it was decided to try to reproduce this 
success for the direct determination of Pt in urine samples.
5.3.2.2. Direct GFAAS determination of Pt in urine
A calibration curve relating to the direct 
determination of platinum (II) in urine was found to be linear 
over comparable ranges studied in aqueous solutions. Linear 
regression analysis of the data yielded the following plot 
following the equation A = 0.081C - 3.866 x 10 J (correlation 
coefficient 0.999) (Figure 5.3.b.).
A negative intercept and decrease in slope compared 
to that noted for aqueous solutions highlights the problems 
involved in the direct determination of Pt in urine (i.e. 
without any extraction or preconcentration steps). The high 
ashing temperature of lOOO^C, and indeed the high atomisation 
temperature (2500°C), theoretically should have removed any 
endogenoeus urine interferents. Higher ashing temperatures were 
investigated (with the atomisation temperature kept constant), 
but these only resulted in a decrease of absorbance of the Pt 
standards. Hence, the optimum ashing temperature useful for the 
direct detection of Pt in urine was in fact the original 
temperature used.
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determined directly in urine down to 0.4 /ig/ml with a 44% 
recovery of the analyte.
Using this technique concentrations of platinum(II) were
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5.4. Adsorptive Stripping Voltammetry
Adsorptive stripping voltammetry has become 
increasingly popular in recent years for the determination of 
species which cannot be determined by anodic and cathodic 
stripping voltammetric techniques, but which can undergo 
accumulation at an electrode surface by adsorption [29,30]. 
Stripping techniques are not particularly suited to the 
determination of the platinum group metals [26], but, Wang et 
al. [25] have reported a method for the determination of 
cisplatin using AdSV. We therefore investigated the application 
of AdSV to the determination of inorganic platinum following its 
complexation with ethylenediammine, as reported in Section
5.3.1.
5.4.1. Initial investigations
A short study was initially undertaken to look at the 
feasibility of using AdSV to determine the [Ptien^] 
complex. When a supporting electrolyte of 0.1 M KC1 -0.01 M 
ethylenediammine (50:50) was investigated using an accumulation 
potential (Eacc) of -1.00 V, and accumulation times (tgcc) 
between 0 - 300 s, a very slight increase was noted in the 
current around -1.45 V. A large increase in current was found, 
however, for a peak at -1.72 V, which has characteristics of a 
catalytic wave due to hydrogen evolution (Figure 5.5.a). The
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E V
f.cc'S
Figure 5.5a. Effect of tacc on the adsorptive 
stripping voltammetric behaviour of the [PtCen^]24" complex 
(4 ng/ml) in 0.1 M KC1- 0.01 M ethylenediammine (50/50) 
solution, b) Plot of current vs tacc relating to a) . tacc:
(1) background); (2) 0; (3) 10; (4) 30;(5) 60; (6 ) 120; (7) 180;
(8 ) 240; and (9) 300 s.
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current due to this peak increased in a non-linear manner as 
shown in Figure 5.5.b, reaching a limiting value for tgcc 
around 300 s. Using a supporting electrolyte of 0.1 M KC1, 
increases were found in the current both at -1.56 V (peak A) and 
at -1.72 V (peak B) (Figure 5.6 .a). The current for peak A, 
increased linearly for tacc up to 120 s, whereas peak B (due 
to catalytic hydrogen evolution) shifted to more negative 
potentials, and its current increased non-linearly over the
range of accumulation times studied, until it eventually merged 
with the supporting electrolyte decay (Figure 5.6.b). The 
supporting electrolyte most suitable for analytical purposes was 
therefore found to be the 0.1 M KC1 - 0.01 M ethylenediammine 
(50:50) solution, as the potential of the catalytic wave due to 
the adsorbed Pt(II) complex was not affected by increasing
tacc in this system.
A further investigation was subsequently carried out 
a few months later, the objective being to look at the effect of 
Egcc» pulse amplitude, drop size and concentration of 
ethylenediammine on the determination of Pt(II). Two major peaks 
were noted during this study; peak A at - 1.38 V and peak B at - 
1.57 V (Figure 5.7.). The shift (of approximately 200 mV) in 
peak potentials of peaks A and B compared to those previously 
reported are likely to be due to replacement of reference frits
and fillings from one study to the next.
The behaviour of ethylenediammine was then monitored 
as a function of time (tacc) with a constant Eacc of - 0.95 
V. One sharp peak at - 1.38 V was observed. This peak increased
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E/V
s
Figure 5.6. a) Effect of tacc on the adsorptive
O I
stripping voltammetric behaviour of the [PtCen^] complex 
(4 ng/ml) in 0.1 M KC1. b) Plot of current vs tacc relating to 
a) tacc: (1) background; (2) 0; (3) 10? (4) 30; (5) 60; (6 ) 
120 and (7) 300 s.
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___________________________________________________ E ( v ) ____
Figure 5.7. Typical voltammetric behaviour of 
[Pt(en)2 ]2+ complex. tacc = 30 s;
Ea„„ = -0.95 V. Concentration of Pt =
0.2 jug/ml in 0.1 M KC1-0.01 M 
ethylenediammine (50:50).
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Figure 5.8. Dependence of peak current of 0.59 M 
ethylenediammine on tacc' ^acc “0-95 
V; scan rate 10 mV/s; pulse amplitude 10 
mV; drop area 0.025 mm2.
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in current linearly up to a time of 150 s, where, above this 
accumulation time, saturation of the electrode surface occurred, 
giving rise to the plateau region seen in Figure 5.8. No wave 
was observed in the potential region for the catalytic wave due 
to [Pt(en)2 ]2+. The peak at - 1.38 V is therefore due to the 
reduction of the complexing agent on its own. Hence, the 
adsorptive stripping voltammetric behaviour of [Pt(en)2 ]2+ 
gives rise to two peaks which do not greatly interfere in the 
measurement of one another. This would appear to be a slight 
improvement in selectivity over the method reported by van den 
Berg and Jacinto [28], who found that the formazone (which was 
used to complex Pt(II)) peak, interferes with the measurement of 
the platinum peak, which appears as a shoulder on the formazone 
peak.
5.4.2. Effect of accumulation potential and time
The effect of the accumulation potential on both peak 
currents was evaluated over the range - 0.70 -> 1.30 V (Figure 
5.9.). The adsorption potential affects the amount of complex 
which adsorbs, and at potentials between - 0.80 and - 0.95 V, 
the largest peaks were observed for [Pt(en)2 ]2+. A gradual 
decrease of the current for this peak was noted at potentials 
more positive than - 0.80 V and more negative than - 0.95 V. The 
peak current for the complexing agent, i.e. peak A, gradually 
increased from - 0.70 V to the optimum current response at -
1.10 V, where at potentials more negative than this, a rapid
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decrease in current response was noted. The optimal adsorption 
potential for analytical purposes for the detection of Pt(II) in 
its complexed form was chosen as - 0.95 V. This potential is 
required for trace platinum concentrations, whereas an 
adsorption potential of - 0.70 V suffices for higher platinum
concentrations (the peak height of ethylenediammine at this 
potential is reduced by almost 50%). The dependence of the 
adsorptive stripping peak currents of [Ptien^] on the 
accumulation time at three concentration levels is shown in
Figure 5.10. The longer the accumulation time, the more 
[Pt(en)22+] adsorbed, and the larger the peak current.
Solutions containing stock concentrations of 10,50,and, 100 
/ig/ml Pt were prepared, and 50 ul of each was added to the cell
to give a final concentration of Pt(II) in the cell of 0.05,
0.25, and 0.5 ¿¿g/ml. For concentrations of 0.5 and 0.25 jLtg/ml
Pt, the peaks increased linearly at first, and then the current 
response leveled off as the accumulation time was steadily 
increased. As expected from the adsorption processes, deviation 
from linearity was observed at shorter accumulation periods for 
solutions of higher Pt(II) concentrations. However, with a 
concentration of 0.05 /ig/ml Pt, adsorption peaks only developed
after an accumulation time of 60 s. These peaks were not fully
resolved from the complex peak compared to those obtained for 
Pt(II) at higher concentrations. Non-linear behaviour was also 
observed on increasing acumulation times above 60 s. This 
behaviour would suggest that a concentration of > 1 0  jUg/ml
Pt(II) is required before full complexation between metal and 
complexing agent is observed using the adsorptive stripping 
technique. -209-
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5.4.3. Effect of drop size, scan rate and pulse amplitude
The effect of drop size, scan rate and pulse
amplitude were also studied in order to find the optimum
conditions for the determination of Pt(II) following
complexation. A mercury drop of 0.025 nr resulted in the 
largest peak currents for both processes. This was expected as 
the greater the surface area of the electrode, the greater the 
amount of analyte adsorbed. A scan rate of 10 mV/sec and a pulse 
amplitude of 100 mV also resulted in better shaped and
reproducible voltammograms of [Pt(en)2 ]2+ and
ethy1 ened i amm i ne.
The adsorbed [Pt(en)2 ]2+ can be measured using
different voltammetric waveforms. Linear scan and differential 
pulse modes were compared, with the differential pulse mode
yielding better defined peaks following accumulation, compared 
to the linear scan mode. Therefore, the differential pulse mode
was used in all subsequent work.
5.4.4. Effect of ethvlenediammine concentration
The effect of concentration of the complex on the
O I
adsorptive stripping behaviour of [Pt(en)2 ] was studied 
over a concentration range of 1 - .001 M ethylenediamine (Figure
5.11.). At concentrations > 0.59 M, the peak at - 1.55 V
decreased in height and was also not fully resolved from the
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Figure 5.11. Effect of ethy1enediammine concentration
on the AdSV behaviour of [Pt(en)2 ]2+ 
complex (peak B) and ethylenediammine
(en) (peak A). Pt(II) concentration in
all cases was 0.25 ¿ig/ml; tacc 60 s.
(a) 1M en (b) 0.59 M en
(c) 0.1 M en (d) 0.01 M en
(e) 0.001 M en ( 1 = background)
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decay of the background electrolyte. As expected, peak A was not 
observed at these lower concentrations. A I M  ethylenediammine 
concentration reduced the peak currents for both peaks A and B, 
where a concentration of 0.59 M ethylenediammine resulted in
better resolution from the decay of the background electrolyte,
and also optimum peak currents for [Pt(en)2 ]2+, in 
particular. For further work, a concentration of 0.59 M 
ethylenediammine was therefore selected.
The effective preconcentration associated with the 
adsorption process results in low detection limits. Using an 
accumulation time of 60 s and adding increasing 5 jx\ aliquots of 
a stock solution of 25 /ig/ml Pt in a cell volume of 10 ml, a 
calibration curve yielded the following equation I = 17.94C - 
0.69 (correlation coefficient 0.987). The limit of detection 
corresponds to 12.5 ng/ml Pt in the cell (i.e 5 /xl of 25 /ig/ml 
Pt in 10 ml of electrolyte solution.
For higher detection limits, shorter preconcentration 
times suffice. The dependence of the peak current on the Pt 
concentration, using a preconcentration period of 30 s is shown 
in Figure 5.12. The response was linear up to 1.25 fxg/ml Pt 
(slope of the linear portion 21.796 /xA/ug/ml; correlation 
coefficient 0.99). The limit of detection using an accumulation 
time of 30 s and increasing the additions of 5 ¡i\ aliquots of 50
jug/ml Pt solution to 10 ml of electrolyte in the cell was 25
ng/ml.
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Figure 5.12. Dependence of tPt(en)2 ]2+ complex 
peak current on Pt(II) concentration 
using tacc of 30 s, scan rate 10 
mV/s, drop size 0.025 mm2.
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5.5. The application of AdSV for the determination of Pt
in its complexed form directly in urine
The adsorptive stripping voltammetric conditions that 
had previously been optimised for the determination of Pt 
(after complexation) in aqueous solutions, were then examined 
for the effective determination of Pt in urine samples. Urine 
samples were collected and centrifuged for 15 min, after which 
1 ml aliquots were spiked with appropriate volumes of the Pt 
standard, and then diluted to 10 ml with 0.59 M 
ethylenediammine, 0.5 M boric acid buffer solution. These 
solutions were then boiled for 2 0  min in a water bath, allowed 
to cool to room temperature and the pH adjusted to 10.0. A 
calibration curve for the determination of inorganic Pt in 
urine, folowing an accumulation period of 60 s is shown in 
Figure 5.13. The current response was found to be linearly 
related to concentration according to the equation I = 1.47C -
0.53 (correlation coefficient 0.98). Using this technique, the 
limit of detection was 0.75 /¿g/ml. Deviations from linearity 
occurred at concentrations of > 2.4 /ig/ml, where a third peak 
at -1.70 V was noted. On running similar urine samples that 
were Pt-free under the same experimental conditions, this third 
peak was provisionally identified as an endogenous component of 
urine, where, at high urine concentrations, this peak 
interferes with Pt measurements. This deviation from linearity 
at high concentrations of Pt and urine, plus the negative 
intercept on the x-axis (concentration axis) suggests that
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there are components in the urine matrix that compete with the 
[Pt(en)2 ]2+ complex for adsorption on the surface sites of 
the electrode. These components appear to displace Pt from the 
surface. Hence to improve the existing limits of detection, a 
longer and time consuming sample clean-up step is probably 
required to remove these inherent interfering components.
However, the results presented here, where no 
pretreatment of the urine is undertaken, allows the quick 
detection of Pt in urine to levels that would be expected 
during cisplatin therapy (see Chapter 1). Also the technique 
does not suffer from interferences from the complexing agent 
during the measurement of Pt and this is an improvement on the 
work presented by van den Berg and Jacinto [28]. It should be 
noted however that the limits of detection are not as good as 
van den Berg and Jacinto [28], due to the higher background 
currents observed at very negative potentials.
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Figure 5.13. Dependence of [Pt(en)2 ]2+ complex 
peak current on Pt(II) concentration in 
urine, using tacc of 60 s, scan rate 
10 mV/s, drop area 0.025 mm2 .
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